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Abstract
DNA has been shown to exist in a variety of different structural forms. X-ray crystallography
has revealed the existence of three distinct tertiary structures, namely A-, B-and Z-DNA. B-
DNA is well established as being the predominant form of DNA in the living cell. The biological
existence and functional relevance of both A- and Z-DNA is less clear. In addition to these
defined structures, DNA can also be induced to bend or kink by a myriad of factors, both
intrinsic and extrinsic to the DNA sequence. By default, biological cues must exist to prompt
transitions between these forms should they occur in vivo, the nature of which, whether
physiological, cell-cycle or developmentally based is unknown. It is known that CpG
methylation can promote transitions between the A-, B- and Z- DNA isoforms. DNA
methylation has also been shown to have effects on both secondary and tertiary DNA structure.
These alterations can affect the positioning of the primary DNA packaging proteins in vitro and
potentially, higher order chromatin structure. A variety of methyl-CpG binding proteins
(MeCPs) have now been identified. These in turn interact with a variety of chromatin associated
proteins capable of interpreting and reacting to the information provided at methylated CpG
sites leading to subsequent changes in gene expression.
Here, I have investigated the structural effects of CpG methylation by a novel method.
I have developed an assay that is able to detect CpG methylation induced conformational
changes in symmetrically methylated double-stranded DNA. The assay is based on the
enzymatic properties of Benzonase, a nuclease that preferentially digests A-form DNA in vitro.
In this study, a range of DNA gene fragments were used as Benzonase digestion substrates to
look for potential A-form regions in CpG methylated DNA. The results suggest that in certain
sequence contexts, CpG methylation promotes the formation of A-DNA. These regions of
potential A-form DNA are also coincident with sequence motifs that have crystallised as A-form
DNA.
In order to test the biological relevance of these results, the affinity of specially
designed methylated and unmethylated substrates for a variety of methyl-binding proteins
(MeCP2-MBD & xMBDl) was investigated. The results of these experiments are discussed in
the text.
From these results, I hypothesise that above the layer of information provided by the
DNA sequence, is another layer of coded information provided by DNA methylation. This
information is represented by 3-dimensional alterations at both secondary and tertiary
structural levels of the DNA helix. These alterations may be in turn, recognised by an array of
MeCPs, which in turn interact with proteins which can cause an array of modifications to the
nucleosomal histone tails. This tailored display on the histone tails constitutes another set of
coded information to influence higher order chromatin proteins, which will operate co-




1.1 The Significance ofCpGMethylation in the cell: An Overview
DNA contains the central core of genetic information of the cell (Avery, 1944). The
order of the four bases: adenine, cytosine, guanine and thymine dictates the
organisation of a gene (Watson & Crick, 1953). However, not all genes are required
to be actively expressed all the time. This would be immensely wasteful and
probably lethal. Sometimes, even the two alleles of a diploid cell are used
differently, an observation first made by the pioneering work of Barbara McClintock
while working on maize kernel colour in the 1950s (Mc Clintock, 1958; Fedoroff,
2002). Throughout development, there are dramatic changes in the pattern of gene
expression, which are stably inherited through cell division. As these patterns of
expression are reversible, they cannot be explained by DNA sequence variation
alone. Consequently, there must be a level of information apart from the primary
DNA sequence that specifies the selective use of genetic information during
development. The variation of gene expression that is not due to changes in the DNA
sequence, is the subject of epigenetics, a term introduced in the 1950s by Conrad
Waddington (Waddington, 1957). A modern definition of an epigenetic phenomenon
is "a mitotically and/or meiotically heritable change in gene function that cannot be
explained by changes in DNA sequence" (Wu & Morris, 2001). The mediators of
epigenetic phenomena include, (1) the methylation of DNA at cytosine residues, (2)
the acetylation and methylation of histone proteins, (3) the modification and
assembly of regulatory protein complexes on DNA and (4) at the post-transcriptional
level, a role for small non-coding RNAs These modifications are functionally linked
and reversible (reviews: Urnov & Wolffe, 2001; Nakao, 2001).
CpG methylation involves the addition of a 5'-methyl-group to the DNA base
cytosine. Figure 1.1 illustrates this process. The modification of CpG methylation is
usually associated with gene repression, a link that was first proposed by both Riggs,
(1975) and Holliday & Pugh, (1975). The methyl groups are transferred to DNA by
DNA methyltransferases (DNMTs) and associated proteins (review: Bestor, 2000;

















Figure 1.1 A, The conversion of cytosine to 5-methylcytosine. A methyl
group is transferred from SAM, S-adenosylmethione to the 5' carbon atom of
cytosine, by the action of DNA methyltransferases. B, The passage of the
replication fork and the establishment ofmethylation. After DNA replication
DNA strands are rendered hemi-methylated. The hemi-methylated strands are
recognised by specific methyltransferases that can use the methylated strand
as a template to reciprocally methylate the other strand, thus restoring complete
methylation post DNA replication.(Adapted from Lewin, Genes VII).
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enzymes, demethylases, but may also be removed by a passive mechanism of post-
replication 'phasing out' in the absence of DNMTs (review: Hsieh, 2000; Zhu et al.,
2000; review: Kress et al., 2001). CpG methylation can affect gene expression by
both direct occlusion of protein binding sites by the methyl-groups and indirect
occlusion by proteins binding to methyl-groups (review: Urnov & Wolffe, 2001).
Cells can utilise CpG methylation intrinsically to alter both genomic expression
levels and also to target extrinsic foreign DNA, such as bacteria, viruses, transposons
and or plasmid invaders (Bestor, 1990, 2000, Yu et al., 2001). Indeed, silencing of
transgenes and transfection vectors by CpG methylation is a common problem in
gene therapy (reviews: Pannell et al., 2001; Morel et al., 2000).
The histone proteins are central to the regulation of CpG methylation
processes. They are the proteins that wrap, fold and compact DNA into the cell. In
eukaryotes, a central core of eight histone proteins (two copies each of histones
H2A, H2B, H3 and H4) wrap 146 bp of DNA through electrostatic interactions in
1.65 left-handed superhelical turns to form the nucleosome particle (Kornberg, 1974,
1977). The linker DNA between nucleosome particles is occupied by histone HI.
The combination of nucleosome and histone HI forms the chromatosome, a basic
building block of chromatin (Simpson, 1978). DNA is successively folded through
increasing compaction to eventually form the metaphase chromosome. Figure 1.2
illustrates this process. It is on this template that transcription, translation and the
majority of genetic control mechanisms must operate. The histones have long basic
N- terminal tails that extend from the nucleosome core. These tails can contact DNA,
other histones and / or other proteins. They can also be modified at specific amino
acids to exert different effects on the regulation of gene expression (reviews:
Brownell et al., 1996; Csordas, 1990). The now classical association is that CpG
methylation and histone deacetylation are associated with gene inactivity and vice
versa, demethylation and histone acetylation are associated with gene activity (Nan
et al., 1998; Jones et al., 1998).
In addition, gene activity can be modified by post-transcriptional RNA-based
mechanisms. These mechanisms involve proteins and small RNA molecules that are
often coded for in the intergenic regions of DNA (Mattick, 2001). Non-coding RNAs






30 nm fibre (solenoid)
10 nm fibre (beads-on-a-string)
Figure 1.2 Higher order levels of chromatin compaction. Chromatin is
folded successively through the 10 and 30 nm fibres and eventually into looped
segments anchored on a protein scaffold. Further compaction of this
component produces the metaphase chromosome. (Image from Dr. S.
Venkataraman, PhD. thesis, 2001).
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other parts of the network. These affect transcription, splicing, RNA processing,
mRNA translation and chromatin. The RNA-directed regulation of chromatin is
homology driven, involving RNA-DNA, RNA-RNA and RNA-protein interactions,
in addition to secondary and tertiary structures (review: Matzke et al., 2001). There
is evidence to suggest that these RNA based mechanisms may interact with other
epigenetic modifications mentioned above at the level of DNA and chromatin,
leading to elaborate but elegant methods of gene control (Mette et al., 2000; Santoro
et al., 2001; Grishok et al., 2001). Figure 1.3 illustrates the potential complexity of
this organised network.
Several epigenetic phenomena in a diverse range of organisms appear to
violate Mendelian laws by using some or all of the above epigenetic modifications to
alter gene expression. In genomic imprinting, paternally and maternally derived
alleles of the same gene are expressed differently (review: Ferguson-Smith, 2001).
Another example is 'X-inactivation', a mechanism of dosage compensation to ensure
that only one X chromosome is active in the female mammal (review: Park &
Kuroda, 2001). Other epigenetic phenomena include 'position effect variegation'
(PEV), the silencing of a gene due to its chromatic environment/location on the
chromosome (Kellum & Schedl, 1991) and silencing of the mating-type loci in yeast
(review: Lustig, 1998).
CpG methylation also plays a distinctive role in a variety of normal and
abnormal developmental phenomena. Programmed DNA methylation changes have
been linked to early development. In mammals, dramatic remodelling ofmethylation
patterns has been reported for both sperm and oocytes prior to fertilisation (review:
Reik et al., 2001). Post-fertilisation, and in early development, methylation levels
change less dramatically, a key role of which may be to enhance the expression of
specific genes while repressing those that are not urgently required (Reviews: Reik
et al., 2001; Meehan & Stancheva, 2001). Evidence for selective expression of genes
in development comes from work by Stancheva & Meehan, (2000) who showed that
transient depletion of the maternal DNA methyltransferase in Xenopus (xDnmtl)
leads to premature gene activation of a number of genes. In terms of abnormal
development, the processes of apoptosis and cancer are both strongly affected by
CpG methylation (Stancheva et al., 2001; Jackson-Grusby, 2001). Hypermethylation
5
RdDM
(nucleus) ^ IR ► SC
Figure 1.3 A model for RNA mediated silencing in plants. RNA directed
DNA methylation (RdDM) and posttranscriptional gene silencing/RNA
interferance (PTGS/RNAi) are both triggered by double-stranded RNAs
(dsRNAs) that are cleaved by RNAse type III enzymes (eg., Dicer, CAF) into
small interfering RNAs (siRNAs), probably in both the nucleus (+ nuclear
localisation signal, NLS) and the cytoplasm (-NLS). In the cytoplasm the
siRNAs serve as guides for the endonucleolytic cleavage of homologous
mRNA degradation in association with the RNA induced silencing complex
(RISC). In the nucleus, short RNAs possibly guide methylation of homologous
DNA (thick arrow), although dsRNA may trigger RdDM directly. RNA triggering
of RdDM may either interact with the Chromomethylase chromodomain (CMT)
guiding it to the homologous DNA sequence, or, unwound dsRNA may base-
pair with homologous single-stranded DNA, producing an RNA-DNA duplex
and single-stranded DNA bulge, an unusual structure that might attract a de
novo DNAmethyltransferase (DNMT). DNA methylation is represented as filled
circles. dsRNAs can be made by transcribing through inverted repeats (IR), or
by the activity of cellular RNA-dependent RNA polymerase (cRdRP) acting on
'aberrant' RNA templates synthesised from single-copy (SC) genes in the
nucleus or generated in the cytoplasm by RISC cleavage of mRNA. Replicating
RNA viruses produce dsRNA by means of a viral RdRP (vRdR). Plant viral
suppressors of PTGS, block accumulation of siRNAa (HC-Pro) and systemic
silencing (p25). The exact nature of the systemic silencing signal is unknown,
but it involves either dsRNA or a special class of siRNAs (dotted lines).
(Reproduced and modified from Matzke eta!., 2001).
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of the usually unmethylated CpG islands associated with gene regulatory regions,
renders these genes inactive. This is a common feature in transformed cells. This
inactivation can affect virtually all of the pathways in the cellular network. For
example, DNA repair (hMLHl, BRCA1, MGMT), the cell cycle (pl6,NK4a pi4ARF,
p]51NK4b ), and apoptosis (DAPK, APAF-1), (review: Esteller & Herman, 2002).
Methylation also has an adverse effect on somatic cloning technology. A large
number of failed cloning attempts have been linked to aberrant methylation
reprogramming in the cloned embryos (Dean, 2001; Bourc'his et al, 2001).
The mechanism by which DNA methylation exerts these effects is complex.
CpG methylation can initially alter DNA structure at both secondary and tertiary
levels (Foloppe et at., 1999). These alterations may produce distinct structural
patterns that are recognised by a range of methyl-CpG binding proteins (MeCPs).
Indeed this has already been speculated on in the context of the rotational positioning
of MeCPs on methylated DNA (Wade & Wolffe, 2001), but not in terms of the
underlying methylated DNA structure, an aspect that is addressed in this thesis.
MeCPs are associated with larger chromatin modifying and remodelling complexes,
which help regulate the repression mechanism (review: Ballestar & Wolffe, 2001).
At different genes, at different time-points, and in different parts of cell, the exact
components of the methyl-binding machinery may alter. This would subsequently
alter higher order chromatin structure and affect the formation of inactive chromatin
domains (review: Wade, 2001).
Thus, a picture emerges where CpG methylation is involved in many cases as
a modification tool for a wide range of epigenetic phenomena. The role of CpG
methylation ranges from gene-specific repression mechanisms to genome-wide
transcriptional changes in early development. It can also influence a number of
cellular processes, a role that when misregulated, can have a catastrophic effect on
the cell, leading to apoptosis or worse, the development of transformed and
cancerous cells. CpG methylation is regulated by an ever-increasing number of
components, at the level ofDNA and RNA structure, in addition to a myriad ofDNA
and chromatin associated regulatory proteins. The result is a complex array of
weaving networks that we are only beginning to understand.
So why do we, the mammals possess this unique tool? One speculation is that
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the additional layer of control that methylation provides, is in effect our fifth
element. It is an evolutionary advantageous tool, adding plasticity to the genome and
promoting adaptability. It may have been a key factor in the radiation of the
mammals and the subsequent emergence of humans.
1.2 The Effects ofCpGMethylation on DNA Bending
In vertebrates, CpG methylation has been harnessed by the cell as a mechanism to
control gene expression. A great deal of information has now been gathered in terms
of (1) what effects methylation has on DNA structure and (2) what protein(s) and
related complexes mediate the effects of methylation of DNA, to regulate
transcriptional repression (reviews: Bestor, 2000; Bird, 2002).
In this section, I will describe a variety of different observations on DNA
structure. The picture that emerges is one of a very dynamic molecule, capable of
many structural alterations, some of which may depend on its methylation status. In
some cases, naturally occurring alterations in structure have been used to influence
gene expression or to allow protein recognition (Wu & Crothers, 1984). It is
important to recognise the fact that whether a gene is expressed or not, depends not
only on the order of the genetic code, but also (1) on the propensity of these
sequences to alter from the 'idealised' Watson-Crick B-form structure of DNA, (2)
how the DNA is packaged into nucleosomes and subsequently, higher-order
chromatin (3) where in the cell nucleus the gene is located and (4) the stage of
development. Of main concern here is the idea that methylation can alter DNA
structure. What these alterations are and what effects they may have on gene
expression and / or protein recognition are of direct relevance to this project.
With the publication of the structure of DNA by in 1953 (Watson & Crick,
1953), a blueprint for life was immediately recognisable from the periodicity of the
structure (a typical B-form molecule) and the organisation of the bases. The same
year Rosalind Franklin published her observations on DNA structure. Her original
crystal structures demonstrated an A-form of DNA, the significance of which is
investigated here (Frankin & Gosling, 1953). Ironically enough, many years later
Crick published the article 'Is DNA really a double helix?' (Crick et al., 1979),
fuelled by earlier speculations on the true nature of the structure of DNA (Crick,
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1970). An alteration of DNA secondary structure in three-dimensional space is
ultimately due to the non-uniformity of the four bases (A, T, C and G). Such
alterations range from small kinks or bends, to larger hairpin-loops and cruciform
structures. These structures can form in palindromic DNA and are known from
mainly bacterial studies, to influence gene expression (Yang et al., 1996).
A collection of studies have focused on methylation of DNA and subsequent
analysis of DNA structure, but these have focused on methylation of adenine, A or
guanine, G residues at various methylatable sites. These have been considered more
important to bacterial genetics, specifically Escherichia, coli, and the Restriction-
Modification (RM) system (review: Low et al., 2001). Recent evidence now
suggests that these modifications may independently influence gene expression in
eukaryotes (Lorincz et al., 2001). As we are primarily concerned with CpG
methylation and the biological consequences thereof, I am limiting the following to a
discussion of predominantly CpG methylation and its effects on DNA structure.
The first direct analyses on CpG methylated DNA structure, were
performed in the early 1980's, utilising Deoxyribonuclease I (DNasel) activity as a
probe for DNA structure. The activity of DNase I has been exploited in a number of
ways, predominantly for its use in the limited digestion of chromatin. DNase I
typically attacks unprotected DNA first, and is known to attack DNA in the minor
groove (Drew & Travers, 1984). An early study utilised DNasel digestion ofDNA to
investigate potential differences between methylated and unmethylated DNA
structure (Fox, 1986). The 5-position of cytosine lies in the major groove; therefore
changes in cleavage rates as detected by DNasel activity can be attributed to DNA
structural changes, rather than due to effects of the enzyme itself. The small
sequence GCGC was methylated at its central cytosines using Hhal methylase.
Altered cleavage of this sequence was observed when methylated, the effects being
small but consistent changes in local DNA structure. In all cases, 5meC enhanced
cleavage of the bond (GpC) on the 5' side of the methylcytosine probably due to the
fact that C5 methylation alters the precise orientation of the phosphodiester bonds
(Fox, 1986).
Evidence that methylation affects DNA curvature has also been supplied by
Diekmann (1987). Different palindromic sequences were ligated to form multimers.
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These were differentially methylated and their migration analysed in 10%
polyacrylamide gels. The migration differences of these oligos were interpreted in
terms of the extent of curvature of the helical axis. It was found that the double-
stranded oligomer dCGGAATTCCG is considerably curved and when methylated at
the central dAs or dCs, shows an even more pronounced curvature. Multimers of
dCGGGATCCCG are straight. Yet when the central dAs or dCs are methylated, a
small curvature is induced (Diekmann, 1987). This could be considered evidence
enough, at least in vitro, that methylation (whether at dAs or dCs) has a general
effect on the curvature of a piece ofDNA. However, three aspects should be borne in
mind with respect to many such observations. (1) The degree of curvature seen when
sequences are methylated is dependent on the degree of curvature seen in the
unmethylated oligonucleotide and thus directly on the sequence of the oligomer. (2)
The number of base pairs involved, whether they have the potential to form hairpin
or cruciform structures and what proportion of the helical axis is being represented
are pertinent questions that were beyond the scope of this analysis. (3) The above
study also demonstrated that multimers of the sequence d(CCATCGATGG), when
methylated at the central most dAs on both strands, has no effect on electrophoretic
mobility. This latter point, while demonstrating that changes in gel mobilities are not
due to an increase in molecular weight, nevertheless dissuades from an argument for
methylation induced curvature acting as a recognition element for DNA-protein
interactions.
To differentiate between the effects of N6-adenine and C5-cytosine
methylation on the kinetics of cruciform extrusion, and thus on helix stability,
Murchie et al., (1989) differentially methylated a selection of inverted repeats
containing central restriction sites by using bacterial methylases. The rate constants
for cruciform extrusion at 37°C were measured. Methylation was found to have a
pronounced affect on the rate of salt-dependent cruciform extrusion. To form
cruciform structures from normally base-paired and unmethylated templates, it is
necessary to have some initial opening of the helix. A mechanism of salt-dependent
(S-type) cruciform extrusion has been proposed (Murchie & Lillie, 1987). It would
be expected that helix stability, being dependent on base-sequence, would have a
large influence on the rates at which cruciform structures are formed. From this
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study it was found that A-methylation weakens the double helix, while C-
methylation results in stabilisation (Murchie et al, 1989). This is in accordance with
other studies of base methylation (Ehrlich et al., 1975; Collins & Myers, 1987;
Yamaki et al., 1988). All generally conclude that N6-methylation of adenine directly
affects base pairing by destabilising hydrogen bonding interactions with thymine.
Methylation at C residues is not at a position that would produce the same effect.
The strength of this study is that it confirms that methylation at A and C residues
have different structural effects, with C5 methylation capable of changing local helix
stability constants by about 10% in supercoiled substrates (Murchie et al., 1989).
The corollary of this being that demethylation ofmeCpG-rich regions could facilitate
local unwinding in vivo, and thus have a direct influence on gene expression.
Sequences of the form (dA)n.(dT)n (A-tracts), both natural and synthetically
derived, are known to exhibit pronounced degrees of stable curvature of the helix
axis. This is dependent on their being in phase with the helical repeat (Koo &
Crothers, 1987). Why exactly this should be so is unclear. Hagerman, (1990a)
investigated further what sequences potentiated DNA curvature (review, Hagerman
1990 b). The effects of the 5-methyl group on DNA curvature were examined in a
series of synthetic molecules in which the position of the 5-methyl group was varied
for both A- and I-tract sequence motifs. Pyrimidine 5-methyl groups were found to
have a significant effect on the degree of curvature. This was also dependent on their
locations within the homo-oligomeric sequences. These effects were observed for
both (dA)n.(dT/dU)n and (dI)n.(dC/d5meC)n sequence motifs. Some previous
experimental and computational studies had argued against a model of 5meC
induced bending (Koo & Crothers, 1987).
However, from this and other more recent work, it is now reasonable to
accept that methyl groups do significantly alter the degree of curvature in a position
dependent fashion. That is, in a follow up study to the above, Hodges-Garcia &
Hagerman (1992, 1995) investigated the effects of cytosine methylation specifically,
on the structure of duplex DNA. This work demonstrated that the effects of cytosine
methylation on A-tract DNA were mediated by the methyl group, and were not a
consequence of being inserted within an already stably curved A-tract.
Electrophoretic mobility analysis led to the observation that methylation of cytosine
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residues up to three base pairs away from a (dA)5.(dT)5 tract (A-tract), still altered
the net curvature of DNA. This depended on both the sequence of the non-A-tract
and the positions of the methylated residues. In addition, the decamer
CAAAAAGme5CCG is characterised by a bend much more pronounced than the
unmethylated decamer, but for the sequence CAAAAAme5CGCG, methylation only
slightly modifies the DNA curvature (Hodges-Garcia & Hagerman, 1992). Further to
this, NMR analysis has revealed that the magnitude of the effect of CpG methylation
i it
is dependent on the sequence context. H-NMR and P-NMR experiments have
been used to compare the octamers d(CATCGATG)2 and d(CTTCGAAG)2. CpG
methylation of the former led to a larger conformational variation than the latter
(Lefebvre etal., 1995a & 1995b).
In conclusion, these results add weight to the main hypothesis explored in
this thesis; that the biological consequences of methylation are mediated in part by
an altered DNA structure, as well as via protein-DNA interactions. A set of 'rules'-
analogous to the rules that govern nucleotide coding sequences and amino acid
production, may govern whether a CpG methylated site will have a positive or
negative regulatory role. This would be dependent on immediate sequence context,
position within a gene, regulatory region or elsewhere, and then on whether the
proteins required are available to bind. Indeed, the number of methylated sites
available, and thus the degree of curvature exhibited, may act as the combined
biological cue for protein binding and subsequent transcriptional effects.
In relation to such observations, what is lacking from the above studies is a
direct functional relevance ofmethylation-induced structural changes on alterations in
gene-expression in vivo. Sequence-specific methylation of eukaryotic RNA
polymerase II- and III- transcribed promoters can cause their inactivation. The precise
reason for this was investigated in terms of the structural effects that methylation
causes in such promoters (Muiznieks & Doerfler, 1994). Three DNA elements were
chosen. The late E2A promoter of adenovirus type 2 (Ad2) DNA, (Ad2E2AL), the
VAI (virus-associated) RNA gene of Ad2 DNA, and an Alu element associated with
the human angiogenin gene. These elements were specifically in vitro methylated
with either the Hpall, FnuDll or the CpG DNA methyltransferase (M-SssI) from
Spiroplasma species. The effects of methylation by these enzymes were analysed in
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terms of their electrophoretic mobilities. The E2AL promoter fragment was shown to
have a sequence-dependent bend consistently at a TACA sequence. In addition,
abnormal migration of sub-fragments of the E2AL promoter confirmed the location
ofmajorly bent DNA to be at the so-called TACA motif. Quantification of the curve
mathamatically, revealed that fluctuations of sub-fragments from the estimated value,
suggested an influence from other DNA 'motifs' on DNA curvature. Similar effects
of methylation on DNA curvature were seen with the other promoters analysed
(Muiznieks & Doerfler, 1994). In all cases, the extent of curvature seen was
dependent on the position of methylation in a given methylatable motif and the
position of that motif in terms of overall DNA topology. Critically, all of the
promoters demonstrated that a few 5-mC residues in 5'-CG-3' dinucleotides can elicit
reproducible changes in DNA topology.
In the case of the E2AL promoter, the critical sequence for bending lies 5'
adjacent to the TATA protein-binding motif. Both the TATA-binding protein and the
transcription factor TFIID bend DNA upon binding. The effect that changes in DNA
topology and bending could have on this interaction was investigated by methylation
of a single CpG site of the E2AL promoter in vitro, which was placed under the
control of a CAT reporter construct and transfected into HeLa cells. Methylation of a
single 5'-CCGG-3' site reduced CAT activity. Progressive methylation of all 5'-CG-
3' sites in the pAd2E2AL-CAT construct, completely abolished CAT expression
from this promoter, indicating a decisive role for methylation induced changes
influencing gene expression (Muizineiks & Doerfler, 1994). The question of how
methylation induced changes in DNA structure directly affect TATA-protein binding
at this promoter, were not addressed. However, several important conclusions have
resulted from this work;
(1) The available data suggests, that methylation of individual 5'-CG-3'
sequences, although capable of inducing minor kinks in DNA, cannot alone be
responsible for significant bending or curvature of DNA over long stretches, given
that many individual kinks may have opposing effects and cancel each other out. It is
possible that long stretches of CG-rich and methylated DNA may significantly alter
DNA structure such that gene expression is also significantly altered. However, it is
also supposed that methylation-induced alterations in DNA structure at single CpG
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sites may have a profound effect on gene expression should these positions hinder
protein binding such as at promoters, enhancers and related control regions.
Interestingly, this study also showed that 5'C methylation of either 5'-CG-3', 5'-
GCGC-3' or 5'-CCGG-3' sequences induces similar DNasel hypersensitive sites 5'
to the methylated C residue. In this vein, a prime example whereby small changes in
methylation status have a profound effect is that of methylation induced changes in
nucleosome positioning at the chicken adult (3-globin gene. Here, methylation at a
CpG triplet can shift a specific nucleosome from an otherwise strong positioning
site, implying that methylation-induced changes influencing chromatin structure
directly (Davey et al, 1997).
(2) Methylation induced curvature of 5'-CCGG-3' fragments is also more
striking when methylated sites are adjacent to each other and at the centre of the
molecule. Perhaps this is significant to a potential cumulative effect of many
adjacent methylated CpG dinucleotides.
(3) Although DNA bending effects are clearly seen with methylated 5'-CG-
3' sequences, these effects are not apparent when cytosine residues in the sequence
5'-CC(A/T)GG-3' are methylated. This could imply that bending is specific for
methylated 5'-CG-3' sequences, however from examples cited earlier and
subsequently, this cannot be considered as the only case, eg: methylation of adenine
in the sequence 5'-GATC-3' by the dam methyltransferase affects bending very
strongly (Muiznieks & Doerfler, 1994).
From the evidence above, it is more than reasonable to conclude that
methylated DNA has an altered DNA structure, which in the case of 5'meC is
dependent on a number of factors. These may include the sequence context of the
methylatable substrate, the length of the substrate involved and GC-richness, among
others. Given that we are primarily concerned with methylated d(CG)n sequences, a
number of these variables can be stabilised, the effects of which will be discussed
later. Structural changes in methylated DNA may be part of the initial mechanism by
which its many effects are executed. As mentioned previously, DNA has now been
crystallised in A-, B- and Z- forms. Methylation of 5'C residues has also been shown
to have a direct effect on whether such alternative forms exist. Thus, crystallography
of methylated sequences of varying length and sequence context has shown
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interesting results pertaining the general structure ofmethylated DNA.
1.3 DNA Conformation: A-, B- and Z-DNA
The elucidation of the structure of DNA by Watson and Crick (1953) heralded a new
era for the biosciences. It is this structure that is most familiar to us all as the right-
handed double helix of B-DNA (figure 1.4), the prevalence and biological
significance of which has been firmly established. However, other structures do exist
(table 1.1). The priorities here are the increasingly studied forms of A- and Z- form
DNA. A-DNA (figure 1.5), is also a right-handed helix, but differs from B-DNA in
how tightly its bases are stacked together. As a result, it has the appearance of an
overwound B-DNA molecule with a hole stretching along the helical axis. Z-DNA
adopts a highly unusual left-handed helical structure which differs considerably from
both B- and A- form DNA (figure 1.6).
DNA is in the B-conformation when the counterion is Na+ and the relative
humidity is 92%. It is regarded as the native form. The two plectonemically coiled
polynucleotide strands wind about a common axis with a right-handed twist, forming
a 20 A diameter double helix. The base pairs form the core of the helix about which
the sugar-phosphate chains are coiled. The ideal B-DNA helix has 10 bp per turn and
therefore a helical twist of 36° per bp. Since the bases have a van der Waals thickness
of 3.4 A and are partially stacked on each other, the helix has a pitch (rise per turn) of
34 A (Voet & Voet, 1990). What is critical in terms of protein recognition ofDNA is
the shape of the major and minor grooves. As seen from table 1.1, B-DNA maintains
a wide and deep major groove, the minor groove being narrow and deep. Many years
later, Wing et al., (1980) revealed that the self-complementary dodecamer
d(CGCGAATTCGCG) crystallises as B-DNA, but with slightly different parameters
to that of the Watson-Crick structure. This raised the point that individual residues
can contribute to the overall structure differently, in an independent fashion. B-DNA
could be considered the average output from any given randomly generated sequence.
When sequences are decidedly non-random in their sequence bias, such as in CG-rich
regions of DNA, the structure generated can differ considerably. As will be discussed
later, the effect of CpG methylation on these transitions may have a large effect on
protein recognition of DNA and subsequently gene expression. At a
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A B Z
Helical sense Right handed Right handed Left handed
Diameter -26 A -20 A - 18 A
Basepairs per 11 10 12 (6 dimers)
helical turn
Helical twist per 33° 36° 60° (per dimer)
base pair
34 A 45 AHelix pitch (rise per 28 A
turn)
2.6 A 3.4 A 3.7 AHelix rise per base
pair
Base tilt normal to 20° 6° 7°
the helix axis
Major groove Narrow and deep Wide and deep Flat
Minor groove Wide and shallow Narrow and deep Narrow and deep
Sugar pucker C(3')-endo C(2')-endo C(2 ')-endo for
pyrimidines; C(3')-
endo for purines
Glycosidic bond Anti Anti Anti for pyrimidines; syn
for purines
Table 1.1 Structural features of idealised A-, B- and Z-DNA tertiary
structures. Of note is that both A- and B-DNA forms are right-handed helices. Z-
DNA is left-handed. The major groove of A-DNA is narrow and deep as opposed
to the wide and deep major groove of B-DNA and the almost flat major groove of
Z-DNA (adapted from Voet & Voet, 1990).
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Figure1.4Thestr ctureofB- DNA.Therepeatingh lixisbas d ontheX-raystructurefelf- complementarydodecam r d(CGCGAATTCGCG)etermined byDickerson&r w(1970).The viewisperpendiculartohh l x axis.A,b llndstick representationofB-DNA.Inblue, thesugar-phosphatebackb nes, windingabouttheperipheryof molecule.Inr d,thbaseswhich occupythecore.B,space-filled modelofB-DNA.Thsugar- phosphatebackboniwhiteand grey,withthbas soccup ing centraloreofthem lecule.As helixaxispassesthrougheb pairs,thehelixssolidc re. (DrawingbyIrvinGeis,adapted fromV et& ,1990;and http://ndbserver.rutgers.edu/NDB/ NDBATLAS).
Figure1.5Thestr ctureof A-DNA.Therep atingh lix wasgeneratedbyDickerson basedonthself- complementaryoctam r d(GGTATACC)asviewed perpendiculartoheh l x axis.A,theb llndstick modelandB,thespace¬ filledmodel.Notthat basepairsrinclin dtoh helixaxisndthate hasollowcore.(Drawing byIrvingGeis,adaptedf om Voet& ,1990;and http://ndbserver.rutgers.edu /NDB/NATLAS/).
Figure1.6Thestr ctureofZ- DNA.Therepeatingh lixwas generatedbyDickersonase ontheX-raystructurefelf- complementaryhexamer d(CGCGCG)eterminedby WangandRich(1984).Theview
isperpendiculartoheh lix.A, theball-and-stickmodelndB, thespace-filledmodel.Notat thehelixisleft-handeda dt thesugarphosphatechains followazig-zagcoursewith alternateriboseresidu sli differentradii.(DrawingbyIrvi g Geis,adaptedfromV et& , 1990;computergra hicfr m http://ndbserver.rutgers.edu/ND B/NDBATLAS.).
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relative humidity of 75%, a transition from B-DNA to the wider, flatter A-DNA is
possible. A-DNA has 11 bp per turn and a pitch of 28 A, which provides A-DNA with
an axial hole. Because its bases are tilted 20 A with respect to the helical axis, A-
DNA possesses a deep major groove and a very shallow minor groove. Typically,
self-complementary oligomers of less than 10 bp can be crystallised in the A-
conformation (Voet & Voet, 1990). In a functional context, there is some evidence to
suggest that A-DNA is formed in the presence of small acid-soluble proteins called
(SASPs) in sporulating bacteria such as Bacillus subtilis. These proteins are activated
after the onset of sporulation and protect the spore from UV damage. SASP protein
binding to DNA changes DNA conformation from B to A-form, whose
stereochemical constraints inhibits thymine-dimer formation (Mohr et al., 1991).
More recent evidence suggests that A-DNA may have a broader functional role in
that CpG methylated DNA can assume an A-DNA conformation under physiological
conditions (Dickerson & Ng, 2001; Hodges-Garcia & Hagerman, 1995). This could
form the structural substrate for proteins known to recognise CpG methylated DNA
(this thesis).
Twenty-six years after the discovery of the Watson-Crick structure, Wang et
al., (1979) solved the crystal structure of d(CGCGCG) as being a left-handed double-
helix which they termed Z-DNA. d(CGCATGCG) also forms a similar structure
(Wang et al., 1979). Z-DNA maintains 12 Watson-Crick base pairs per turn and a
pitch of 45 A. As a result, Z-DNA has a deep minor groove and no obvious major
groove. The base-pairs are flipped 180° relative to B-DNA, and the repeating unit is
that of a dinucleotide pair following a zig-zag pattern, very unlike the other structures
(figure 1.6). Alternating purine-pyrimidine steps in high salt conditions, are the most
favoured for this conformation. Having established that this structure does exist, the
function of its existance has been more elusive. Various interpretations exist. Sera
obtained from patients with autoimmune diseases have been shown to produce
antibodies specific for Z-DNA (Lafer et al., 1983). In addition, both the puffed
regions associated with transcriptionally active polytene chromosomes in Drosophila
melanogaster (but not in the banded regions normally associated with
heterochromatin) (Lancillotti et al., 1987) and the transcriptionally active
macronucleus of ciliated protozoa (but not the transcriptionally dormant
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micronucleus), show reactivity to Z-DNA antibodies. Some evidence suggests that Z-
DNA forms behind a transcribing RNA polymerase, stabilised by negative supercoils
produced in transcription (review: Hill, 1991). A great deal more is known about Z-
than A-form DNA. For this reason and to highlight the functionality of different
conformations of DNA, this will be discussed below in addition to current
observations on the A-form structure. Of direct relevance to this thesis is the effect
that CpG methylation has on the A-, B- and Z-DNA. This will be discussed below.
1.4 The Effects ofCpG methylation on DNA Conformation
1.4.1 Z-DNA
The advent of X-ray crystallographic techniques in the early 1960's (Kendrew el al.,
1960) and the subsequent development of triester methods of DNA synthesis (Itakura,
et al., 1975) together led to the first direct analysis of highly purified crystals ofDNA
of predetermined sequence. These studies led to the discovery of left-handed Z-DNA
(Wang et al., 1979; Drew et al., 1980). A variety of sequences have now been
crystallised in the Z-conformation. These crystallographic forms are summarised in
table 1.2.
The B to Z transition is favoured by alternations of purines/pyrimidines.
Typically, dC/dG alternating sequences are a favoured substrate. Left handed Z-DNA
has been observed by X-ray crystallography and NMR for a variety of synthetic
d(CpG) oligos of varying sizes, in addition to poly(dG-dC).poly(dG-dC) and
poly(dA-dC).poly(dG-dT) (Wang et al., 1979; Drew et al., 1980; Crawford et
al., 1980; Arnott et al., 1980; Pohl et al., 1972). However although these studies
clearly demonstrated the existence of Z-DNA, problems do exist with their
comparison, given the conditions under which the crystals are prepared vary greatly.
The analysis of DNA structure by X-ray crystallography, NMR and other
methods, extended into looking at the effect of methylation on DNA conformation.
Behe and Felsenfeld (1981) compared various methylated and unmethylated
oligonucleotide substrates for their efficiency of the B->Z transition. The synthetic
oligonucleotide poly(dGm:,dC).poly(dGm?dC) was found to be capable of forming Z-
DNA, but at salt concentrations much closer to physiological conditions, unlike its
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Sequence Type of Reference
DNA
A. Pyrimidine start
CGCG Z Drew et al. (1980)
CGCGCG Z Wang et al. (1979)
CACGTG z Coll etal. (1988)
CGCGTG z Ho etal. (1985)
(CACGCG).(CGCGTG) z Sadasivan & Gauthan (1995)
(CGCACGMCGTGTG) z Sadasivan & Gauthan (1995)
CGCATGCG z Fugii et al. (1985)
CGCGCGCG z Fugii et al. (1985)
CGCICICG z Kumar et al. (1992)
CGTACGTACG z Brennan et al. (1986)
m5CGm5CGm5CG
Yoon etal. (1988)
z Fugii etal. (1982)
br5CGbr5CGbr5CG z Chevrier et al. (1986)
m5CGUAm5CG z Zhou & Ho (1990)
B. Purine start
GTGTACAC A Jain etal. (1987)
GTACGTAC A Takusagawa (1990)
ATGCGCAT A Clark etal. (1990)
GTACGTAC A Langlois et al. (1993)
GTGCGCAC A Bingman et al. (1992a)
GCGTACGTACGC A Bingman et al. (1992b)
Gm5CGCGC A Moores et al. (1995)
Gm5CGm5CGC A Moores et al. (1995)
GCACGCGTGC A Ban & Sundaralingam (1996)
GCGCGCGCGC Z Ban et al. (1996)
Gm5CGm5CGCGCGC A Tippin et al. (1997)
d(GGCGm5CG)2 A Vargason et al. (2000)
d(GGCGm5CC)2 E Vargason et al. (2000)
Table 1.2 Crystal structures of alternating oligonucleotide sequences. Highlighted in red,
m5C, is 5-methylcytosine; in blue, br5C, is 5-bromocytosine; in yellow, CGCATATATGCG,
containing three consecutive AT base-pairs, crystallises in a right-handed conformation and is
the only B-DNA sequence included in this list; in purple, GCGCGCGCGC, which contains four
consecutive CG base-pairs, is the only purine start sequence that crystallises in a left-handed
conformation. E-DNA is a stable intermediate in the transition of B-DNA to A-DNA (Adapted
from Tippin et al., 1997).
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unmethylated counterpart. In addition, experiments involving mixed copolymers of
dC and m5dC, indicated that the introduction of methyl groups has a direct effect in
lowering the transition point between B and Z-forms. With 30% of the cytosine
• 2"bresidues methylated, the B->Z transition occurs at a Mg concentration 1/35th of that
required for the completely unmethylated polymer (Behe & Felsenfeld, 1981). This
was confirmed in similar studies by Takeuchi et al., (1994) and additionally indicates
that a small number of methylated sites have the potential to exert long-range
structural changes on alternating CG dinucleotides.
Subsequent work by Fujii et al., (1982) demonstrated similar results in that the
synthetic oligo (m5dC-dG)3 formed Z-DNA by single crystal X-ray diffraction
analysis. The Z-structure is similar to that of the unmethylated form, with the methyl
group causing slight changes in the twist angle between successive base pairs (Fujii et
al., 1982). The above analyses were all carried out on isolated fragments of DNA.
Although alternating purine-pyrimidine (dC-dG)n sequences are generally considered
the ideal structure for Z-DNA formation, NMR analysis of the decamer
d(br5CGbr5CGATbr5CGbr5CG) and a similar dodecamer, have revealed this too is
capable of forming Z-DNA (Feigon, et al., 1985; Hua et al., 1989). Of note here is
that despite the presence of the central AT pair disrupting the sequence alternation,
this decamer is still capable of forming Z-DNA. This is apparently aided by the
bromination of cytosine, a modification very similar to C5 methylation.
Unfortunately, this is aided by high salt and methanol conditions, but perhaps if this is
also true for C5 methylation in vivo, these conditions are compensated for by a
stabilisation due to MeCP binding properties (Wade & Wolffe, 2001).
Klysik et al., (1983) used circular dichroism of both restriction fragments and
recombinant plasmids to observe the B->Z transition. Unlike the previous examples,
ionic strengths higher than physiological levels were required to form Z-DNA, when
the methylated Z-forming region is adjacent to typical non-Z forming regions in both
fragments and plasmids. Therefore, the effect of B-Z junctions is significant in the
promotion of Z-DNA via methylation in vitro, even though these levels were not as
high as those required to form Z-DNA from non-methylated templates. Z-DNA can
also be stabilised by negative supercoiling. In this regard, supercoiled plasmids
containing up to (dC-dG)29 methylated sequences were found to significantly reduce
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the number of negative supercoils required to stabilise the Z-conformation.
Concluded from this work was the prospect that constrainment of DNA supercoiling
within nucleosomes of eukaryotic DNA could result in the elimination of a trigger for
Z-DNA formation, a trigger that DNA methylation was subsidising (Klysik et al.,
1983).
The power of methylation to induce changes in DNA conformation in both a
structural and energetic sense was determined by Zacharias et al., (1988) using 2-D
gel electrophoresis. Plasmid constructs containing either dC-dG or m5dC-dG inserts
were compared in terms of their AG0 values (free energy for formation) of Z-DNA
based on various structural parameters relating to the B->Z transition. Quantitatively,
comparisons between energies required to form Z-DNA revealed that the methylated
insert significantly aided the transition to Z-DNA. Also qualitatively, a plasmid
construct containing two dC-dG blocks separated by 95bp of random sequence
underwent independent B->Z transitions whereas the same dC-dG blocks separated
by only four base-pairs (GATC), performed the transition to Z-DNA as one unit,
which included the 4 bp linker region (Zacharias et al., 1988). This indicates that the
extent ofmethylation and the distance between methylated sites are both important in
relation to the formation of new structures. Also, there may not need to be a
requirement for successive CpG sites to be methylated for an overall change in DNA
structure to occur, and hence the possibility exists that this may have some bearing in
terms ofmethylation-mediated repression of gene expression.
More recently, Zacharias et al (1990) have investigated the effect of cytosine
methylation on Z-DNA formation in vivo. DNA supercoiling has been found to
significantly stabilise Z-DNA. Importantly this work looked at supercoil-stabilised E.
coli DNA as plasmid inserts. Cytosine methylation was found to directly enhance Z-
DNA formation of dC-dG segments of varying length. The B->Z transition was
promoted by utilising Hhal methyltransferase (M.HhaY) and for all lengths of inserts
methylation enhanced the transition at the superhelical density present in E. coli.
Overall, this work further indicates that methylation influencing the B->Z transition
could constitute a mechanism for the modulation of DNA-protein interactions and
gene expression.
Although it is now firmly established that methylation significantly promotes
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the transition to Z-DNA, the purpose of this and indeed the general significance of Z-
DNA in its own right are questionable. The initial focus of Z-DNA analysis was in
terms of the purine/pyrimidine alternations that promote this structure. In the absence
of methylation and supercoiling effects, Z-DNA can also be stabilised by polyamines
such as spermine, and specific Z-binding proteins (review; Herbert & Rich, 1996).
Efforts to uncover the potential biological role of Z-DNA have focused on
uncovering potential Z-DNA binding proteins. The quest for Z-DNA binding proteins
has thrown forth a variety of puzzling candidates. The first studies isolated proteins
from SV40 DNA that bound to negatively supercoiled, Z-DNA containing sequences
(Azorin & Rich, 1985). Since then, other examples come from the isolation of a
Drosophila Z-DNA binding Topoisomerase II homolog (Glikin et ah, 1991; Arndt-
Jovin et al., 1993), Z-DNA-binding proteins from bull testis (Gut et al., 1987) and an
example of the bovine ocular lens zeta-crystallin protein (Gagna et at., 1998). Apart
from these disparate examples, the main focus in recent years has been on the
polyamine group of proteins and ADAR1, a protein first isolated for its role in RNA
editing.
Research into the polyamine group of proteins (putrescine, spermidine and
spermine) has combined protein-binding studies with Z-DNA detection antibodies.
These experiments have shown that these natural polyamines can bind to sequences
of the type (dG-dC)n, (Thomas et al., 1991), d(CGs), (Ohishi et al., 1991, 1996) and
poly(dG-m5dC).poly(dG-m5dC), (Thomas et al., 1988a & 1988b). The main feature
of polyamine binding to any of the above sequences is that they seem to be capable of
provoking the Z-conformation as opposed to stabilising an already Z-form DNA.
ADAR1 or DRADA1 (double-stranded RNA adenosine deaminase) is an
enzyme first discovered for its role in pre-mRNA editing. It has the ability to
deaminate adenosine to inosine, which is then read as guanosine. Editing of pre-
mRNA thus allows variant proteins to be produced from the same DNA coding
sequence. ADAR1 isolated from chicken lungs has now also been shown to bind
specifically to Z-DNA (Herbert et al., 1995a & 1995b). Within the protein two Z-
DNA binding motifs have been isolated, Z-alpha and Z-beta (Herbert et al., 1997 &
Berger et al., 1998), which interact to form a functional DNA binding site. Not only
do these domains seem to recognise potential Z-forming sequences, but also seem to
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be capable of then flipping them into the Z-conformation. This is even the case for the
sequence d(TA)3. A model has been proposed to explain these seemingly disparate
roles of the same protein; Z-DNA binding motifs may target ADAR1 to regions of
negative supercoiling (which stabilises Z-DNA). Supercoiling accompanies the trail
of an actively transcribing RNA polymerase, and in this sense, RNA editing enzymes
could thus be targeted to freshly transcribed regions, where they could take effect
before other mechanisms such as RNA splicing and subsequent translation, can take
effect (Herbert et al., 1998).
Structural characterisation of the Z-alpha domain has revealed a winged helix-
turn-helix motif, placing it in the class of proteins that contains histone H5 (Herbert &
Rich, 1999; Schade et al., 1999a & 1999b; Schwartz et al., 1999a & 1999b). This
domain has recently been characterised not only as a Z-DNA binding molecule, but
also as a double-stranded Z-RNA binding molecule. Interestingly, Z-alpha has been
shown by spectroscopic analysis, to induce a slow transition from the right handed A-
conformation to the Z-conformation in the duplex r(CG)6- A speculative role for the
Z-alpha domain in targeting RNA viruses is discussed (Brown et al., 2000). Problems
exist however, in proposing a viable in vivo model(s) for the role of Z-DNA in light
of various artefacts associated with the analysis of Z-DNA. For example, some
antibody binding studies, (such as those that detected Z-DNA in the polytene
chromosomes of Drosophila), have used acetic acid as a fixative (Hill & Stollar,
1983) which removes histones from DNA resulting in a reservoir of free energy that
could be used for the promotion of Z-DNA regions (review; Hill, 1991). This was re-
addressed in experiments that varied the acetic acid concentration and additionally
used frozen sections prepared in ethanol with no acetic acid present. These results still
indicated that Z-DNA formation correlates with the transcription puffs seen in
polytene chromosomes but not in the resting state. However, by the author's own
admission, these results did show some variance due to the conditions used
(Lancillotti et al., 1985 & 1987). Pardue et al., (1983) used immunofluorescence to
show effectively the same phenomenon- that Z-DNA correlates with transcriptionally
active regions of DNA (Pardue, et al., 1983). In a different type of assay, biotin-
labeled anti-Z monoclonal antibodies were incubated with permeablised mammalian
cell nuclei. The antibodies can diffuse within the nucleus over a small concentration
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range. Radiolabeled streptavidin detects the bound antibody indicating that Z-DNA
is associated with transcriptional activity, but to a lesser extent with replication.
Topoisomerase I also dissolves the transcription-Z-DNA correlation (Wittig et at,
1991). Using the same technique, Wittig et al looked at transcription of the human c-
myc gene, using a laser to crosslink the antibodies to DNA. Subsequent restriction
analysis revealed that the majority of Z-forming regions were centred on the
promoter. Intriguingly, once the cells start to differentiate and c-myc transcription is
down-regulated, the Z-DNA level goes to undetectable levels within 30-60 minutes
(Wittig et al., 1992).
Additionally, some proteins are known to cause DNA bending (eg: CAP) and
thus the problem exists as to whether the structure being observed is a cause of the
sequence context directly, or a consequence of non-specific protein-induced bending
(El Hassan & Calladine, 1998). Another example is that of HMG1 and 2 proteins,
found to bind brominated synthetic Z-form oligos of the type poly(dG-dC).poly(dG-
dC), yet not capable of binding Z-DNA in supercoiled plasmids (Christen et al., 1990;
Rohner et al., 1990). It has not yet been demonstrated whether the C5 -methylated
version of the above sequence shows the same affinity with the HMG1 and 2
proteins. The ability of histones HI and H5 to bind alternative sequences has also
been questioned. With a set of tester oligomers it was found that H1/H5 bound Z-
form DNA more readily than B-form, with H5 binding much stronger to the Z-
sequence than HI (Mura & Stollar, 1984). While observations such as these may
reflect the ability of the lysine rich histones to enable various conformational
changes, and thus have an effect on chromatin condensation in regions of sequence
bias, the authors have not pursued this aspect.
Other evidence relating to chromatin structure relates to the ability of Z-DNA
to be incorporated into nucleosomes (Miller et al., 1985). This may be important in
terms of gene regulation. Supercoil stabilised Z-form DNA consisting of a
d(CG/GC)i2 plasmid insert was found to be completely refractory to nucleosome
assembly. This is in stark contrast to the B-form of the same sequence, which readily
allows nucleosome assembly (Casasnovas & Azorin, 1987). Similarly, reconstitution
of nucleosomes onto a relaxed and supercoiled (G-C) rich template, shows that
supercoiled (Z) DNA is not incorporated well. Micrococcal nuclease digests of
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radiolabeled templates revealed that Z-form G-C sequences will sit outside the
nucleosome core particles, whereas B-form G-C sequences are readily incorporated at
the centre (Garner & Felsenfeld, 1987).
And finally, some phospholipid binding proteins that also bind Z-DNA were
found only to do so because of a structural similarity to a phospholipid binding
region (review: Herbert & Rich, 1996). Others, have used chemicals such as
[Co(NH3)63+] to induce Z-DNA at unrealistic concentrations and concluded a
physiological relevance (Ma et al., 1995). It seems the only consistent correlation
however, is that a transcribing polymerase causing an increase in superhelical
density behind itself, which may help stabilise Z-DNA, however transiently (Liu &
Wang, 1987). In this respect, the only real function of Z-DNA could be to provide
breathing space for a transcribing polymerase and to deflect nearby polymerases
from approaching too soon. It is certainly true that Z-DNA is highly immunogenic,
due to the high degree of exposure of the bases in this structure) as shown by many
examples of a broad range of non-specific protein binding (review: van Holde &
Zlatanova, 1994) and in effect such a barrage of temporary non-specific (or if proven
otherwise, specific) protein binding could be simply to prevent re-transcription of
such a region. Finally, in terms of me5C, stabilisation of Z-DNA by methylation
seems to override effects due to supercoiling (Casasnovas et al., 1987, 1989), the
function of which can be widely speculated on - in terms of transcription, replication
and repair mechanisms; the reality being an immense lack of hard evidence.
1.4.2 A-DNA
It is more than reasonable to imagine a situation where the three
conformations of DNA exist in a dynamic equilibrium with each other, yet can be
stabilised in one form or another dependent on the situation. For example, we have
seen that the B to Z- transition can be promoted and stabilised by DNA supercoiling,
methylation, bromination and / or protein binding. Similar stabilising forces may
also come into play for the transition to A-form DNA.
Sequences that are CG rich DNA are quite versatile and there does not need to
be alternation of sequence for A-DNA to form. The dodecamer
d(CCCCCGCGGGGG), has been crystallised as the first example of a complete turn
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of A-DNA (Verdaguer et al., 1991). Additional A-DNA studies have included
analysis of sequences under unusual conditions. For example, Vorlickova et al.,
(1991), demonstrated that the sequence poly(dl-dC) is capable of forming Z-DNA in
concentrated (NaCl + NiCF) solution, yet can form A-DNA in trifluoroethanol
solution. Additionally, some early studies, using transient electric dichroism,
demonstrated that by varying alcohol/water concentrations for a poly[d(G-C)]
fragment, it could be induced to form either A- or Z- DNA. The degree of hydration
of both major and minor grooves was found to differ between both B- and A-forms,
A-DNA being more heavily hydrated; the suggestion being that this may have some
bearing on whatever role A-DNA may have in vivo (Crothers et al., 1990). Single
crystal structure analysis of oligonucleotide sequences provides more information
regarding local variations in helix structure for a given sequence than can X-ray
diffraction. In this respect, a tetramer d(iodo-CCGG) has been crystallised as a double
stranded A-DNA helix (Conner et al., 1982).The problem with some of these
structural analyses is that the formation of A- or Z-DNA is not strictly confined to the
base stacking preferences of a particular sequence. It also depends in some cases, on
extrinsic factors/experimental conditions, which have altered the behaviour of the
molecules. For example the use of extremely high salt and trifluoroethanol in some
studies have played a large role in the production of not only A-DNA analysis but Z-
DNA analysis also.
Methylation has also been found to influence the transition to A-form as it has
for the B->Z transition. Mooers et al., (1995) have solved the single-crystal X-ray
structures of two different hexanucleotides: the alternating d(Gm5CGm5CGC)
sequence and the non-altemating d(Gm5CCGGC) sequence, which both form A-
DNA. Methylation of these sequences was found to confer stability to A-DNA,
which in other cases has been provided by high salt or alcohol conditions. Therefore,
CpG methylation may provide the physiological lever between the different
conformational isomers in some sequence contexts.
Tippin et al., (1997a) has found that the sequence d(CCGGGCCCGG) could
be crystallised as A-DNA. When methylated or brominated at different cytosine
residues, it also forms A-DNA, but with different influences on DNA bending, the
structures fall into different orthorhombic groups. In addition to methylation,
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spermine binding also promotes the A-conformation. Given that methylation and
polyamines are so central to influencing gene expression, it seems reasonable to
suppose that A-DNA may have a role in vivo in such processes.
Interestingly, Tippin et al (1997b), in an accompanying paper, have
reconfirmed the promotion / stabilisation that methylation confers on A-DNA. They
demonstrate that the alternating decamer d(GCGCGCGCGC) is expected to form, and
is crystallised as Z-DNA. When this sequence is methylated to form
d(Gm5CGm:'CGCGCGC), this structure no longer crystallises as Z- but as A-form
DNA. This is the first example of a sequence that when methylated forms A-DNA
from the Z-conformation. From this study it was determined that 10 bp is the critical
length upon which the handedness of d(CG)n type sequences is determined in the
crystalline state (Tippin et al, 1997b). This occurs only after double methylation of the
sequence - a feature consistant with the results of Mooers et al., (1995), who found
that the sequence d(GCGCGC) required methylation of at least one of the cytosines
for it to be crystallised as A-DNA. This provides a situation in which the same
sequence can be resolved into all B-, A-, and Z-forms. It had been observed that the
hydration patterns of B- and A- DNA are very different. Mayer-Jung et al., (1998)
have focused on this issue by analysing the hydration patterns around methylated CpG
steps in three high-resolution crystal structures of A-DNA decamers. In certain
structural and sequence contexts, the methylated cytosine base is more hydrated than
the unmodified form. The water molecules are coordinated to the methyl group
through the formation of C-H'"0 bonds. The A-DNA structure also has magnesium
cations bound to its major groove in a manner distinct from that of the unmethylated
form. The suggestion is that methylated cytosine residues could be recognised by
protein or DNA polar residues via their tightly bound water molecules (Mayer-Jung et
al., 1998).
Further to the above, a recent review article has speculated similarly; that bent /
curved DNA that mimics a negative supercoil (Z-DNA) or a right-handed superhelical
writhe (A-DNA) can help organise local chromatin infrastructure by directing some of




1.5 MeCP binding proteins and DNA Recognition: A role for DNA
Structure?
The significance of unusual forms of DNA to the methylation process is unknown.
However, information is rapidly gathering about the protein complexes that attach to
methylated DNA sites. The process by which methylated DNA is rendered
transcriptionally inert is via the binding ofmethylation specific binding proteins such
as MeCPl and MeCP2 (review: Meehan et al., 1993). MeCPl can recognise and
bind strongly to fifteen or more symmetrically methylated CpG dinucleotides
(Meehan et al., 1989) whereas MeCP2 recognises a single methyl CpG pair (Lewis et
al., 1992). Recent evidence provided by two independent groups, has shown that
MeCP2 interacts strongly with a corepression complex containing mSin3A, a
transcriptional repressor, and histone deacetylases HDAC1 and HDAC2 (Nan et al.,
1998, Jones et al., 1998). Thus, it is via the convergence of two global mechanisms
of gene regulation, methylation and histone deacetylation, that a repressive
chromatin structure mediated by MeCP2, is established. MeCP2 has been found to
contain an 85 amino acid long methyl-binding domain (MBD), which is responsible
for binding of one or more symmetrically methylated CpGs. It also contains two
short motifs that are also found in proteins that bind to the minor groove of AT-rich
DNA. This is a non-specific DNA binding activity as the methyl group of cytosine is
known to lie in the major groove of DNA, and competition experiments reveal that
this activity is not required for methyl-specific binding (Nan et al., 1993). It is not
clear from these studies whether MeCPs can recognise and bind to A-form DNA. If
methylation promotes the formation ofA-DNA in vivo as it does in vitro, then it may
be some feature specific to the nature of A-DNA that methyl-binding proteins such
as MeCP2 can recognise and bind to. In support of this hypothesis, the affinity of
MeCPl for methylated DNA was challenged with different competitor DNA and
RNA sequences: dsRNA (poly I.polyC), dsDNA poly (dl.dC) and poly d(I-C).d(I-C).
Neither single (not shown) nor double stranded RNA competed with methylated
DNA for MeCPl complex binding, whereas both of the other two competitors could
successfully compete for MeCPl binding (figure 1.7; R. Meehan, unpublished). The
poly (dl.dC) sequence has been shown by circular dichroism spectroscopy to form A-
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Figure 1.7 A-form DNA successfully competes with methylated DNA for MeCP1 binding.
Competition experiment for rodent liver MeCP1 activity. MeCP1 activity can be effectively
competed by poly (dl.dC) or poly d(l-C).d(l-C) but not by poly (I.C) competitors. The range of
competitor used was: 0.2-2 pg. Mouse DNA competitor is shown for the purposes of
comparison. (Unpublished data supplied by Dr. R. Meehan).
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DNA (Vorlickova & Sagi, 1991). This has been confirmed by Raman spectroscopy
(Fabriciova et al., 1998). Further to this, it has also been shown that poly-(dl-dC) can
be stabilised in the A-form on binding to berberine chloride at more physiological
conditions than the studies mentioned above (Kumar et al., 1992). It is possible that
MeCPl binding also has the same effect.
This experiment (figure 1.7) demonstrates that at least MeCPl may require as
a substrate, A-DNA or some feature of it. For example, recent evidence supports
water molecule coordination to methylated cytosines in A-DNA (Mayer-Jung et al.,
1998), a feature that may aid in their recognition by MeCPs. Other methyl binding
proteins could possibly also recognise A-form structures. This may be a universal
feature of CpG methylated DNA. On the otherhand, this could provide a potential
mechanism whereby other MeCPs are deflected from MeCPl binding sites. It is
possible that differences in CpG methylation densities can promote alternative DNA
structures. It may be these methylation-induced changes in structure that help
determine where and when different methyl-binding proteins bind to different
methylation sites. The possible formation of A-DNA at methylated CpGs is
investigated in this thesis.
1.6Methyl-CpG Binding Proteins: the family.
Over the last ten years, a growing family of methyl-binding proteins has emerged
from initially biochemical and subsequently database analysis. MeCP2 (Methyl-CpG
binding protein 2) is the family prototype (Meehan et al., 1989). Subsequently
followed MBD1, MBD2, MBD3 and MBD4 (Hendrich et al., 2001). These are all
vertebrate methyl-binding proteins. They vary significantly in 3' end structure, but
they commonly possess a methyl-CpG binding domain (MBD), see figure 1.8 A and
1.8 B.
Based on the hypothesis that methylated DNA may exert its effects via
chromatin-associated proteins, the large multisubunit MeCPl complex was identified.
MeCPl was isolated from band-shift assays using nuclear extracts as having specific
binding to CpG methylated DNA. At least 12 symmetrically methylated CpG pairs are
required for MeCPl complex binding (Meehan et al., 1989). The chromatin
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Figure 1.8 A, The methyl binding proteins. This figure depicts the organisation of the
mammalian MBD containing protein family members in addition to Kaiso (not drawn to
scale). The various members of the MBD family involved in transcriptional repression
are depicted (adapted from Wade & Wolffe, 2001). Kaiso is a DNA methylation-
dependant transcriptional repressor with links to the cell surface via p120 catenin
(Prokhortchouk et al., 2001). MBD, methyl-binding domain. TRD, transcriptional
repression domain. CxxC, repeated motifs that can be alternatively spliced in the
cDNA. E repeats, glycine repeats. Zn, zinc fingers indicate DNA binding domains. DNA
A/-Glycosylase, a domain responsible for demethylation activity. POZ/BTB, a Kriippel-
like DNA binding domain. B, Sequence alignment of the MBD from the methyl
binding proteins. Positions of p-strands (arrows), loops (thick lines), and the a-helix
(rectangle) defined by the solution structures of MeCP2 and MBD1, are indicated
above the alignment. MeCP2 numbering is located above the sequence. General
numbering is located below the MBDs. Conserved residues are shaded, with those
essential for meCpG binding indicated by an asterisk. Four Rett syndrome mutants
occuring in the MBD are indicated by grey circles.
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complex, MeCP2 was found to be a single protein of « 55 kDa, with the ability to
monomerically bind to a single symmetrically methylated CpG site (Lewis et at.,
1992; Meehan et al.t 1992; Nan et al., 1993). The amino-terminal region contains a
methyl-CpG binding domain (MBD), identified by deletion analysis. The C-terminal
contains a transcriptional repression domain (TRD) required for transcriptional
repression both in vitro and in vivo, in addition to several short motifs that bind to the
minor groove of AT-rich sequences (Nan et al., 1997, Jones et al., 1998). These
sequences are thought to contribute to a general non-specific binding of MeCP2 to
DNA (Nan et al., 1993). MeCP2 causes repression in a chromatin context. Both the
MeCP2 protein and the isolated MBD bind to nucleosomes associated with
methylated DNA (Nan et al., 1993; Chandler et al., 1999). Repression is also time-
dependent (Kass et al., 1997) requiring chromatin assembly before complete
repression can be achieved. Subsequent analysis found that the TRD domain of
MeCP2 can stably associate with the transcriptional co-repressor Sin3A and histone
deacetylases HDAC1 and HDAC2. Moreover, in both mammalian cells and Xenopus
oocytes, histone deacetylase inhibitors can partially relieve the repression exerted by
the MeCP2-TRD at methylated gene promoters (Nan et al., 1998; Jones et al., 1998).
More recently, it has been found that MeCP2 also interacts with two co-repressors, c-
Ski and N-CoR, in addition to mSin3A. Antibodies directed against c-Ski and Sno
(ski-related novel gene) shows colocalisation with MeCP2 and also abolishes Gal4-
MeCP2 mediated transcriptional repression (Kokura et al., 2001). The regulatory
implications of these interactions are discussed later.
The solution structure of the MBD of rat MeCP2 (Wakefield et al., 1999) and
the solution structure ofMBD1 (Ohki et al., 2001) have now been determined. Figure
1.9 illustrates the structure of the MBD domain from both proteins. The fold of the
MBD of both proteins is very similar. The strands (32 and (33 and the flexible loop
show a high degree of similarity. The MBD is essentially a wedge shaped structure,
one face of which has a series of hydrophobic basic residues that interact with DNA.
For MeCP2, three of these solvent exposed residues (Tyrosine 123, Isoleucine 125
and Alanine 131) are likely to interact with the methyl groups in the major groove of
DNA (Wakefield et al., 1999). Mutation of any of these residues reduces the binding
efficiency of MeCP2 (Free et al., 2001). In MBD1, only one of these positions
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Figure 1.9 A The structure of the MBD domain from MeCP2. The MBD protein sequence is
shown in / above. The MBD, as shown in ii above is wedge shaped, with one face comprising a
p-sheet, the other consisting of an a-helixand hairpin loop. The vertex of the wedge is extended
by a long loop between two of the p-strands and contains several basic residues vital for binding
DNA. Binding DNA changes the resonance of several residues in this loop, in p-strands 2-4 and
in the a-helix. These residues define the surface of a wedge that is likely to interact with DNA.
Structural flexibility of the loop is of vital importance in this interaction. Three solvent exposed
hydrophobic residues are proposed to interact with the methyl groups in the major groove.
(Adapted from Wakefield etal., 1999). Image contributed by Dr. R. Meehan.
/' ii
Figure 1.9 B The solution structure of the MBD of MBD1. The MBD is illustrated in complex
with DNA in / above and the different domains illustrated in ii, above right. The MBD folds into an
structure almost identical to that of the MBD of MeCP2. That is, an a/p sandwich structure
comprising a layer of twisted p-sheet, backed by another layer formed by the a1-helix and a
hairpin loop at the C terminus. Loop L1 undergoes major structural rearrangements upon
binding DNA. Its flexible loop conformation adopts a well defined hairpin-like structure. The N-
andC- termini are on opposite faces of the molecule. (Adapted fromOhkiefa/., 2001).
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contains a hydrophobic amino acid (tyrosine 34) and is absolutely conserved in all
members of the MBD family that bind methylated DNA. Mutation of this residue
completely abolishes binding by MBD1. It is likely that the hydrophobic residues on
strand (33 contact the methyl groups in the major groove of DNA and the charged
residues in strand /62, (34 and the flexible loop interact with the DNA backbone
(review: Wade, 2001).
Underlining the importance of such MBD mutations in vivo has recently been
uncovered. Patients who suffer from the neurodevelopmental disorder Rett Syndrome
have mutations in the MeCP2 gene (Amir et at., 1999). Since then, more than 90
different mutations clustering in the MBD and TRD, are present in more than 400 Rett
Syndrome patients (Amir et at., Buyse et al., Bienvenu et at., Cheadle et at., Hampson
et al., Huppke et al., Kim & Cook, Obata et al., Xiang et al., 2000). This is illustrated
in figure 1.10. MeCP2 expression is highest in the postnatal brain consistent with a
role in the mammalian central nervous system. Confirmation of the role in Rett's
syndrome comes from MeCP2 null mice and brain specific deletion mutant mice.
Specifically, mice deleted of the MeCP2 gene by the Cre-loxP recombination system
at embryonic day (E) 12 have resulted in a phenotype identical to that of the null
mutation. The results of this study also indicate that the role of MeCP2 is not limited
to the immature brain, but becomes crucial in mature neurons (Chen et al., 2001; Guy
et al., 2001).
The MBD sequence from MeCP2 was used in an EST database search to try
and identify other proteins with the same structural motif, which might also bind to
methylated DNA. This led to the identification of PCM1 (Cross et al., 1997), later
renamed MBD1. MBD1 can bind to and suppress transcription from a methylated
template. MBD1 is a 70 kDa protein containing an N-terminal MBD. It is not a
component of the MeCPl complex as had been originally thought (Ng et al., 2000). It
also contains 2-3 cysteine-rich motifs (CxxC motifs) that are also present in DNA
methyltransferase protein 1 (DNMT1) and the mammalian trithorax-like protein
HRX. Alternative splicing determines the exact number of the CxxC motifs present.
Interestingly, a second splicing event exists in mouse brain in the third exon, resulting
in loss of the C-terminal half of the MBD, and another third splicing event that



















































Figure 1.10 Mutations in MeCP2 found in Rett Syndrome patients.
Mutations in MeCP2 corresponding to the neurodevelopmental disorder Rett
Syndrome have been identified in 76% of the sporadic cases and in 45% of the
familial cases of the disease. The amount and location of mutations can
contribute to the severity of the disease (Van den Veyver etal., 2000). MeCP2 is
abundantly expressed in the brain in addition to other somatic tissues, giving
support to the idea that mutations in MeCP2 may affect human development in
a neurological phenotype (Tate et al., 1996). The missense mutations (R106W,
R133C, F155S, T158M) within the methyl-binding domain impairs selectivity for
methylated DNA. The nonsense mutations (L138X, R168X, E235X, R255X,
R270X, V288X, R294X) truncate all or some of the transcriptional repression
domain (TRD). These affect the ability to repress transcription and have
decreased levels of stability in vivo. Two missense mutations, one in the TRD
(R306C) and one in the C-terminus (E397K), have no noticible effects on




terminus. Altogether there are at least five alternatively spliced variants of human
MBD1 mRNA, with less in mouse (Hendrich et al., 1999). The relevance of these
alternative splice variants in biological terms is not yet understood, but not thought
important for DNA binding at least (Cross et al., 1997).
Like MeCP2, MBD1 localises to euchromatin with additional high
concentrations at pericentric chromatin on mitotic chromosomes (Fujita et al., 1999;
Ng et al., 2000). MBD1 associates remain unknown. Antisera specific for MTA1,
HDAC1 and SAP30 do not deplete MBD1 suggesting that it is not part of the
chromatin reorganising Mi-2/NuRD and Sin3 complxes, but is sensitive to deacetylase
inhibitors. The effects of MBD1 and its splice variants on methylated DNA differ in
their affects on transcription in transient assays (Fujita et al., 1999). The solution
structure of the MBD domain of MBD1 has also been solved (Ohki et al., 1999)
showing remarkable similarity to MeCP2. Interestingly, of the three hydrophobic
residues predicted to bind methyl groups in MeCP2, only one of these is conserved
(Wakefield et al., 1999). Although no evidence exists, it is possible that these
different structural organisations of the MBD allow interactions with different types
ofDNA structure perpetrated by different combinations ofmeCpGs.
Several more genes were subsequently identified from EST database
searches. These were MBD2, MBD3 and MBD4. Figure 1.8 B shows the amino acid
sequence alignment of the different MBD containing complexes. Among the methyl-
binding proteins, it appears that the MBD of MeCP2 and MBD4 share most
similarity, while MBD1, MBD2 and MBD3 constitute a separate subfamily
(Hendrich & Bird, 1998). All contain a conserved intron, linking them evolutionarily.
All of the mbd genes are expressed in all murine tissues analysed (Hendrich & Bird,
1998) and are not expressed to any appreciable level in ES cells, as expected, as they
do not require / possess methylation. MBD1, 2 and 4 (but not MBD3), all bind
specifically to methylated DNA in vitro. Consistent with this, MBD-GFP constructs,
apart from MBD3, also localise to heavily methylated satellite DNA regions
(Hendrich & Bird, 1998).
MBD2 can exist as MBD2a, a 43.5kDa protein or MBD2b, a 29.1 kDa protein
that lacks the amino terminal 140 amino acids. This is dependent on where initiation
of translation takes place. Alternative splicing can also result in a variety of nonsense
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transcripts. MBD2b can repress transcription from a methylated template and in this
respect behaves similarly to MeCP2. It is also physically associated with HDAC1 and
Sin3A in mammalian cells, making it a good candidate for MeCPl complex
involvement (Boeke et al., 2000). It also interacts with RbA p48/p46 by
coimmunoprecipitation analysis (Ng & Bird, 1999). However, in the same analysis, it
was not found in this case to interact with mSin3A and Mi-2/NURD complexes (Ng et
al., 2000). The exact components of the MeCPl complex have since been delineated
in a separate study. Feng and Zhang (2001) have purified the lMDa MeCPl complex
from HeLa nuclear extracts, to homogeneity. It contains 10 major polypeptides. They
include 90% of the total [MBD2], two uncharacterised polypeptides of 66 and 68kD,
and components of the NuRD complex; (HDAC1/2, RbAp46/48, the histone
deacetylase core; Mi2, a SWI2/SNF2 type helicase/ATPase involved in the chromatin
remodelling function of the NuRD complex; and MTA2, MBD3). This complex of
proteins has been found to bind to, remodel and deacetylate methylated nucleosomes
in vitro (Feng & Zhang, 2001). Recently, a candidate for one of the unknown MeCPl
components has been found in a yeast two-hybrid screen using MBD2 as bait. A novel
zinc finger protein, MIZF of between 60 and 68 kDa was found to interact with
MBD2 (Sekimata et al., 2001). In vitro binding assays and IPP experiments confirmed
this. MIZF contains 7 zinc fingers in its' C-terminal, 4 of which are required for
MBD2 binding. Interestingly, MIZF mRNA is expressed in all human tissues and cell
lines examined, but the MIZF protein localises diffusely in the nucleoplasms region,
while MBD2 localises to major satellite regions. The two proteins do co-localise in
some regions of the nucleus, however. MIZF classically behaves as a transcriptional
repressor that interacts with HDAC1, the repression being attenuated by trichostatin A
and is completely dependent on interacting with MBD2. With specific relevance to
this project, MIZF interacts with some DNA sequences but not all. The subset of
sequences that it recognises may be a factor in silencing specific genes with the aid of
MBD2 and NuRD complex components. Initial evidence also suggests an interaction
with MBD3, another member of the MeCPl / NuRD complex (Sekimata et al., 2001).
Controversially, MBD2b has been suggested to have demethylase activity
(Bhattacharya et al., 1999), adding weight to the idea that demethylation is not solely a
passive mechanism: ie: that methylation levels are reduced by replication in the
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absence of a DNA methyltransferase. However much uncertainty remains over the
validity of these results, as attempts to reproduce them by other groups have not been
successful (Ng et al., 1999; Wade et al., 1999).
MBD3 also has splicing variants. The predominant form is a 32 kDa protein
with a high degree of homology (70% identity) to MBD2b. Despite the high degree of
homology it is clear that MBD2 and MBD3 in mice, play distinctive but interacting
roles. In mice, MBD3 fails to bind methylated DNA yet MBD3(-/-) mice die in early
embryogenesis. In contrast, MBD2 binds methylated DNA, yet MBD2(-/-) mice
survive and are fertile but show defective maternal nurturing. MBD2 and MBD3 do
interact genetically, the evidence favouring a model whereby MBD2 may recruit the
MBD3 containing Mi-2/NuRD complex to DNA (Hendrich et al., 2001). The less
frequent form has a major deletion in the MBD domain (MBDA). Both isoforms exist
in human and mouse (Hendrich et al, 1999; Wade et al., 1999; Zhang et al., 1999).
Xenopus laevis has an additional 'long form' variant containing a 20 amino acid
insertion in the MBD. MBD3A and MBD long form do not bind methylated DNA
(Wade et al., 1999). Mammalian MBD3 will only bind methylated DNA in vitro very
weakly. However, both the Xenopus (Wade et al., 1999) and Zebrafish (Macleod et
al., 1999) MBD3 homologues, can bind methylated DNA. Despite a less acidic C-
terminal, the xMBD3 has two conserved residues that are mutated in the mammalian
variants. These may be responsible for this: a K/R30H mutation and another change to
a Y at position 34 (Ohki et al., 1999). These residues correspond to the same sites in
MeCP2 that are mutated in some Rett's patients (Ballestar et al., 2000; Yusufzai et
al., 2000). Additionally, these residues when mutated in MBD1, also abolish DNA
binding (Ohki et al., 1999). The function of MBD3 in these variant isoforms is not
understood. As one possibility, it has been tested for demethylase activity but to date,
none has been detected (Wade et al., 1999). It is, as mentioned part of the Mi2
complex from HeLa cells (Feng & Zhang, 2001). This is also the case in Xenopus
eggs (Wade et al., 1998). However, both Xenopus and Zebrafish developmental
programmes do not contain the global demethylation events characteristic of
mammalian development, and therein may be clues to the difference in behaviour of
the MBD components. In both these organisms a period of transcriptional silencing
precedes their developmental programme and may be at this stage that the MBD
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proteins are most active in gene repression (Stancheva & Meehan, 2000; Martin et al,
1999). An interesting paradox exists in that an MBD2/3 homolog, dMBD-like, exists
in Drosophila melanogaster, which has little or no DNA methylation. The dMBD-like
protein fails to bind methylated DNA, but possesses the biochemical properties
consistent with roles as a component of a histone deacetylase-dependent corepressor
complex similar to the vertebrate Mi-2 complex (Ballestar, et al., 2001).This suggests
a broader role in terms of chromatin repression mechanisms than simply binding to
methylated DNA. It may also suggest that there is a specific pattern of DNA
methylation that dMBD-like may recognise that has not been tested yet.
MBD4 is 62kDa and like the other MBDs, has splice variants, although no
splicing event occurs within the MBD. MBD4-GFP fusions localise to densely
methylated DNA sequences in mouse cells. MBD4 is also the only member of the
MBD family not associated with histone deacetylase activity. Interestingly although
the MBD of MBD4 has the highest homology to MeCP2, the MBD4 C-terminus has
homology to bacterial DNA repair enzymes (Hendrich & Bird, 1998). These include
the 8-oxoGA mispair-specific adenine glycosylase MutY of E. coli, and the
photodimer-specific UV-endonuclease ofMicrococcus luteus. Based on this similarity
it was tested whether MBD4 has any repair activities directed to methyl-CpG sites. It
was found that MBD4 can efficiently remove mispaired U or T residues from CpG
sites in vitro and thus functions to decrease the mutation rates at highly mutagenic
CpG sites (Hendrich et al., 1999). It is thus a DNA repair enzyme specific for
methylated DNA. This is strengthened by the isolation of mutations in the MBD4
gene from carcinomas with microsatellite instability, where DNA mismatch repair is
defective (Bader et al., 1999; Riccio et al., 1999).
Apart from the above mentioned proteins which were identified due to (1) the
ability to bind methylated DNA, (2) the presence of an MBD or (3) the ability to
interact with another MeCP or component of the NuRD / MeCPl complex, several
other proteins have come to light. One of these is a BTB/POZ domain zinc finger
transcription factor called Kaiso (Prokhortchouk et al., 2001). It has structural
similarity to a family of known Drosophila transcriptional regulators. It has now also
been isolated from Xenopus embryos (Dr. Rusov, pers. comm.). Kaiso was first
identified for its interaction with the catenin pl20ctn protein. pl20ctn is an Armadillo
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repeat domain protein that interacts directly with E-cadherin, a transmembrane cell
adhesion molecule. E-cadherin is involved in diverse functions, but pl20ctn does not
seem to be involved in these and may be a downstream effector of these pathways
(Daniel et al., 1999). Kaiso was then found to be capable of binding specifically to
DNA with a consensus sequence containing multiple meCpG sites. It shows no
sequence similarity to the known MBD proteins, yet associates in vivo with HDAC1,
and HDAC2 (Prokhortchouk et al., 2001). This distinct preference for a consensus
sequence adds weight to an hypothesis of a sequence based coding system for an array
ofMeCPs, recognising methylated CpGs by their density and sequence context. These
aspects are discussed further in the Discussion, Chapter 6.
It has been the search for candidate genes for tumourigenesis that had led to
the identification of a cluster of proteins that may also be involved in methyl-mediated
repression. These proteins were not identified in any of the previous MBD screens. In
B-Cell Chronic Lymphocytic Leukemia a large region of chromosome 13ql4 is
deleted. Analysis of this region led to the identification of three candidate genes for
leukomogenesis. These are CLLD6, CLLD7 and CLLD8. The CLLD8 protein contains
an MBD domain, a preSET domain and a SET domain, suggesting an involvement
with methylation mediated transcriptional repression. The SET domain was also first
identified in the Drosophila chromosomal regulator proteins; Su(var)3-9, Enhancer of
zeste (E[z]), and Trithorax (TRX) (Tschiersch et al., 1994) but is present in a huge
range of transcriptional regulators from a variety of species (Hobert et al., 1996).
CLLD8 is most similar to the Su(var)3-9 subgroup. The preSET domain, also known
as the SAC domain (SET domain-associated cysteine-rich domain), is probably
involved in chromosome binding (Huang et al., 1998). SUV39H1, the human
homologue of Drosophila Su(var)3-9 has also a SET and preSET domain. It has
recently been reported to be a histone methyltransferase (Rea et al., 2000). CLLD8,
containing an MBD in addition to SET/preSET domains, is also likely to be
associated with methyl-mediated transcriptional repression, which also involves
histone methylation (Mabuchi et al., 2001). Several more histone methyltransferases
have now been discovered. Along with the histone acetyltransferases, the
methyltrasferases play a key role in regulating gene expression in a chromatin
complex (review: Zhang & Reinberg, 2001; Jenuwein & Allis, 2001).
43
<Jhapter 1: Introduction
The large unstructured tails of the histone proteins can also be phosphorylated,
ubiquitinated and brominated at specific amino acid residues leading to the hypothesis
that there is a 'histone code' that operates analogously to the DNA code. The
combinatorial nature of the different modifications seems to provide functional and
heritable epigenetic information on a particular gene sequence or region of DNA. The
complexity is increased if the array of modifications on a particular histone tail can
combine its coded information with adjacent histone tail modifications (Jenuwein &
Allis, 2001). Specific examples include (a) the parent-specific complementary
patterns of histone H3-K9 and H3-K4 methylation at the Prader-Willi syndrome
imprinting centre (Xin et al., 2001) and (b) the involvement of HMT activity in Rb-
mediated transcriptional repression, which also utilises HDACs for this purpose
(Vandel et al., 2001). This last example reveals what may be a complex interplay of
the histone acetylation and methylation machinery responding to the effects of
methylation mediated repression.
It is now impossible to say whether DNA sequence, structural topology or
histones alone are ultimately responsible for, or can directly control gene expression.
What must exist is a circular interweaving pathway between these components
maintaining the heritable nature of these modifications in a form of cellular memory.
Figure 1.11 is a summary of some of the components of the methylation machinery
that may interact at a given point in time to enable this system of regulation to be
perpetuated. What follows is an investigation into the role that CpG methylation of





























Figure 1.11 The methylation machinery interacts with chromatin
remodelling complexes containing a variety ofHistone Deacetylases. This
diagram illustrates how the methyl-binding proteins interact with chromatin
remodelling complexes, which in turn interact with a variety of histone
deacetylases (HDACs). The potential for differrent interactions of these
componants illustrates the maleability of regulation at genes under this type of
regulation. Targeting of these complexes is mediated by the methyl-DNA
binding proteins. (Image received from Dr. R. Meehan).
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The Aims of this thesis are centred on an investigation into the effect that CpG
methylation of DNA may have on DNA structure. The initial premise was to either
devise a novel in vitro assay or to modify an existing one, with the purpose of
investigating the effects of CpG methylation on DNA structure. The object was then
to pursue the relevance of any potential methylation-induced structural changes in a
functional context.
Here I demonstrate, that CpG methylation in a variety ofDNA substrates can
cause significant structural alterations. These alterations occur in a specific sequence
context and are consistent with the formation of A-form DNA. An assay for
methylation induced DNA structural changes was developed using Benzonase, a
nuclease with a distinct preference for the digestion ofA-DNA. For this, a number of
'tester' sequences, and a variety of specific gene sequences were methylated and
subjected to Benzonase digestion.
The results reveal the possibility that a DNA structural code is induced by
differential methylation. These patterns may be individually recognised by an array
of methyl-binding proteins, thus providing complex patterns of gene regulation at
specific sites in DNA.
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Unless otherwise stated, all molar concentrations in this section are final
concentrations and chemicals were obtained from BDH
2.1 Materials
2.1.1 List ofSuppliers
ABgene: ABgene House, Blenheim Road, Epsom, Surrey. KT19 9AP
England. U.K. Tel: +44(0)1372 723456.
Ambion: Ambion (Europe) Ltd, Spitfire Close, Ermine Business Park,
Huntingdon, Cambridgeshire PE29 6XY.England. UK.Tel 0800 138 1836
Amersham-Pharmacia Biotech UK Ltd. Amersham-Pharmacia Biotech UK Ltd.,
Amersham Place , Little Chalfont, Buckinghamshire HP7 9NA. England. UK.
Customer Services: 0800 515 313.
Applied Biosystems: Applied Biosystems, 7 Kingsland Grange, Woolston
Warrington, Cheshire WA1 7SR. United Kingdom. Phone: 44 1925 825650
BDH: Merck House, Poole, Dorset. BH15 1TD. England. UK. Tel: 01202 669700.
Beckman: Oakley Court, Kingsmead Business Park, London Road, High Wycombe,
Buckinghamshire. HP11 1JU. England. UK. Tel: 44-1494-441181
BIO-RAD: Bio-Rad House, Maylands Avenue, Hemel Hempstead
Hertfordshire HP2 7TD. England. UK. Toll free: 1 -(800) 4 BIORAD.
Difco Laboratories Ltd.: PO Box 14B, Central Avenue, West Molesey, Surrey,
KT8 2SE. London. UK. Phone: 0181 979 9951.
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Fisher Scientific UK Ltd: Bishop Meadow Road, Loughborough Leicster, LE11
5RG. England. UK. Phone: 01509 231166.
Greiner Labortechnik: Unit 5, Stroudwater Business Park Brunei Way,
Stonehouse, Gloucestershire GL103SX. England. UK. Phone: 01453 825 255.
Helena-Biosciences Ltd.: Colima Avenue, Sunderland Enterprise Park, Sunderland,
SR5-3XB. Phone: 0191-549 6064.
Hybaid Ltd: Action Court Ashford Road, Ashford Middlesex. TW15 1XB.
England. UK. Phone: 01784-425000.
Invitrogen Ltd. Life Technologies Ltd: Unit 3 Fountain Drive, Inchinnan Business
Park, Paisley. PA4-9RF. Scotland. UK. Phone: 0141-814 6100.
MBI-Fermentas Ltd. Helena Biosciences Ltd., Colima Avenue, Sunderland
Enterprise Park, Sunderland, SR5-3XB. Phone: 0191-549 6064.
Molecular Probes Europe BV. PoortGebouw, Rijnsburgerweg 10, 2333 AA
Leiden. The Netherlands. Phone: +31-71-5233378.
MWG Biotech AG (UK) Ltd.: Mill Court, Featherstone Road, Wolverhampton
Mill South Milton Keynes. MK12 5RD. England. UK. Phone: 01908 525 500.
New England Biolabs (UK) Ltd: 73 Knowl Piece, Wilbury Way, Hitchin,
Hertfordshire. SG4 OTY. England. U.K. Freephone: 0800-318486.
Novagen: Boulevard Industrial Park, Padge Road, Beeston, Nottingham. NG9 2JR.
UK. Freephone: 0800-622935.
Pierce Ltd.: Perbio Science UK Ltd., Century House, High Street, Tattenhall,
Cheshire. CH3 9RJ. Tel: 01829-771 744.
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Princeton Separations: CP Instrument Co. Ltd., Unit 3, The Shires, Shirehill
Industrial Estates, Saffron Walden, UK. CB11 3AN. Phone: 01719-581-321.
Promega UK. Delta House, Chilworth Research Centre, Southampton. SO 16 7NS.
England. UK. Phone: 023-8076 0225.
Qbiogene. Oakland Park Road, Oakbank Business Park. Livingston. EH53 OTG.
England. UK. Phone: 0800-328-8401.
Qiagen Ltd: Boundary Court, Gatwick Road, Crawley, West Sussex. RH10-9AX.
UK. Orders: 01293-422-922.
Roche Diagnostics Ltd: Bell Lane, Lewes, East Sussex. BN7 1LG. England. UK.
Phone: 01273-480444.
Sigma-Aldrich Company Ltd: Poole, Dorset. England. UK. Phone: 01202-733144.
Sorval / Heraes Brands: Kendro Laboratory Products Ltd. Stortford Hall Park
Bishop's Stortford. Hertfordshire. CM23 5GZ. UK. Phone: 01279-827700.
Stratagene Europe Corporate Office: Gebouw California, Hogehilweg 15, 1101
CB Amsterdam Zuidoost, The Netherlands. Phone Orders (UK) 0800-585-370.
Thermo-Hybaid Ltd. Medical Supply Co. Ltd. Damastown, Mulhuddart. Dublin
15. Republic of Ireland. Phone: 00-353-31-82224 222
UVP Inc. (Europe Office): Ultra Violet Products Ltd., Unit 1, Nuffield Road,
Trinity Hall Farm Estate, Cambridge. CB4 ITG. England, UK. Phone: 01223-
420022.
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Acrylamide, 30% (v/v) 29:1 (acryl:bis-acryl): This solution was used for all non-
denaturing polyacrylamide gels. It was made by mixing three parts of 40%
acrylamide (Fischer) with one part ddH20.
Acrylamide, 30% (v/v) 19:1 (acryl:bis-acryl): This solution was used for all
denaturing polyacrylamide-urea gels. It was made by mixing three parts of 40%
acrylamide (Fischer) with one part ddH20.
Ampieillin (Sigma) solution: This antibiotic solution was made by dissolving
ampicillin in ddH20 to a final concentration of 100 mg/ml. The solution was filter
sterilised, aliquoted to 1ml in eppendorf tubes and stored at -20°C. The working
concentration is typically between 50 and 100 pg/ml of bacterial growth media.
APS (10%): Ammonium persulphate was used for catalysing polymerization of
polyacrylamide gels. It was prepared by dissolving 1 g of APS in 10 ml of ddH20
and stored at 4°C for up to two weeks.
APS (25%): Ammonium persulphate was used at 25% (w/v) for catalysing the
polymerisation of denaturing PAGE / urea gels. It was prepared by dissolving 2.5 g
ofAPS in 10 ml of ddH20 and stored at 4°C for up to two weeks.
Bandshift Buffer: For Protein-DNA interactions by PAGE. A 5X solution contains
100 mM Hepes, 5 mM EDTA pH 8.0, 15 mM MgCl2, 50 mM (3-mercaptoethanol, 50
% glycerol and 0.5 % Triton X-100.
BCA-200 protein assay kit (PIERCE): This kit was used for the determination of
protein concentrations using spectrographic standards of bovine serum albumin
concentrations, according to the manufacturer's instructions.
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BPC (Buffered phenol-chloroform): BPC was used for DNA
extraction/purification methods. To prepare, 25 parts of buffered (TE-saturated)
phenol, 24 parts of chloroform and 1 part of isoamylalcohol was mixed by vigorous
vortexing, left until phases separated and stored in the dark at 4°C.
BPB (bromophenol blue): This tracking dye for gel electrophoresis was prepared by
dissolving 1 g of BPB in 10 ml ddH20. The solution was aliquoted to one ml
eppendorfs and stored at -20°C.
Buffer A (Midipreps): 25mM Tris-Cl, pH 8, 10 mM EDTA, 50 mM glucose.
Buffer B (pET6hMBD purification): A solution containing 50 mM NaCl, 50 mM
sodium phosphate, pH 7, 10% glycerol and 0.1% Triton X-100 was made by
dissolving all components in a flask in 500 ml ddH20. The solution was then made
up to 1L with ddH20.
Buffer Z: For HIV-1 integrase purification protocol. A stock solution contains 1 M
NaCl, 20 mM Hepes pH 7.5, 2 mM P-mercaptoethanol, 0.3 mg/ml lysozyme and 5 %
glycerol. The solution is made to 500 ml with ddH20.
CaCl2 (1M): A 1L solution of calcium chloride was prepared by dissolving 219g of
CaCl2-6H20 in 800ml ddH20. Once dissolved the volume was adjusted to 1 litre with
ddH20 and sterilised by autoclaving. The solution was stored at room temperature.
Coomassie Blue staining solution: For the staining of SDS-PAGE gels. To prepare
a 1L solution, 2.5g of 'Coomassie Brilliant Blue R-250' was dissolved in a mixture
of 450 ml methanol, 100 ml acetic acid and 400 ml ddH20. The volume was adjusted
to 1L with ddH20 and the solution stored at room temperature.
Destain I solution: For the destaining of Coomassie stained SDS-PAGE gels. A
stock solution is made by mixing 500 ml methanol, 400 ml of acetic acid and 100 ml
ddH20.
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Destain II solution: For the destaining and re-sizing of gels destained with 'Destain
II' solution detailed above. A stock solution is made by mixing 200 ml ofmethanol,
100 ml of acetic acid and 700 ml of ddEEO.
DNA polymerase I large (Klenow) fragment: For use in all PCR amplification
protocols, was obtained from New England Biolabs, and used according to
manufacturer's instructions.
DNase I Solution: Deoxyribonuclease I (ABgene) solution was used for the
enzymatic cleavage of DNA and prepared as follows: 10 mg of DNase I was
resuspended with 0.1 M Tris, pH 7.5 and aliquoted into eppendorf tubes to a final
concentration of 10 mg/ml The working concentration used was typically at 1-100
pg/ml with 5 mM MgCl2pH 7.0 - 8.5.
DTT (1M): A 20ml solution of 1,4-dithio-DL-threitol (DTT, MW=154.25) was
made by dissolving 3.085g of DTT in 20 ml of lOmM sodium acetate (pH 5.2). The
solution was divided into 1 ml aliquots and filter sterilised through a 0.2 pm filter.
Aliquots were stored at -20°C.
Gel Loading Buffer (6 x): This was used for sample loading in polyacrylamide gel
electrophoresis: 60 pi 30% (w/v) Ficoll 400, 30 pi 10 x TBE, 3 pi 2% (w/v) XC, 3 pi
2% (w/v) BPB and 4 pi ddH20 was mixed together.
EDTA (Na2+EDTA) 0.5M, pH 8.0. A one litre solution is made by dissolving
186.12 g of disodium ethylenediaminetetracetate -2H2O (Mw=372.24) in 800 ml
H20 and stirred vigorously on a magnetic stirrer. The pH was adjusted to pH 8.0 with
NaOH (approx. 20g NaOH pellets), made up to 1 L with EI2O and sterilised by
autoclaving.
EtBr (sigma)lO mg/ml: A stock solution of ethidium bromide, for the staining of
DNA in agarose and polyacrylamide gels, was prepared by dissolving 1 g of EtBr in
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100 ml ddH20. The solution was stored in a dark container at 4°C. For gel staining:
0.5 - 1 ug per ml of agarose solution was typically used.
Gel Extraction buffer: Buffer for the extraction of DNA from polyacrylamide gels.
A stock solution was made of 0.3 M NaCl, 20 mM Tris-Cl pH 7.51 and 1 mM EDTA
to a total volume of 50 ml.
Gel loading buffer for agarose and polyacrylamide gels was prepared by mixing 500
pi 10 x TBE, 400 pi 30% (w/v) Ficoll 400, 80 pi 2% (w/v) BPB and 20 pi 2% (w/v)
XC.
GTE buffer: For use in alkaline lysis preparation of plasmid DNA: 50 mM glucose,
25 mM Tris-HCl pH 7.4 and 10 mM EDTA was dissolved in ddH20 and made to a
final volume of 50ml.
Hepes (1M): A stock solution is made by dissolving 23.83 g in 80 ml of ddE^O. The
pH is adjusted to 7.5 with 0.5 N NaOH.
IPTG (lOOmM): A 50ml solution of IPTG was made by dissolving isopropyl b-D-
thiogalactopyranoside (IPTG, Mw=283.3) in 40ml EDO. The volume was adjusted to
50ml with H20, divided into 5ml aliquots, filter sterilised and stored at -20°C.
KOAc (0.1 M) Buffer: Acidic potassium acetate solution was made as follows:
(a) A solution of 0.2M acetic acid was made by mixing 11.55ml of glacial acetic
acid in 500ml H20 and the volume adjusted to 1L with ddH20.
(b) A solution of 0.2M potassium acetate was made by dissolving 19.62g of
KOAc, (Mw=98.14) in 800ml ddH20 and the volume adjusted to 1L with
h2o.
A quantity of each solution is mixed proportionately to give a specfic pH and made
to a final volume of 100ml with ddH20. The quantities used are tabulated in
Sambrook, 1997.
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K Phosphate (0.1M) Buffer: A 200ml solution of 0.1M potassium phosphate was
prepared as follows:
(a) A solution of 0.2M potassium phosphate, mono-sodium salt was prepared by
dissolving 27.2g of KH2PO4 (Mw= 136.09) in 500 ml H20 and the volume
adjusted to 1L wilth ddH20.
(b) A solution of 0.2M potassium phosphate, di-sodium salt was prepared by
dissolving 34.8g of K2HPC>4 (Mw=174.18) in 500 ml ddH20 and the volume
adjusted to 1L with ddH20.
A quantity of each solution is mixed proportionately to give a specific pH and made
to a final volume of 200 ml with ddH20. The quantities used are tabulated in
Sambrook, 1997.
LB (Luria broth) medium: A solution was made by dissolving 10 g bactotryptone,
5 g bacto-yeast extract and 10 g NaCl in ddH20 to 1L and subsequently autoclaved.
LB Agar: 15 g/1 of agar was added to LB medium (see above) and autoclaved.
If required, the appropriate antibiotic was added immediately before pouring the
plates, when the liquefied Agar had cooled to at least 50°C.
Lysis buffer (plasmid preparation): 200 mM NaOH and 1% (w/v) SDS was
dissolved in ddH20 to 50ml final volume.
Lysozyme: Stock solution is made by dissolving 10 mg/ml in lOmM Tris-Cl, pH 8.0.
MgCl2 (1M Magnesium Chloride): A 1L solution of MgCl2 was made by dissolving
203.3 lg MgCl2-6H20, Mw=238.31) in 800ml H20. The volume was adjusted to 1L
with ddH20 and sterilised by autoclaving.
NaCl (5M): AIL solution of 5M Sodium Chloride was made by dissolving 292.2g
(NaCl, Mw=58.44) in 800ml H20. The volume was adjusted to 1L with ddH20,
sterilised by autoclaving and stored at room temperature.
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NaCl (1M): A 500ml solution was made by mixing 100ml of 5M NaCl (see above)
with 400ml of ddH20.
NaOAc (3M): A 1L solution of sodium acetate was made by dissolving 408.24g
Na0Ac-3H20 (Mw=136.08) in 800ml of ddH20. The pH was adjusted to 5.2 with
glacial acetic acid and made up to 1L with ddH20. The solution was sterilised by
autoclaving and stored at room temperature.
NaOH (IN): This is equivalent to 1M NaOH solution and is made by dissolving 40 g
in 1000 ml ddH20.
Na Phosphate Buffer (0.1M): A 200ml solution of 0.1M sodium phosphate was
prepared as follows:
(a) 0.2M sodium phosphate, mono-sodium salt was prepared by dissolving 27.6g
of NaH2P04-lH20 (Mw=138) in 500ml of ddH20 and the solution adjusted
to 1L with H20.
(b) 0.2M sodium phosphate, di-sodium salt was prepared by dissolving 53.62g of
Na2HPC>4 -7H20 (Mw=268.1) in 500ml of ddH20 and the solution adjusted
to 1L with H20.
A 200ml solution of the desired pH is prepared by mixing a quantity of solutions (a)
and (b) together to a final volume of 200ml with ddH20 The exact amounts are
according to Sambrook, 1997.
dNTPs: Deoxyribonucleotide triphosphates: dATP, dCTP, dTTP and dGTP;
(Pharmacia Biotech) were diluted to 10 mM each, in ddH20 and stored at -20°C.
PEG solution A solution of polyethylene glycol was prepared for use in alkaline
lysis preparation of plasmid DNA: 20% (w/v) PEG-6000 and 2.5M NaCl were
dissolved in ddH20 to 50 ml.
Phenol (Buffered pH 8.0): 250 g of solid phenol (Fluka) was dissolved overnight at
room temperature in 127 ml of 2 M Tris-Cl (pH 7.5). Following mixing, the phenol
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was centrifuged at 2000 x g for 1 minute, and the aqueous bottom layer was
discarded. Then, 55 ml of 2 M Tris (pH 8.0), 13.75 ml of m-cresol, 550 pi of P-
mercaptoethanol and 275 mg of 8-hydroxyquinone was added. The solution was
mixed and divided into aliquots, which were centrifuged to separate the buffer and
phenol layers prior to storage at 4°C in the dark.
PBS (10X PBS Buffer): A solution was made by dissolving 80g NaCl2 , 2g KC1,
26.8g Na2HP04-7H20 and 2.4g KH2P04in 800ml H20. The pH was adjusted to 7.4
with HC1 and the volume increased to 1L with H20. The solution was sterilised by
autoclaving and stored at room temperature.
PBS/2 % dried milk: 1 g ofMarvel is dissolved in 50 ml of IX PBS.
PMSF: A phenylmethyl sulphonyl fluoride (PMSF) solution was made by dissolving
solid PMSF in isopropanol to a final concentration of 250mM. The solution was
maintained soluble at > 30°C.
Ponceau S solution: An 100 ml solution was made by dissolving 2g of Ponceau S
(sigma), 30g of trichloroacetic acid and 30 g of sulfosalicylic acid in 80 ml of
ddH20. The volume was adjusted to 100 ml with ddH20, and the solution stored at
room temperature.
Proteinase K was obtained from NBL at 50 mg/ml and stored at -20 °C.
Radioactive nucleotides: a-32P-dCTP and y-32P-dATP (Amersham-Pharmacia) were
purchased at 0.37 MBq/pl = 5000 Ci/mmol = 10 mCi/ml.
RNase A: Bovine pancreatic ribonuclease A (BCL) was dissolved at 10 mg/ml in
0.01 M sodium acetate pFI 5.2 and boiled for 15 minutes to destroy any
contaminating DNase I activity. After the RNase had cooled slowly to room
temperature 0.1 volumes of 1 M Tris-Cl (pH 7.4) were added.
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SDS {10% (w/v)} An 100 ml solution was prepared by dissolving 10 g in 90 ml
ddH20. To aid the process the solution was heated to 68°C. The pH was adjusted to
7.2 with HC1 (approx. 5 pi), the volume adjusted to 100 ml with ddH20 and the
solution stored at room temperature.
SDS-PAGE (10X) running buffer: This was made by dissolving lOg of SDS, 30.3
g of Tris and 144.1 g glycine in 800 ml ddH20. The volume was adjusted to 1 L with
ddH20 and the solution stored at room temperature.
SDS-PAGE (2X) sample buffer: Aliquots of an 100 ml stock solution were made
by mixing 10 ml of 1.5 M Tris (pH 6.8), 6 ml of 20% SDS, 30 ml of glycerol, 15 ml
of (3-mercaptoethanol and 1.8g of bromophenol blue. The volume was adjusted to
100 ml with ddH20, aliquoted into 10 ml stock solutions and stored at -20°C.
Working solutions were stored at 4°C.
SOB medium: A 1 L solution is made by mixing 20g of Bacto-Tryptone (Dipco), 5g
of Bacto-Yeast extract (Dipco), 0.5g of NaCl and 2.5 ml of 1M KC1 in 900 ml of
H20. The pH was adjusted to 7.0 with 10M NaOH (approx. 100 pi) and ddH20
added to 990 ml. The solution was sterilised by autoclaving and stored at room
temperature. Before use, 5 ml of sterile 1M MgCl2 and 5 ml of sterile 1M MgS04
was added to the medium.
SOC medium: The solution is identical to SOB medium (see above) except that it
additionally contains 20 ml of sterile 1M glucose.
SSC (20X) Buffer, pH 7.0: This was prepared by dissolving 175.3g NaCl and 88.2g
sodium citrate-2H20 in 800ml H20. The pH was adjusted to 7.0 with HC1 and the
solution made to a final volume of 1L with ddH20. The solution was autoclaved.
TAE (50 X) Buffer: A 1 L solution of Tris-acetate buffer was made by dissolving
242g Tris in 500ml H20. To this, 100 ml of 0.5M Na2EDTA (pH 8.0) and 57.1 ml of
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glacial acetic acid was added. The volume was adjusted to 1L with ddH20 and stored
at room temperature.
TB (terrific broth) growth medium was made with 12 g bactotryptone, 24 g bacto-
yeast extract, 4 ml glycerol, 17 mM KH2PO4, 55 mM K2HP04 and 20mM glucose,
dissolved in ddH20 to a final vol. of 1L and subsequently autoclaved.
TBE (10 X) Buffer: A 1 L solution Tris-borate buffer was made by dissolving 108 g
of Tris base, 55 g orthoboric acid and 9.3 g EDTA in ddH20 to a final volume of 1L
The solution was autoclaved and stored at room temperature.
TBS: Used for Western Blots. A solution is made by mixing 25 ml of 1 M stock of
Tris-Cl pH 8.0 (50 mM final) and 15 ml of 5M NaCl (150 mM final) to a final
volume of 500 ml in ddH20.
TCA (100% Trichloroacetic acid): 500g of TCA was added to 227ml H20 to make
an 100% solution.
TE (IX): 10ml of 1M Tris (pH 8.0, 7.6 or 7.4) and 2ml of 0.5M Na2EDTA (pH 8.0)
was added to 800ml ddH20, mixed and the volume adjusted to 1L. The solution was
autoclaved and stored at room temperature.
Transformation Buffer ('TB'): A 500 ml solution of'TB' contains 1.5 g of PIPES
(10 mM final), l.lg of CaCl2 (15 mM final) and 9.3g of KC1 (250 mM final). The pH
was adjusted to 6.7 with KOH and then MnCl2 added to 55 mM (5.44g). The solution
was sterile filtered at 4°C. and stored in 100 ml aliquots at -20°C.
Tris-HCl (1M tris(hydroxymethyl)aminomethane): A solution was made by
dissolving 121.14 g of Tris base (Mw=121.14) in 800ml of ddH20 and the pH
adjusted to the desired value with concentrated HC1.
e.g: pH 7.4 : Approx 70ml, pH 7.6 : Approx 60ml, pH 8.0 : Approx 42ml.
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The volume was adjusted to 1L with H20, sterilised by autoclaving and stored at
room temperature.
XC (Xylene Cyanol) 2% (w/v) for tracking of buffer fronts in gel electrophoresis:
1 g was dissolved in ddH20 to a final vol. of 50ml.
2.2. Methods:
The following methods are those used in Results, Chapters 3, 4, 5 and Chapter 7.
A list of Bacterial host strains and plasmid vectors used is provided in table 2.1.
Bacterial Host Strains Genotype
XL1-blue F'::Tn 10 proA^B* lac?A(lacZ)M15/recA1 endA1 gyrA96 (Nalr)
thi hsdR17 (rK"mK+) glnV44 relA1 lac
JM110 rpsL thr leu thi hsdR17 (rK~, mC) lacY galK galT ara tonA tsx
dam dcm supE44 A(lac-proAB) [F' traD36 proAB lachZAM15
BL21(DE3)pLysS F-, ompT, hsdSB (rB-, mB-). dcm, gal, A(DE3), pLysS (Cmr)
Plasmids Contents
pBS SK(-/+) (chip30) An MeCP2 ChIP assay pull down sequence (Appendix)
Obtained from Dr. I. Stancheva
pBR322 Standard vector, no DNA insert (Chapter 3). Commercial.
pGEM9zF(-) pGEM vector with 167 bp DNA insert (Chapter 3)
Obtained from Dr. A. Pingoud.
pUC9 (a-globin) pUC9 cloning vector with human a2-globin DNA insert (Ch 3).
Obtained from Prof. A. Bird
pBS KS(-)1 (P-globin) The chicken (3A-globin gene (Chapter 4)
Obtained from Dr. C. Davey
pET6hMBD HIS tag protein expression vector with MeCP2-MBD (Ch5)
Obtained from Dr. R. Meehan
pGEX-3T-MBD GST tag protein expression vector with MeCP2-MBD. (Ch 5)
Obtained from Dr. R. Meehan
pIN '"zoofi 85K/C280S Soluble mutant of Human HIV-1 integrase pET expression
vector (Ch 7). Obtained from Dr. R. Craigie
Table 2.1 List of commonly used Bacterial cells and plasmids in this thesis. XL1-blue
cells were obtained from Stratagene, BL21 (DE3) pLysS cells from Novagen. JM110 cells
were a gift from Dr. C. Davey.
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2.2.1 Preparation of Competent Cells
This procedure was modified from a high efficiency transformation procedure
detailed by Inoue et al., 1990, and was performed on XL-1 Blue, JM110 and
BL21(DE3)pLysS cells. Glycerol based cell stocks were stored at -80°C for long
term storage. A cell scraping was made from a still frozen vial on ice and used to
initiate a starter culture by inoculating 5 ml of LB medium. Antibiotics were added if
required, and the cells grown overnight at 37°C. Control reactions were set up
containing LB only to confirm that the LB was indeed an uncontaminated stock. The
following day the 5ml culture was used to inoculate 250 ml of SOB medium. The
culture was grown at 18°C to an OD6oo= 0-6. The culture was then placed on ice for
10 minutes and then spun at 2500 x g (5000 rpm in a Sorvall GSA or 3000 in a
Beckman J-6B centrifuge) for 10 minutes at 4°C. The cells were gently resuspended
in 80 ml of ice cold transformation buffer and left on ice for 10 minutes. The cells
were then spun again at 2500 x g for 10 minutes at 4°C. Cells were resuspended in
40 ml of ice cold transformation buffer. DMSO was added to a final concentration of
7% and the cells kept on ice for 10 minutes. Aliquots of 1 ml were made in
eppendorf tubes placed in ice and the cells snap frozen with liquid nitrogen.
Competent cells were stored at -80°C until required.
2.2.2 Transformation andgrowth ofplasmid DNA in bacterial host strains
For transformation of plasmid DNA into a bacterial cells, 200 pi of freshly prepared
competent cells were taken and allowed to thaw on ice. To these, 3 pi ofDMSO was
added and 15 ng to 200 ng of the desired plasmid DNA. These were mixed gently
with a pipette and left on ice for 30 minutes. The cells were heat shocked at 42°C for
1.5 minutes in a heating block to promote uptake of plasmid DNA. To these 1ml of
LB was added and the cells placed in a shaking incubator at 37°C for 1 hour. They
were then spun down gently at 2000 rpm for 30 seconds and the excess LB removed
with a pipette. The cells were resuspended in the remaining LB and aseptically
plated onto antibiotic containing selective LB plates. Controls of non-transformed
cells were also plated on antibiotic containing plates and LB only plates. Plates were
incubated overnight at 37°C to allow colonies to grow.
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2.2.3 Agarose Gel Electrophoresis
Agarose gels were prepared according to standard methods (Sambrook, 1997).
Typically a 1% gel was made by dissolving lg of agarose (sigma) in 100 ml of IX
TAE buffer, by heating the solution to boiling point. The solution is allowed to cool
while being continuously stirred. EtBr is added to the desired concentration (0.5
pg/ml), the solution poured to a gel mould and allowed to set. For Low melting point
gels, Seaplaque™ agarose was used according to manufacturer's instructions.
2.2.4 Polyacrylamide Gel Electrophoresis
Polyacrylamide gels were prepared according to standard methods described in
Sambrook, 1997. Typically a 12 % polyacrylamide gel for oligo purification was
made by mixing 40 ml of 30 % acrylamide, 49.3 ml of ddH20, 10 ml of 10X TBE
and 0.7 ml of 10 % APS. The solution is mixed and 50 pi of Temed (Sigma) added.
It is again mixed, poured carefully into the gel mould and allowed to set at room
temperature. A 90 ml solution suitable for the preparation of two 5% PAGE gels for
DNA or protein analysis was made by mixing 15 ml of 30 % acrylamide (29:1), 65
ml of ddH20, 9 ml of 10X TBE, 1 ml of 10 % APS and 120 pi of Temed.
Polymerisation is rapid and within 5 minutes. 5% PAGE gels for bandshift analysis
were made to Zi the normal concentration of TBE (ie: 0.5X TBE) and run in the cold
room in 0.5 X TBE Buffer.
2.2.5 Staining ofAgarose and PAGE gels
After the gel run is complete, agarose and polyacrylamide gels were stained with
either EtBr from a solution of 0.5 mg / ml. Typically, EtBr is added before agarose
gel electrophoresis until the solution turns only very slightly pink when mixed. EtBr
can also be added after agarose gel electrophoresis and always after PAGE gel
running. This provides a more consistent staining pattern. The gel is placed in a dish
with a lid and is surrounded by running buffer. EtBr is added to a final concentration
of 0.5 pg/ml or until the solution is markedly red. After 20 minutes of agitation the
solution is washed away. Replacement buffer without EtBr is added to destain the
gel. After destaining, the gel is ready to be viewed under UV light which allows
visualisation of sites in DNA where EtBr has intercalated.
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Another method used is SYBR gold (Molecular Probes) staining. Where
this is used is indicated in the main text. It is a fluorescent dye that can also be
visualised under UV light but is more sensitive than EtBr. It detects dsDNA and
ssDNA as well as RNA. SYBR-gold is diluted as 5 pi in 50 ml gel-staining buffer
solution, which is the same as the running buffer. Application must be done in the
dark as SYBR-gold is light sensitive.
2.2.6 Medium scale growth (midiprep) ofplasmidDNA
A 10 ml culture was set up by picking a single colony from a transformation plate to
10 ml LB containing antibiotic (eg: ampicillin at 50 pg/ml). This starter culture is
allowed to grow at 37°C overnight in a shaking incubator. The following day, 5 ml
of the starter culture was transferred to a flask containing 200 ml of LB containing
the appropriate antibiotic. The culture was allowed to grow at 37°C in a shaking
incubator until it reached an OD6oo of 0.8. The cells were then spun down in a
Sorvall GSA centifuge at 4000 rpm for 10 minutes. The pellet was resuspended in 5
ml 'Buffer A' with lysozyme at 5 mg/ml and left on ice for 5 minutes. To this, 10
mis of 0.2 N NaOH and 0.1% SDS were added in that order. The solution was left on
ice for no more than 5 minutes. 7.5 ml of 5M Potassium acetate pH 4.8, was then
added and again the solution was left on ice for no more than 5 minutes. To the
suspension 5 ml of chloroform was added and mixed well. The solution was
centrifuged at 3,000 rpm for 5 minutes in a table top swing rotor. The supernatant
was removed and an equal volume of isopropanol was added at room temperature.
Immediately, the solution was centrifuged at 12,000 rpm for 10 minutes. The pellet
was washed with 70% ethanol and again centrifuged at 12,000 rpm for 10 minutes.
The pellet was dried at room temperature for 10 minutes. To this, 3 ml of TE was
added with RnaseA (@ 20 pg/ml) and incubated at 37°C for 30 minutes. An equal
volume of phenol was then added, the solution mixed and the aqueous and organic
phases resolved by centrifugation at 3,000 rpm for 5 minutes. The aqueous layer was
removed to an equal volume of phenol/chloroform and the mixture again centrifuged
at 3,000 rpm for 5 minutes. The aqueous supernatant was added to an equal volume
of chloroform, the solution mixed and centrifuged at 3,000 rpm for 5 minutes. The
supernatant is taken and aliquoted into 2 ml eppendorf tubes with 800 pi in each
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tube. To each tube, 1/10 volume of 3M Sodium acetate and 2 lA to 3 volumes of ice-
cold 100% Ethanol was added to precipitate the DNA. Each tube was placed at -
20°C overnight to aid precipitation. The tubes were centrifuged in an eppendorf
centrifuge at maximum speed, 13,000 rpm. The pellets were washed with 70%
Ethanol and allowed to dry at room temperature for 10 minutes. The pellets were
allowed to dissolve in 400 pi TE (for the total 200 ml culture), at 4°C overnight.
Samples were tested for purity and concentration by both spectrometry and agarose
gel electrophoresis.
2.2.7 Small-scale growth (miniprep) ofplasmid DNA.
A single colony is picked from an overnight transformation plate and used to
inoculate 5-10 ml of Terrific Broth containing the appropriate antibiotic (eg: 50
pg/ml ampicillin). The starter culture was grown up overnight at 37°C. The cells
were centrifuged at 13 K for 5 minutes and resuspended in 600 pi TELT. The
resuspension was transferred to an eppendorf tube and 40 pi of 100 mg/ml of
lysozyme added and left for 2 minutes. The suspension was boiled for 1.5 minutes,
then cooled on ice for 10 minutes. Cell debris was pelleted by spinning the
suspension for 15 minutes at 14 K in an eppendorf centrifuge. The supernatant was
removed to a fresh tube and 0.6 of a volume (360 pi) of isopropanol was added. The
solution was left on ice for 2 minutes and then spun out at 14 K for 20 - 30 minutes.
The pellet was washed in 70% ethanol and allowed to dry in air for 15 minutes. The
pellet was then resuspended in 50 pi of TE buffer and a sample removed for
quantification by agarose gel electrophoresis.
2.2.8 Amplification ofDNA by the Polymerase Chain Reaction (PCR).
Amplification of DNA by the polymerase chain reaction (PCR) is a technique used
to produce large amounts of a specific DNA fragment. Forward and reverse primers
are annealed to a target plasmid or dsDNA sequence and copies of the target
sequence created by repeated rounds of primer annealing and extension of primers
with DNA polymerase to create dsDNA products. Primer annealing and extension
conditions determined according to standard methods described in Sambrook, 1997.
Here, PCR is used to amplify regions of plasmid DNA useful for Benzonase, DNasel
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and/or Footprinting analysis. Table 2.2 lists the primers and primer sequences used
for PCR analysis.
2.2.9 Dephosphorylation of5'-ends ofdsDNA for radioactive labelling
Dephosphorylation of 5' ends of dsDNA was required to prepare an efficient
template for 5' labelling with y-32P-ATP. For marker DNA, approximately 2 pg of
either pBR322/BsuRI (MBI) or pUC19/Hin61 were dephosphorylated with CIAP
(MBI-fermentas) or Shrimp Alkaline Phosphatase (Amersham) in a 50 pi reaction
volume according to methods described by each company. For Benzonase, DNasel
and Footprinting analysis, typically 2-10 pg ofDNA is dephosphorylated.
2.2.10 Preparation of radiolabeled marker DNA
For denaturing PAGE-urea gels, a variety of markers were used. These were
radiolabeled with 32P-y-ATP (Amersham). Commercial markers used were pBR322
cut with RswRI {HaeWl} (MBI-fermentas) and pUC19 cut with Mspl {HpaW} (MBI-
fermentas). The pBR322 marker ranges from 8 bp to 587 bp and the pUC19 marker
ranges from 26 bp to 501 bp. Therefore, they provide complementary information
about different sized bands, for the same size range. Both have a concentration of 0.5
mg/ml. For each marker, a 10 pi sample was taken, dephosphorylated as described
and subsequently radiolabelled. Labelling of between 10 and 100 pmoles of dsDNA
was performed with 32P-y-ATP (Amersham) in a final volume of 50 pi, with 12 units
of T4 polynucleotide kinase in IX T4 PNK reaction buffer. Labelled markers were
purified using CentriSpin-10 columns (Princeton-Separations) and stored for use at -
20°C in a Perspex container. For gel analysis, a 2 pi sample was taken, diluted to 20
pi with Sequencing gel buffer and 5 pi of this mix loaded per lane as required.
Other markers used for PAGE-urea gels were generated from the DNA
fragment being observed. For example to highlight specific regions of interest a
sample of between 20 ng to 500 ng of 5'-labelled unmethylated DNA was kept aside
prior to either Benzonase or DNasel analysis. This fragment was digested with
Hin6\ {Hhal} (MBI-fermentas) to highlight 5'-GCGC-3' regions, or with HpaW to
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2.2.11 Radioactive labelling of substrate DNA for Benzonase, DNasel and
Footprinting analyses.
Radioactive labelling of DNA at the 5'-ends with 32P-y-ATP for Benzonase, DNasel
and footprinting analyses was essentially carried out as described for the preparation
of radiolabeled markers. In some cases the reaction was scaled up to obtain a high
incorporation rate of radiolabel. After labelling of the 5' ends ofDNA, the DNA was
purified by a CentriSpin-20 (Princeton) column and one of the 5' labelled ends of the
fragment removed by restriction enzyme digestion. Centrispin -30 or -Ah columns
were used to remove the labelled end. In most cases removal was unnecessary as the
cleaved DNA fragment was small enough to not interfere with structural analysis. If
the restriction enzyme buffer was suitable, Benzonase digestion could be carried out
directly. In most cases the DNA was either re-purified on a CentriSpin column or
phenol-chloroform extracted, ethanol precipitated and resuspended in ddffO.
2.2.12 Preparation and Running ofdenaturing PAGE/urea Sequencing gels
Denaturing PAGE/urea gels were prepared in line with standard methods described
in Sambrook, 1997 with some modifications made according to the apparatus used
and improvements to the gel mix to improve image resolution. Four different
concentrations of PAGE/urea were prepared as shown in Table 2.3 below.
Percentage 6 % 8 % 10 % 12 %
urea 187.43 g 187.43 g 187.43 g 187.43 g
40% Acrylamide (19:1) 69.94 ml 93.53 ml 117.26 ml 140.52 ml
10XTBE 44.64 ml 44.64 ml 44.64 ml 44. 64 ml
ddH20 197.92 ml 174.33 m 150.59 ml 127.41 ml
Table 2.3 Denaturing PAGE/urea gel mix recipies. The above components were each
mixed together and gently heated on a heating block to promote solubilisation of urea. The
mass of each solution is approximately 500 g. For a single gel, 100 ml of solution is used is
taken. To this 90 pi of 25 % APS and 125 pi of Temed is added. The solution is mixed
thoroughly and used quickly as polymerisation is rapid. 20-30 ml of the solution is used to
wash out gel pouring apparatus (syringes and tubing) and the rest is used to pour the gel.
Sequencing gel apparatus used was obtained by BIO-RAD and is the Sequi-Genll
model. Gel pouring is through the base of the gel. A 14 well comb was added to the
top of the gel, which is then sealed with clingfilm and allowed to set. For use, the gel
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is preheated at 50 W for Zi hour to 1 hour until the temperature reaches a stable
50°C. The wells are rinsed to remove urea prior to sample loading. The gel is again
run at 50 W for 2 to 3 or more hours depending on the % acrylamide and the size of
the DNA fragment.
2.2.13 Drying and Exposure ofPAGE/urea gels
Denaturing PAGE-urea gels were typically run for between 2 and 3 hours. Once
electrophoresis was complete, the gels were allowed to cool back to room
temperature. The plates were separated carefully and the gel allowed to soak in a
layer of 10 % acetic acid / 10 % methanol solution to leach out the urea. The acetic
acid/methanol was added carefully to the surface of the gel, which was balanced
over a drainage sink. After 15 minutes, the solution was tipped off and the gel
surface rinsed, with several careful washes of ddH20. Two layers of 17 CHR paper
(3MM) were cut to gel size and soaked briefly in ddfEO. Each sheet was levered
gently onto the gel surface. To ensure no air bubbles are present, the paper was
flattened by rolling a long glass rod from one end of the gel to the other. Two larger
17 CHR sheets were used as backing and the gel flipped over and placed
horizontally so that the glass plate holding the gel faced upwards. The plate was
carefully lifted, while the 3M paper was removed from underneath along with the
gel. The removed gel was covered with Saran ™ wrap and dried on a gel drier for
30-40 minutes at 80°C under air suction. The dried gel was then placed in a
phosphorlmager (Fugifilm) cassette with a white Fugifilm-screen and left overnight
at room temperature. The following day, the screen was scanned in a
phosphorlmager (Fugifilm) according to manufacturer's instruction with 16 bit
resolution, 500 dpi and a sensitivity of Fl=1000. Scanned images were later reduced
in size to TIFF and JPG files if this did not result in any loss of resolution.
2.2.14 SDS-PAGEfor the denaturation and resolution ofproteins.
Standard SDS-PAGE analysis was carried out for all protein expression and
purification stages mentioned throughout the thesis.
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Table 2.4 outlining the volumes of each component used to obtain different
concentrations of separating gels for SDS-PAGE is provided below.
Percentage 7% 10% 12% 15%
ddH20 5.05 ml 4.05 ml 3.35 ml 2.35 ml
1.5 M Tris-CI, pH 8.8 2.5 ml 2.5 ml 2.5 ml 2.5 ml
10% SDS 0.1 ml 0.1 ml 0.1 ml 0.1 ml
Acrylamide/Bisacrylamide
(30%/0.8% w/v), 29:1
2.3 ml 3.3 ml 4.0 ml 5.0 ml
10% APS 0.05 ml 0.05 ml 0.05 ml 0.05 ml
TEMED 5 pi 5 pi 5 pi 5 pi
Total Monomer 10 ml 10 ml 10 ml 10 ml
Table 2.4 Separating gels for SDS-PAGE analysis. Separating gels are prepared to the
desired concentration dependent on the range of protein separation required. Temed is
added last to the reaction and mixed thoroughly. Gels are poured as described in Sambrook,
1997 and according to the manufacturers recommendations, in this case BIO-RAD.
Separating gels are allowed to polymerise at room temperature and are overlayed with
ddH20 to aid the process. Once set the ddH2) is poured off and a 4% stacking gel is
overlayed and allowed to set. Stacking gels are made by mixing 3.3 ml of ddH20, 1.25 ml of
0.5 M Tris-CI, pH 6.8, 50 pi of 10 % SDS, 670 pi of acrylamide/Bisacrylamide (30%/0.8%
w/v), 25 pi of 10% APS and 15 pi of Temed.
2.2.15 Induction procedurefor GST-taggedMBD protein
The following is an optimised protocol for the bacterial cell based expression of the
rat GST tagged MBD protein. It was also applied to a series of purifications of the
methylated DNA binding protein, Kaiso. These purifications were not used in this
thesis but may be used by others. Many attempts were made to obtain pure and
active protein based around standard methods of GST-fused protein induction. Four
sets of 20 ml starter cultures containing LB with ampicillin at 50 pg/ml were grown
up overnight at 37°C in a shaking incubator. These contained a scraping from a
culture of BL21(DE3)pLysS cells transformed with pGEX-3T-MBD; a plasmid
containing the MBD domain of the rat MeCP2 protein. The following day 15 mis of
each culture were each transferred to a flask containing 1L of LB with ampicillin at
50 pg/ml. Herein I will describe the fate of one of these cultures. The culture was
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grown at 37°C in a shaking incubator, until it had reached an OD6oo of 0.6 (approx. 2
to 3 hours). At this point an 100 pi sample (pre-induction) was taken for SDS-PAGE
analysis, and stored at 4°C. Protein production was induced with IPTG (1M stock),
which was added to the main culture to a final concentration of 4 mM. The culture
was grown at 30°C for a further 2 hours. The reduced temperature was found to
produce larger amounts of more active protein. After induction the cells were
pelleted by centrifugation in 1L bottles at 3K for 10 minutes. The cells were
resuspended in 50 ml of PBS, pH 7 with 1 protease inhibitor cocktail tablet (Sigma)
pre-dissolved or with 4 mM PMSF. Another 100 pi sample (post-induction) was
taken for SDS-PAGE analysis and stored at 4°C. The resuspension was then
sonicated on ice with a large probe, for 30 seconds. Each resuspension was in turn
sonicated between 4 and 5 times. A third 100 pi sample (post-sonication) was taken.
The sonicated cells were then pelleted by centrifugation at 8K for 15 minutes.
Supernatant and pellet were separated and an 100 pi sample of both was taken and
stored at 4°C. The supernatant containing the soluble protein was removed and
stored at -20°C. The supernatant and pellet were subsequently subjected to a series
of purifications to remove it from all contaminating proteins.
2.2.16 Fast Method to test IPTG induced cell cultures for effective protein
expression.
This method was devised to test IPTG induced bacterial cell cultures for efficient
protein production before proceeding to full-scale purification of the protein batch.
This is described for GST-fused proteins but can also be applied to other binding
matrixes. A 40 pi sample was taken of glutathione sepharose 4B (Amersham-
Pharmacia), the GST-binding material for protein purification. The suspension
contains a mixture of glutathione beads suspended in ethanol. The beads were
washed three times by spinning the suspension down slowly in an eppendorf tube for
5minutes at 5K, removing the ethanol supernatant and resuspending the beads in 40
pi of IX PBS. Once the beads were washed, a 0.5 ml sample of the cell lysate
supernatant was added to the beads, mixed gently and incubated at room temperature
for 30 minutes. The beads were centrifuged at 5K for 5 minutes and the supernatant
kept for analysis. The beads were then washed 3 more times with 40 pi of IX PBS as
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before but with each wash the supernatant was removed and kept for analysis. To
each sample taken, a 20 pi of 2X SDS sample buffer was added. The 40 pi sample of
pelleted beads was also taken for SDS-PAGE analysis. The samples were taken and
run on a 10% SDS-PAGE gel to determine that the protein was (a) expressed and (b)
correctly binding to the glutathione beads (data not shown). When the protein had
been expressed to appreciable levels and was appearing to bind and elute correctly,
the cell lysate supernatant was subjected to further purifications.
2.2.17 GSTpurification using Glutathione Sepharose 4B beads
Glutathione sepharose 4B beads (Pharmacia) were used to purify GST tagged
proteins. Disposable 10 ml columns (BIO-RAD) were packed with 2 to 3 cm of
glutathione sepharose 4B beads (GST-beads). The gel was washed through with 5-10
bed volumes of IX PBS to remove ethanol and then equilibrated with 3 bed volumes
of IX PBS. The protein containing supernatant was filtered through a 0.45 pm filter
before being applied to the column. In cases where the sample is still too
concentrated, it was diluted in PBS + 1% Triton X-100. The protein extract was
applied to the column and a sample kept back of the supernatant for testing. The
eluent was collected and kept for analysis. The column was washed through with 10
bed volumes of IX PBS to remove bacterial proteins from the applied lysate. The
bound protein was eluted with at least 5 bed volumes of elution buffer. The elution
buffer contained 50 mM to a maximum of 100 mM glutathione in 50 mM Tris-HCl,
pH 8.0. The eluted protein was collected as 1 ml fractions. Samples of the lysate,
eluent and fractions collected were all taken and run on a 12% SDS-PAGE gel. The
GST-tagged protein was used in some initial Bandshift experiments (data not shown)
and was later shelved in preference of a histidine tagged version of the MBD protein.
2.2.18 Expression ofpET6hMBD; a histidine taggedMBD protein.
BL21(DE3)pLysS cells transformed with pET6hMBD; a histidine tagged protein
expression vector containing the MBD domain of rat MeCP2 were used to inoculate
a 10 ml culture of LB-broth and 100 pg of ampicillin and grown overnight at 37°C.
The following day the culture was used to inoculate 500 ml of TB broth containing
ampicillin @ 100 pg/ml. The culture was grown to an OD6qo of 0.4-0.6 at which
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point they were induced to express protein with IPTG to a final concentration of 0.4
mM. The cultures were grown for a further 2 hours after which point they were put
in 1 L containers and pelleted by centrifugation for 10 minutes at 3.5K The cells
were then resuspended in 15 ml of Buffer B with 1M urea and then sonicated three
times each for 2 minutes each, on ice. The cell debris was pelleted by centrifugation
for 35 minutes at 13,000 rpm using a JA20 rotor, after removing an 100 pi sample
(pre-spin) for SDS-PAGE analysis. After the spin, another lOOpl sample was
removed from both the supernatant (post-spin-sup) and pellet (post-spin pellet). The
pellet was then dissolved in 10 ml buffer B (+ 2.5 M urea + 0.8 M NaCl), and a
sample removed for SDS-PAGE gel analysis.
2.2.19 Dialysis ofthe dissolvedpellets from pET6hMBD expression.
To obtain the maximum amount of expressed MBD protein possible, pellets
containing insoluble MBD protein from the induction procedure, above, were
dissolved in buffer B containing 2.5 M urea and 0.8 M NaCl. To maintain their
solubility they were dialysed slowly to remove the urea. This was achieved as
follows. The dissolved pellets were carefully transferred to sterilised dialysis bags
and clipped with sterilised clips. The dialysis bags were then placed in a 1 L beaker
containing a 4°C solution of 1000 ml Buffer B with 2 M urea and 0.6 M NaCl. The
pellets were allowed to dialyse for 1 hour at 4°C, while the buffer was being mixed
with a magnetic stirrer. After this the buffer was exchanged to Buffer B containing 1
M urea and 0.4 M NaCl. Again, the buffer was precooled at 4°C, and the pellets were
allowed to dialyse in the cold room at 4°C for 1 hour. Again, the buffer was
exchanged to a pre-cooled Buffer B, containing 0.5 M urea and 0.2 M NaCl, and the
procedure followed as described. The final two buffers for dialysis contained Buffer
B containing (0.2 M urea + 0.1 M NaCl) and Buffer B only, in that order. In
summary, the buffer order was as follows: (a) Buffer B (+ 2.5 M urea + 0.8 M
NaCl), (b) Buffer B (+2 M urea + 0.6 M NaCl), (c) Buffer B (+ 1 M urea + 0.4 M
NaCl), (d) Buffer B (+0.5 M urea + 0.2 M NaCl), (e) Buffer B (+0.2 M urea + 0.1 M
NaCl) and (f) Buffer B only. Post-dialysis a sample was taken for gel analysis.
Finally, the collective dialysed pellets were centrifuged at 15K for 30 minutes and a
sample taken from both supernatant and pellet for SDS-PAGE analysis.
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2.2.20 Purification of the MBD protein pellet using a Fractogel EMD-SOf -650
column.
The isoelectric point of the MBD protein domain from MeCP2 was estimated by
using a web-based program from SWIS-PROT at http://www.expasy.ch/sprot. The
sequence of the MBD domain of MeCP2 was obtained from Meehan et al., 1993.
From this information a purification protocol was designed. The MBD contains 85
amino acids with an estimated Mr= 10,000 Da. The estimated pi is 9.7. It is therefore
a cationic protein and capable of binding to an SCVcolumn. The fully dialysed pellet
of MBD protein as described above, was suspended in 25 ml of Buffer B. Having
firstly retained an 100 pi sample for SDS-PAGE analysis later, the protein sample is
applied to a 20 ml BIO-RAD disposable column containing 5 ml of Fractogel EMD-
SC>3~cation exchanger that has been washed through several times with Buffer B.
The flow through was collected and the column washed 3 times with Buffer B. To
elute the bound protein the cation exchange gel was challenged with increasing
concentrations of NaCl, effectively competing with bound protein for binding sites
in the gel matrix. Buffer B containing concentrations of 0.4 M, 0.5 M, 0.6 M, 0.7 M,
0.8 M, 0.9 M and 1.0 M were in turn passed through the column in volumes of 1.5
ml. The fractions were collected and an 100 ml sample of each removed for
subsequent gel analysis. The fractions containing a large quantity of the potential
MBD protein were pooled. However, these fractions also contained a large amount
of other SO3" binding proteins. Further purifications were required to remove excess
protein.
2.2.21 Purification of the Fractogel purified histidine tagged MBD protein over a
•2~F •
Ni charged affinity column.
Fractions of protein collected from elution with NaCl in the range 0.5 M to 1M,
9+
described above were pooled. A Ni charged column was set up by carefully adding
2ml ofwell-mixed Chelating Sepharose Fast Flow (Pharmacia) to a disposable 20 ml
BIO-RAD purification column. The gel was allowed to settle and was subsequently
washed through with 10 gel volumes of ddH20. A 250 mM stock of NiCl2 was
prepared to a final volume of 50 ml in 50 mM Sodium acetate, pH 6. Three times the
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gel volume of NiCl2 solution was added to the column. As it flowed through the
column the gel matrix shifted from white to green. The excess was washed through
with several more gel volumes of ddH20. When no more green eluent was removed
from the column, the matrix was assumed to be at maximum retention ofNi2+ ions.
The Ni2+ charged Sepharose was then equilibrated with 3 gel volumes of Buffer B.
A 0.5 M stock of L-Histidine was made up in ddH20. This was used to make a
diluton series of different concentrations of L-histidine to effectively compete with
the bound protein for Nickel ions. From this stock, L-histidine solutions were made
in Buffer B to a final volume of 50 ml in the range 2 mM to 80 mM. An 100 pi
sample of the pooled protein fractions was retained for analysis and the rest was
applied to the column. The solution was allowed to drip slowly through and the flow
through collected on ice. The bound histidine tagged MBD protein was eluted with
increasing concentrations of L-histidine in Buffer B as 1 ml fractions. The
experiment was repeated several times until the optimal concentration of L-histidine
was determined for both maximum purity and maximum concentration of protein.
An 100 pi sample of each fraction was taken for gel analysis and the rest of the
protein fractions were snap frozen in liquid N2 and stored at -80°C. The collective
samples from each fraction were run on a 10% SDS-PAGE gel.
2.2.22 Purification ofsupernatantfraction from pET6hMBD expression.
As described for pET6hMBD expression above, post IPTG-induced expression,
bacterial cells were sonicated, centrifuged and the expressed protein was split
between a soluble supernatant fraction and an insoluble pellet fraction. The pellet
fraction was treated as described above, with urea solubilisation and subsequent
column purifications over a cation exchange column and a Ni2+ charged column. The
supernatant fraction was purified similarly, except that the dialysis as described was
not required as the supernatant was already in a solution of Buffer B. Therein, the
procedure of purification was performed on the supernatant fraction as it was for the
pellet. Finally, purified fractions of the original supernatant from the nickel column
were combined with solubilised and purified fractions from the pellet, reapplied to a
nickel charged column and eluted to obtain a higher concentration of purified
protein.
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2.2.23 Annealing ofcomplementary ssDNA oligomers
Annealing of DNA is carried out for substrates for Bandshift analysis and for
substrates for the HIV-1 integrase assay. One radiolabelled (if required) primer is
annealed by incubating it with a 1.2 M excess of the complementary strand in an 100
pi solution of 50 mM Tris, pH 7.5 and 10 mM MgC^. The mixture is placed in a
85°C heating block for 5 minutes. The block is removed and placed on a metal stand
at room temperature to allow the block to cool gradually. This ensures correct
template annealing and the elimination of any secondary structure anomalies.
2.2.24 Bandshift analysis using bacterial cellpurifiedproteins
A selection of proteins were purified by virtue of having either a GST-affinity tag or
a histidine affinity tag. Purified proteins obtained in this manner included (1) GST-
MBD and HIS-MBD, the MBD domain of MeCP2 fused to a glutathione sepharose
(GST) or a histidine (HIS) tag, respectively. (2) GST-MBD1, in collaboration with
Dr. Irina Stancheva (3) GST-Kaiso-ZF, the Kaiso zinc fingers domain only, in
collaboration with Dr. Alexey Rusov. However, purifications of Kaiso did not prove
to be active and therefore bandshifts with this protein are not shown in this thesis.
Subsequent purifications may be used by others in the laboratory. Highly purified
fractions of each protein, as determined by Coomassie staining of SDS-PAGE gels
were chosen for bandshift analysis. Protein concentration of each purification was
estimated by using a BCA-200 protein assay kit (PIERCE) according to
manufacturer's instructions and/or by spectrophotometry.
A variety of DNA oligomers were chosen for bandshift analysis. These were
chosen based on published articles on the crystal structure of various dsDNA
fragments in the literature. Table 1.2 provides a summary of that information and
table 5.1 shows the oligomers that were synthesised. All oligos were synthesised by
MWG Biotech. One of the ssDNA oligomers was 5'-labelled with 32P-y-ATP. The
complementary strand was added in excess and annealed.
Bandshifts were performed in IX Bandshift Buffer with increasing
concentrations of purified protein. For each sample, approximately 10 ng (10 pi) of
5' labelled DNA is incubated with increasing concentrations of protein in IX
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Bandshift Buffer. For competitive bandshifts lpg of DNA is added to each lane bar
the control lanes. The volume is made to 50 pi with ddFfO. Samples are incubated
on ice for 30 minutes to allow protein binding to occur. A 5 % PAGE gel made with
0.5 X TBE is pre-run in the cold room. From each reaction 40 pi is taken to which 4
pi of glycerol is added. Normal 6X loading buffer interferes with protein-DNA
interactions. Gels are run between 100 and 200 V in 0.5 X TBE. They are then dried
down at 80°C for 40 minutes and exposed to either autoradiographic film or a
Fugifilm Phosphorlmager screen.
2.2.25 Protocol for Benzonase Digestions ofRadiolabelled DNA
Substrate DNA for the Benzonase assay can be obtained from a variety of different
sources. Plasmid DNA was generally prepared by midipreparation. DNA fragments
generated by PCR were PAGE purified to remove primers and incomplete PGR
products and cleaned up with ethanol precipitation followed by washing with 80 %
ethanol. Fragments prepared by restriction enzyme digests of plasmid DNA were
agarose or PAGE gel purified and the DNA extracted by cutting the relevant bands
from the gel. Slices were placed in single eppendorf tubes along with 1 ml of Gel
Extraction Buffer. The slices were left overnight on a rotating wheel in the cold
room. The following day the supernatant was removed from the gel slices and was
phenol-chloroform extracted, ethanol precipitated and resuspended in 50 pi TE
buffer. Once DNA created by either PCR or plasmid digests is purified it is ready to
be 5'-end labelled with ,2P-y-ATP. One of the 5'-end must then be removed by
restriction digests and the fragment is then ready to be digested by Benzonase. More
details are provided in Table 2.5, which outlines the basic protocol used.
2.2.26 Protocolfor DNAaselDigestions ofRadiolabelled DNA
The protocol for DNasel analysis of DNA fragments is the same as that described
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after DNA fragment preparation. An example of the basic protocol with more details
pertaining the DNasel assay specifically is provided in Table 2.6.
2.2.27 Protocolfor Footprinting Analysis ofRadiolabelledDNA
The protocol for Footprinting analysis on DNA fragments is the same as that
described above for Benzonase analysis. There are distinct differences in the
Footprinting protocol after DNA fragment preparation. An example of the basic
protocol and information specific to the Footprinting procedure used in this thesis is
provided in Table 2.7.
2.2.28 Western Blotting Procedurefor histidine tagged or GST taggedproteins.
An SDS-PAGE gel is run as normal on a small BIORAD protein gel system at 200 V
for 40-60 minutes. The gel is soaked in IX Transfer Buffer for 10 minutes to leach
out the SDS. At the same time, one gel-sized sheet of nitrocellulose and two of 3MM
paper are also soaked in the same buffer. The BIO-RAD transfer apparatus is set up
according to the manufacturer's instructions. The gel is then layered on one side with
the nitrocellulose sheet and on both sides with 3MM paper. Outside of the 3MM
paper, a sponge is placed. The sandwich is placed in a holder and the gel transferred
at 200 mA for 1 hour with a stirrer and cooling bar. Pre-stained markers help to
monitor the transfer. After transfer the gel is washed with H2O, stained with a 1/20
dilution of stock ponseau S to identify bands. Molecular weight bands can be marked
with a pencil. The filter is destained with ddFEO and the filter blocked for 20
minutes with PBS/2% dried non-fat milk/0.1% azide. The filter is then incubated
from 1-4 hours to overnight with a 1/1000 dilution of antibody in TBS/1% FCS. The
blot is then washed three times for 15 minutes with TBS/0.5 % Tween 20. HRP
conjugated anti-mouse rabbit IgG at a 1/3000 dilution in TBS/10 % FCS for 1 hour.
The blot was again washed three times for 15 minutes with TBS/0.5 % Tween 20
and then finally with ddFEO. Commercial ECL solutions were mixed according to
instructions and applied to the filter. After 1 minute the filter was wrapped in
clingfilm, placed in a cassette and autoradiographed to develop the fluorescent
reaction of the antibody and conjugated substrate.
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3.1 Devising a method to detect the presence of A-DNA in CpG
methylated DNA.
3.1.1 Introduction
The background of this thesis has been detailed in the introduction (chapter 1) and is
concerned with CpG methylated DNA structure and its' relevance in the context of
higher order chromatin structure and gene regulation. The aims of this thesis as
described in section 1.7, were to devise a method or to use/modify an existing one, to
investigate whether CpG methylated DNA can induce the A-form tertiary DNA
structure in gene regulatory regions. The Abstract describes the course of action
taken in this work. Prior to establishing Benzonase as the choice enzyme for this
analysis, other methods were investigated. In this chapter I will introduce these
methods and also describe in detail how the Benzonase enzyme was applied for use
on CpG methylated DNA.
The first method tried for the detection ofA-DNA was a retroviral integration
based assay. The experimental data from this approach is detailed in the appendix
(chapter 7). This assay proved to be a complicated method of choice. It is dependent
on the action of the HIV-1 integrase protein. The integrase protein in vivo, directs the
integration of the viral HIV-1 genome into host DNA. It does this by recognising and
binding to long terminal repeats (LTRs) at the ends of the viral DNA and
recombining them with nicked host DNA by the method of site-specific
recombination. The integrase assay developed by Chow et al., (review: Chow, 1997)
uses in vitro expressed and purified HIV-1 integrase to integrate a substrate sequence
of interest into a target plasmid. Figure 3.1 summarises the procedure. The substrate
DNA is first constructed by PCR to contain a copy of the HIV-1 LTR at each end,
which HIV-1 integrase can recognize and bind. It then integrates many copies of the
substrate into the target plasmid. After integration the target plasmid should contain
copies of the substrate DNA at the preferred sites of integration for HIV-1 integrase.
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Figure 3.1 The Integrase Assay: An Outline. Schematic representation of the PCR based
assay. The preprocessed substrate DNA has viral DNA recognition sites for HIV-1 integrase.
Both protein and substrate combine and by the action of HIV-1 integrase, the substrate DNA is
inserted into the target plasmid containing the gene of interest. The sites of integration are based
on preferences of the HIV-1 integrase protein. These are usually regions of altered DNA
structure; ie: bent DNA, nucleosomal DNA and CpG methylated DNA (Muller & Varmus, 1994;
Pruss etal., 1994a & 1994b; Kitamura etai, 1992). These integration sites can be identified by
PCR, as depicted, with a radiolabelled primer to the substrate DNA and a primer to a region in or
5' to the target gene of interest. Amplified products can be separated on a denaturing
PAGE/Urea gel. This method can be used to identify the effect of CpG methylation on insertion
site preference and therefore on DNA structure. (Adapted from Chow, 1997).
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These include DNA with a wide major groove, unusual secondary structures, CpG
methylated DNA and nucleosomal DNA (Kitamura et al., 1992; Pruss et al., 1994a
& 1994b, Muller & Varmus, 1994). Detection of integration sites is via PCR with a
radiolabeled forward primer specific to the target plasmid and an unlabelled reverse
primer specific to the integrated substrate DNA. The resultant PCR fragments can
then be run on a denaturing PAGE/urea gel. The position of each fragment on the gel
should then correspond to the site of integration in the plasmid. Some sites will show
preference over others.
It was hoped that CpG methylated DNA would provide hotspots for
integration, with highly integrated regions showing pronounced structural differences
from their unmethylated counterparts. The plan was to then investigate further the
nature of these methylation dependent altered sequences. However, several problems
were encountered as the assay depended on many experimental variables. These
problems are discussed in the Appendix, Chapter 7. Additionally, the assay would
only highlight DNA regions corresponding to preferred integration sites of unusual
or an altered structure from typical B-form DNA. It does not tell us what they are and
does not differentiate between small secondary structure alterations and larger
conformational changes. It detects them all, as long as they provide a good binding
site for HIV-1 integrase (Muller & Varmus, 1994). Finally, requests for a chemically
synthesised chiral probe specific for A-DNA, which would help to isolate A-DNA
from other structural alterations, was declined by the researchers concerned (Mei et
al., 1988). This approach was then abandoned.
It was subsequently found that research into the bacterium Serratia
marcescens led to the discovery of an extracellular DNA/RNA non-specific
endonuclease called benzon nuclease, now known commercially, as 'Benzonase'
(BDH), (Meiss et al., 1995). Investigations revealed that this enzyme has preferred
sites of nuclease activity. In these experiments Meiss et al., used PCR to generate
specific DNA fragments from pBR322. The fragments were y-32P-ATP labeled at
one end. The labeled fragments were digested with Benzonase and the fragments
separated on a denaturing PAGE/urea gel. This work showed that regions of DNA
known to contain regions that form A-DNA crystals, reacted strongly with the
enzyme in vitro (Meiss et al., 1999).
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The above experiments did not involve the analysis of methylated sites, so we
decided to try and use Benzonase for methylated DNA analysis. If Benzonase proved
to be reactive with CpG methylated DNA, it would provide a more direct link to
establishing sites of potential A-form DNA, than any retroviral integration assay
could establish. It was also commercially available in highly purified and
concentrated form as it is used in the large-scale removal of nucleic acids in
pharmaceutical products. It would also be a novel use of this enzyme in methylation
analysis, and perhaps tell us a little more about DNA structure and gene regulation.
For these reasons, Benzonase was investigated as a potential tool for methylation
analysis.
In this thesis, I have investigated the effects of Benzonase on DNA further.
Initial questions included: Can Benzonase be used in a qualitative-quantitative assay
to detect small (1-10 bp) regions of A-DNA? Can it be used to find methylation-
dependent changes in DNA structure? Are these changes useful and informative in
relation to gene regulation?
3.1.2 Results
3.1.2.1 Can the Benzonase Assay detect A-form DNA in CpG methylatedDNA?
To investigate the effects of Benzonase on DNA, several initial experiments were
performed to establish the correct concentration range to use such that there is on
average 50 % digestion of the DNA fragments being analysed. This would allow
visualization of a digestion pattern in the DNA, without extending to complete
digestion of DNA. This experiment was repeated several times using the plasmid
pBR322, and a large concentration range of Benzonase (data not shown). It was
consistently found that Benzonase is a very potent nuclease. A dilution ratio of
1:10,1000, still provides strong nuclease activity on DNA. Having determined
activity ratios of Benzonase to DNA, a pilot experiment was used to determine if any
preference existed for CpG methylated DNA in terms of DNA digestion rates. Given
that CpG methylated DNA can form A-DNA in certain sequence contexts (see
introduction and table 1.2), it was reasonable to hypothesise that this might be
reflected in Benzonase digestion rates on DNA. If CpG methylated DNA can form
A-DNA, then perhaps it could be recognised and digested faster than unmethylated
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DNA. The pBR322 plasmid was transformed into DH115 cells, midipreped, purified
and split in half. DH115 cells were used as a host E. coli strain as they do not possess
any intrinsic methylation activity, ensuring that methylation of adenine or cytosine
has not already occurred on the sequence prior to analysis. One half of the DNA
sample was treated with SssI methylase which methylates the 5' position of cytosine
in the context of double-stranded d(CpG)n. It was then purified by phenol-chloroform
extraction, ethanol precipitated and resuspended in 100 pi of ddH20. The complete
methylation of the plasmid was tested by a methylation protection assay, an example
of which is shown later in figure 3.12. The concentrations of both unmethylated and
methylated pBR322 samples were estimated by spectroscopy at A26o/280 nm The
volume of each sample was adjusted to achieve the same DNA concentration in each
sample. Both samples were divided into aliquots and subjected to a Benzonase digest
for 5 minutes at increasing enzyme concentrations. The samples were purified and
run on a 2 % agarose gel and visualized by staining with SYBR gold™ (Molecular
Probes). As seen from figure 3.2, Benzonase appears to digest both unmethylated and
methylated samples at similar reaction rates-with perhaps some increased sensitivity
to methylated DNA. There was no indication from this experiment that CpG
methylated DNA, (according to the hypothesis, having more regions forming A-
DNA than the unmethylated sample), was digested appreciably faster by Benzonase.
However, it was also possible that CpG methylation alone was not enough to
change the overall reaction dynamics, but perhaps the effects were localized and
would only show altered cleavage dynamics at specific sites. It was decided to
pursue this question using an assay based on the method of Meiss et al., (1995, 1998,
1999). It was not clear at this stage whether the assay would be suitable for small
stretches of A-DNA formation and whether it would be suited to methylation
analysis. These aspects are addressed below.
D
3.1.2.2 Benzonase Analysis on the Amp gene of pBR322 : the effect of
methylation
Some initial 'tester' DNA sequences were chosen for their known ability to form A-
DNA by other methods. These were used to confirm that Benzonase would perform
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Figure 3.2 Benzonase digest of pBR322 plasmid. SYBR gold stained 2% agarose gel of
benzonase digestion of Sssl methylated (+M)and unmethylated (-M) pBR322 plasmid. AT, Gene
Ruler™ DNA Ladder Mix (MBI), m pBR322 digested with BsuR\. Equal concentrations of
pBR322 were subjected to a Benzonse digest for five minutes each, with increasing
concentrations of Benzonase. The gel is stained with the sensitive nucleic acid fluorescent dye
SYBR-gold (Molecular Probes), and scanned on a Fugifilm™ Phospholmager.
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in my hands, in vitro, as described by Meiss et. al., (1988). The first of these tester
sequences was previously shown to contain A-DNA (Mei et al., 1998). In this study,
a chiral probe, Tris(tetramethylphenanthroline)ruthenium(II) was synthesised and
used as a tool to cleave A-DNA specifically, after activation with UV treatment, in
conditions where little or no reactivity is seen with B-DNA. The same DNA
sequence used by Mei et al., was employed here to compare the reactivities of the
chiral probe data to Benzonase digestion of the same sample.
The procedure adopted for the Benzonase assay both here and in subsequent
analyses is summarised in figure 3.3. The protocol for digestion follows that
described below for all Benzonase digestions unless otherwise stated. More detailed
information is provided in Chapter 2. For Benzonase analysis, Hindlll - Sspl DNA
fragments were prepared from pBR322 by PCR. DNA fragments can also be
prepared by large-scale plasmid digestion. The full sequence of the fragment used is
shown in figure 3.4 /.and ii. The PCR products were then split in half, one half of
which was Nsvl methylated. The extent of methylation was confirmed by a
methylation protection assay (data not shown). Both unmethylated and methylated
samples were Benzonase digested and the fragments run on a 10 % denaturing
PAGE/urea gel (figure 3.5 A). The marker lane was prepared from unmethylated and
labeled HindlU - Sspl fragments which were digested individually with Sssl, Hhal,
DdeI, HaeIII, EcoRI and Clal. An aliquot of each of the digested fragments was run
in separate lanes on a 10 % PAGE gel to confirm the correct cleavage and sizes of
the DNA (data not shown) These fragments were combined and run alongside the
Benzonase digested fragments as marker DNA. As can be seen from figure 3.5 A the
unmethylated pBR322 fragments shows hotspots of Benzonase activity throughout
the sequence analysed.
As this fragment is the same as that used in the study by Mei et al., (1988), I
have compared the ability of Benzonase to cleave A-DNA with the pattern generated
by the A-DNA specific Ruthenium complex over the entire fragment. This is
provided in figure 3.4 Hi. As can be seen from the two patterns, Benzonase reacts in
the same way with the pBR322 fragment as does the Ruthenium complex. This
confirms that Benzonase is indeed a useful tool for the detection of A-form DNA,
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Figure 3.3 The Benzonase Assay: An Outline. Fragments for analysis can be prepared by
large scale and purification of plasmid DNA containing the sequence of interest, then restriction
digested to release the sequence, which can be separated and purified by agarose
electrophoresis or PAGE. Sequences can also be generated by PCR or they can by artificially
synthesised. Fragments can then be methylated with a variety of methylases. They are then y-
32P-ATP labelled at both ends, with one end later removed by restriction digest. Labelled
fragments are then subjected to Benzonase digestion and the resultant fragments purified and
separated on a denaturing PAGE/Urea gel. The gel is then dried down and exposed to X-ray film
and/or to a phophorimaging screen to identify the position of the radiolabeled digested
fragments of DNA. The results are analysed on a Fugifilm Phospholmagermachine.
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Figure 3.4 The sequence of pBR322 used for Benzonase analysis. In #
above is an illustration of the fragment from pBR322 used for Benzonase
analysis. The exact positions of each CpG is indicated and relevant restriction
sites. In ii above is the exact sequence used. In green are highlighted the PCR
primers used to amplify this sequence. In yellow, d(AATATT) is an Sspl site and
d(AAGCTT) is a H/ndlll site. In blue, a Hha\ site with two methylatable CpGs
and the position where methylation enhanced cleavage is seen with
Benzonase digestion. In red, other methylatable CpGs in the sequence that
show reactivity with DNasel but not with Benzonase (this thesis).Underlined is
the sequence used by Mei et al., 1988 to detect cleavage by a Ruthenium
complex designed to target A-DNA. Hi below shows the sequence used for
detection of potential A-DNA using a chiral probe by Mei et al., 1988 and is
adapted from this paper. The region from pBR322 used by Mei et al., is shorter
than that used in this thesis, but overlaps with a central region of it as
underlined above. The Hha\ site was not incorporated into their study, nor was
the effect of methylation on this sequence. The vertical lines indicate the
degree of cleavage at each site (Mei etal., 1988).
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Figure 3.5 A Benzonase digestion of pBR322 fragments. Benzonase digestion of PCR
generated pBR322 fragments in CpG methylated (+M) and unmethylated (-M) states, m, marker
lane generated by restriction digestion of unmethylated pBR322 samples, with C/al, EcoRI,
HaeIII, Ddel, Hha\ and Sspl. The digested fragments were combined to create the DNA ladder
shown here. The methylatable CpGs in the sequence are shown by large arrowheads along the
margin. These are shown to indicate that the predominant methylation induced structural
change in this sequence occurs at a Hha\ site containing two methylatable CpGs adjacent to





Figure 3.5 B Magnified view of Image 3.5 A. Benzonase Digest on
pBR322.This enhanced view is to show clearly the methylation induced
changes visible over a Hha\ recognition site as detected by Benzonase on the
methylated (+M) side of this gel. The marker is Hha\ digested unmethylated
pBR322 fragment which exactly pinpoints the region of structural change in the
fragment.
Figure 3.5 C Peak determination scan of figure 3.5 A. In this figure a region covering the
methylation induced change at position 111 bp, bracketed in figure 3.5 A, has been scanned
using Aida software in conjunction with a Fugifilm phospholmager machine. The bracketed
region from lane 5 for the unmethylated strand is compared to lane 5 for the methylated strand.
Regions where CpG methylation has induced a distinct structural change, as detected by
Benzonase, are indicated by an arrow. The intensity along the Y axis are arbitrary values
assigned by the Aida software over the full scale of intensity values available in the data set. The
X-axis refers to position within the gel overthe region scanned.
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The biggest revelation in this analysis is in the CpG methylated DNA. For the CpG
methylated pBR322 fragment, there is a different banding pattern at one location
only. The CpG methylation dependent change is highlighted and blown-up in figure
3.5 B. A peak determination analysis was performed on unmethylated and
methylated regions covering the methylation induced structural change. This was
performed using Aida™ software developed specifically for use with a Fugifilm
Phospholmaging machine. The results of this analysis are shown in figure 3.5 C.
There are ten CpG sites in the pBR322 fragment. Figure 3.4 ii shows the full
sequence of the pBR322 fragment. The Wsl methylase enzyme has the ability to
methylate all of the CpG sites highlighted in the text. From DNasel analysis of the
methylated sequence, this appears to be the case (see below). With this in mind, it is
surprising that only one of these sites reacts strongly with Benzonase. When the
DNA sequence surrounding each CpG was analysed, it was found that there was only
one CpG that was contained in an alternating GC string. The rest, even though
surrounded by cytosine and guanine residues, had neither sequence alternation nor
adjacent methylatable sites-both features that would promote consistency and the
formation ofA-DNA. The highly reactive sequence at 108 bp and 110 bp, represents
a Hhal cutting site. It has two adjacent CpGs, and alternation of sequence for 4 bp,
(5'...CCGCGC...3'). In the entire sequence there are no other adjacent CpG
doublets. It is reasonable to conclude that; from the alternating nature of this
sequence, the fact that X-ray crystallographic studies have shown this type of
methylated sequence to form A-DNA (Mooers et al., 1995; Tippin et al., 1997a &
1997b) and its reactivity with Benzonase, that this methylated sequence is capable of
forming A-DNA. This is the first example of CpG methylated DNA showing
sequence specific structural changes by this assay.
• /? •3.1.2.3 DNasel analysis on the Amp gene ofpBR322: the effect ofmethylation
DNasel analysis was employed on the same pBR322 fragment as used above.
There are several reasons for this analysis. DNasel is also a strong endonuclease and
has been employed as a useful tool in DNA structural analysis (see Sambrook, 1997
for applications). DNasel however, has different site preferences to Benzonase.
Unlike Benzonase, it reacts more strongly with the minor groove of DNA than the
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major groove, but is much less regular in its cleavage patterns. As the 5'-position of
cytosine lies in the major groove, any changes in cleavage rate by DNasel must be
due to DNA structural changes rather than altered hydrophobic contacts between the
endonuclease and DNA (Fox, 1986). DNasel shows altered cleavage patterns with
unusual DNA secondary structures, such as kinks, bends, cruciform structures and
methylated DNA. However, it cannot discriminate between them (Drew & Travers,
1984; Fox and Waring, 1984; Fox, 1986). DNasel concentration was optimised in
several experiments on both plasmid DNA and radiolabeled DNA to give
approximately 50 % digestion rates (data not shown). A DNasel assay was carried
out on the sequence. The process for DNasel analysis follows the illustration for
Benzonase analysis shown in figure 3.3.with DNasel in place of Benzonase. When
DNasel analysis is applied to the pBR322 fragments in unmethylated and methylated
states (figure 3.6 A), it is clear that the DNasel pattern is very different from the
Benzonase pattern (figure 3.5 A). Figure 3.6 A shows that now, instead of one highly
reactive methylated CpG region, there are now reactive sites at every CpG
methylated site. The marker lane is the same mix of digested fragments as that used
in 3.1.2.2 above. This assay confirms that: (a) DNasel is capable of picking out every
CpG in the methylated lanes of the digested pBR322 fragment. Therefore, the Sssl
methylation reaction was highly successful, (b) Each methylated CpG contributes to
an altered secondary structure in the DNA sequence that makes it more accessible to
DNasel activity, and (c) Benzonase is neither reacting randomly with methylation
induced altered DNA secondary structure, nor regions that have a slightly widened
DNA minor groove, as detected by DNasel. It only prefers to digest particular
regions ofCpG methylated DNA.
There is only one prominent band in the DNasel analysis that corresponds
exactly with the Benzonase analysis. Next to the marker at 111 bp are at least two
strongly reactive bands in the methylated lanes (figure 3.5 B and 3.6 B). At this
position there are two adjacent CpG sites surrounded by alternating C and G
residues, constituting a Hhal recognition site. It is this site that Benzonase reacts
strongly with. As stated, this methylated sequence has been crystallised as A-form




















mm mm mmm • i
mm mm mm* mm ' . .





0 12 3 4 0 1 2
Figure 3.6 A DNasel digestion of pBR322 fragments. A DNasel digestion of PCR
generated fragments from pBR322. These fragments correspond to the same fragments used
for Benzonase analysis in Figure 3.5. m, marker lane generated by restriction digestion of
unmethylated pBR322 with C/al, EcoRI, HaeIII, Ddel, Hha\ and Sspl. Small arrowheads
indicate the sizes of these combined markers. Large arrowheads indicate methylated sites in
the DNA sequence that react strongly with DNasel. The bars along the left hand side indicate
regions analysed for peak determination scans, which are shown in figures 3.6 C(i, iiand iii).
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Figure 3.6 B Magnified view of Image 3.6 A. DNasel analysis on pBR322.
This enhanced view is to show the pattern of DNasel digestion on unmethylated
(-) and methylated (+) fragments of the pBR322 plasmid. This view is to
demonstrate the enhanced cleavage at the CpG triplet, marked by a Hha\











































Figure 3.6 C Peak determination scan of selected regions of the DNasel digestion
analysis shown in figure 3.6 A. Selected regions were scanned using Aida software coupled
to a Fugifilm Phospholmager. The results of these scans are shown in figures/', /'/'above and Hi
on the following page. In all cases the regions scanned are colour coded on the left hand side of
each figure. The same bars are shown in figure 3.6 A, indicating the regions selected from the
gel. The intensity values are arbitrary values assigned by Aida software and refer to the
complete range of intensity values available in the data set. Vertical arrows show regions of
methylation enhanced cleavage by DNasel. For the scans shown in figures /', /'/' and /'/'/', lane 4
was chosen for the unmethylated strand and lane 3 was chosen for the methylated strand.
These were judged to be the most similar in terms of overall intensity values by Aida software




Figure 3.6 C Peak determination scan of selected regions of the DNasel
digestion analysis shown in figure 3.6 A. Selected regions were scanned
using Aida software coupled to a Fugifilm Phospholmager.The region
scanned is colour coded in orange on the left hand side of each figure. The
same bar is shown in figure 3.6 A, indicating the region selected from the gel.
The intensity values are arbitrary values assigned by Aida software and refer
to the complete range of intensity values available in the data set. Vertical
arrows show regions of methylation enhanced cleavage by DNasel. For the
scans shown in figures /, #7 and iii, lane 4 was chosen for the unmethylated
strand and lane 3 was chosen for the methylated strand. These were judged to
be the most similar in terms of overall intensity values by Aida software and
therefore suitable for comparison. (+M) is the CpG methylated fragment. (-M)
is the unmethylated fragment.
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Peak-determination analysis was performed on the DNasel digested fragments shown
in figure 3.6 A. Unmethylated and methylated regions of figure 3.6 A were chosen for
analysis with Aida software linked to a Fugifilm™ phospholmaging machine. The
results are shown in figure 3.6 C (i, ii and iii). Three regions of the DNasel digestion
analysis were selected that showed pronounced reactivity with DNasel. Regions
selected are clearly marked in each figure. The results clearly demonstrate the degree
of alteration of the sequence in response to methylation at specific sites.
The fact that Benzonase shows high reactivity with this sequence only, while
there are clearly other methylation induced structural alterations in the sequence, is a
tribute to its' specificity. Of note here also is the fact that stable A-DNA intermediate
structures have been crystallised. It has been shown that this transition is completely
promoted by CpG methylation. Vargason et al., (2000) have shown that the sequence
d(GGCGCC)2 forms B-DNA but the sequence d(GGCGm5C)2 forms E-DNA, a stable
intermediate between A-and B-DNA forms. As this sequence also exists in the
analysed fragments here, it is of note that it does not seem to be picked out by
Benzonase. Perhaps Benzonase requires the complete transition to A-DNA before it
can react readily enough to show heightened interaction at methylated CpGs?
Interestingly, a stable intermediate can also be seen for the B-DNA transition in non-
methylated DNA sequences (Ng et al., 2000). Both studies illustrate the fluidity of
DNA structure. It is not a rigid uniform structure, but dynamic in its changeability, a
feature that is echoed in this thesis.
3.1.2.4 Benzonase analysis ofa fragment of thepGEM9zf(~) plasmid vector
From the above studies it is clear that Benzonase can be used effectively for
methylated DNA analysis. It can distinguish between small structural changes that
are more readily picked out by DNasel analysis and larger conformational changes in
DNA. It is established that Benzonase can react in the same way with a pBR322
fragment as a chiral ruthenium complex that specifically recognizes A-DNA. To
further confirm that Benzonase was behaving as hoped and expected, a sample of the
original tester DNA from Dr. Pingoud was kindly donated to the project (Meiss et
al., 1999). The plasmid pGEM9zf(-) contains an 167 bp tester fragment which was
amplified by PCR. Herein it is called 'Pingoud'. These fragments were purified, with
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half the volume Sssl methylated. Both unmethylated and methylated samples were
y-32P-ATP labeled at both ends with one of the labeled ends removed, in this case
the Sail end. The Pingoud fragment used in this analysis is shown in figure 3.7 with
the CpGs highlighted. They were then subjected to Benzonase analysis. The results
of this experiment are seen in figure 3.8 A. It is apparent that Benzonase is behaving
as it does for Meiss et ai, 1999. The unmethylated lanes show the same hotspots for
Benzonase activity as in the original study. However, it is also very apparent that
there is a major difference now in the methylated fragments. As indicated in figure
3.8 A, there is a major shift from the unmethylated to methylated fragments. At this
region the sequence contains a string of (CG)n dinucleotides that are unreactive to
benzonase. However, when these dinucleotides are methylated they become highly
reactive to Benzonase. A much longer stretch of nucleotides are affected by
methylation here than in the previous analysis, which centred on a specific alteration.
This region was selected for Peak determination analysis, the results of which are
shown in figure 3.8 B. A similar experiment was performed using Hhal methylase
(methylates the central cytosine in GCGC) instead of SssI methylase. The pattern of
digestion showed the same region of enhanced interaction with Benzonase
confirming that it is alternating and methylated CG rich DNA that alters DNA
structure (data not shown).
These initial experiments highlight both the usefulness of Benzonase in
structural analysis of small CpG induced structural transitions and larger structural
transitions. It also highlights the very dramatic changes that DNA is capable of, when
CpG methylated. Such large structural alterations must have a strong regulatory role
in vivo, but these aspects of gene regulation in eukaryotes are still poorly understood.
3.1.2.5 Refining the technique: The use of urea to promote specificity of
Benzonase
Meiss et al., (1995) investigated the effects of various reaction conditions on
Benzonase activity and specificity. They demonstrated that the use of urea could
enhance the effect of Benzonase at preferred cut sites. This aspect of Benzonase
activity was reinvestigated here in an effort to refine the technique for A-DNA more
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Figure 3.7 In / above is an illustration of the fragment from pGEMZf9(-)
used for Benzonase analysis. This is the same fragment as that used by
Meiss etal., (1999). The position of each CpG is indicated in red. In //'above is
the exact sequence used. In green are highlighted the PCR primers used to
amplify this sequence. In yellow, d(TCTAGA) is an Xba\ site and
d(GTCGACGA) is a Sal I restriction site. Underlined are Hha\ recognition sites
and the positions where methylation enhanced cleavage is seen with
Benzonase digestion (this thesis). In boxes are sequences that correspond to
different types of DNA tertiary structure as deduced from several CD, NMR or
crystallographic studies. d(GGGCGCCC)2, A-type, (Eisenstein et al., 1988);
d(A)d(T)-tract, B-type, (Alexeev et al., 1987); d(GGTATACC)2, A-type, (Weston
et al., 1992; Zhou et al., 1987, 1988; Wang et al., 1987; Jamin et al., 1985);
d(CCAACGTTGG)2, B-type, (Prive et al., 1991); d(CGCGCGCG)2, B-type,
(Butkus et al., 1987); d(C)d(G)-tract, A-type, (Heinemann et al., 1994);
d(GCCCGGGC)2, A-type, (Heinemann et al., 1987, 1991). The 5'-CAATT-3'
fragment shown in purple is used to separate the different structural motifs. The
plasmid pGEMZf9(-) containing the above 167 bp insert was a gift from Dr.
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Figure 3.8 A Benzonase digest on pGEM9Zf(-) fragments. Benzonase
digestion was performed on Sssl methylated (+M) and unmethylated (-M) PCR
generated fragments from pGEM9Zf(-)A-H/>7fl, DNA digested with Hirrf\. The
fragments were labelled at one end and the fragments run on a 6 % PAGE / Urea
gel. There is a repeat of this experiment shown in figure 3.10 which shows the
methylation dependant changes in a higher percentage gel and is therefore
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Figure 3.8 B Peak determination scan of the Benzonase analysis performed in figure 3.8
A. The region scanned from figure 3.8 A is indicated alongside the image by a bracket. Only the
region of most pronounced cleavage by Benzonase was chosen for analysis. The peaks were
determined using Aida software coupled with a Fugifil Phospholmager. Lane 2 in the
unmethylated fragment was compared to lane 5 in the methylated fragment. Vertical
arrowheads indicate regions of enhanced cleavage in the methylated fragment as judged by
Benzonase Analysis. (+M), the CpG methylated DNA fragment. (-M), the unmethylated DNA
fragment.
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specifically. PCR fragments generated from pBR322 were split in half. These are the
same fragments used by Mei et al., (1988), that were generated here for benzonase
analysis as described in 3.1.2.2 above. Again, one batch was methylated with .SssI
methylase and checked for successful methylation with a methylation protection
assay (data not shown). The batches were y-32P-labeled at one end and subjected to a
benzonase assay in the absence and presence of 4 M urea. The results of this
experiment are shown in figure 3.9. In the digestion pattern, unmethylated DNA is
compared to methylated DNA in both the standard Benzonase digestion buffer and
the same buffer containing 4 M urea. The difference due to methylation is clearly
seen in both methylated samples digested and is highlighted in figure 3.9. This
pattern does not seem to be enhanced in the urea containing samples. Both
methylated digestion patterns seem to have the same frequency of cutting in standard
and urea containing samples. There also appears to be the same frequency and
pattern of digestion in the unmethylated sample lanes. In conclusion from this
experiment there appears to be no advantage in adding urea to the digestion buffer
solution. However, to further confirm this result the experiment was repeated as
described below.
Fragments generated from pGEM9Zf(-) were prepared as described in 3.1.2.4
above and are the Pingoud fragments used in 3.1.2.4 above. These correspond to the
same fragment as that used by Meiss et al., (1999). Benzonase analysis was carried
out on these fragments in the absence and presence of 4 M urea. Figure 3.10 A shows
the results of this experiment. Again, in each methylated sample, the digestion
pattern clearly reveals a methylation dependent change at the same region as that
shown in figure 3.8. As this analysis showed a clearer pattern of the methylation
enhanced cleavage, the region of most pronounced cleavage corresponding to the
d(CGCGCGCG)n sequence was selected for peak determination analysis. The results
of this analysis are shown in figure 3.10 B. In fact this image provides a more
accurate view of the methylation induced structural changes, especially over the B-
forming alternating d(CG)4 sequence, indicated by the Hhal digest in marker lane M.
In the unmethylated sample this is poorly reacted, but as soon as it is CpG
methylated it becomes a highly efficient cutting site. This methylation-induced
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Figure 3.9 Benzonase digest of pBR322 fragments in altered conditions.
Benzonase digest of PCR generated fragments from pBR322 in standard
Benzonase reaction buffer conditions (1X buffer Y+, MBI), compared to
standard Benzonase reaction buffer containing 4 M Urea. Fragments were Sssl
methylated (+M) and unmethylated (-M). m, Hha\ digest of unmethylated
pBR322 fragment. The bracketed region shows the change in structure due to
methylation. This is the same methylation induced change as seen in either (+)
or (-) Urea. It is also the same shift in pattern as that seen in figure 3.5.
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Figure 3.10 A Benzonase digest of pGEM9Zf(-) fragments in altered conditions.
Benzonase digest of PCR generated fragments from pGEM9Zf(-) in standard benzonase
reaction buffer conditions (1 x Buffer Y+, MBI) compared to standard benzonase reaction buffer
containing 4 M urea. Fragments were Sssl methylated (+M) and unmethylated (-M). m, 20 bp
DNA Ruler (Bio-Rad); M, Hha\ digested unmethylated pGEM9ZF(-) fragments. The star symbol
indicates an anomalous band present at this position across the gel. The sequences within the
fragment are indicated by bars on the left hand side of the image.
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Figure 3.10 B Peak determination scans of the Benzonase digestion
assay shown in figure 3.10 A The region scanned is highlighted in figure 3.10
with a heavy bracket alongside the gel image. This corresponds to the sequence
d(CGCGCGCG). There are four methylatable sites present in the sequence and
it appears that when methylated this sequence shows enhanced cleavage with
Benzonase. Lane 2 of the methylated fragment was compared to lane 2 of the
unmethylated strand for the 4M urea treated lanes. (+M) refers to the
methylated fragment. (-M) refers to the unmethylated fragment. Vertical arrows
indicate sites of methylation enhanced cleavage as judged by Benzonase
analysis.
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observation was made here and was not a feature of any of the analyses by Meiss et
al., (1995, 1998, 1999). However in this experiment, there does not seem to be any
increased specificity due to the presence of 4 M urea. The unmethylated samples also
show the same patterns of digestion in both standard and 4 M urea containing
reaction buffers. In conclusion, although Meiss et al., (1995) have reported increased
specificity for Benzonase in the presence of urea, coupled with the reduction of
cleavage at non A-forming sequences, by my analysis I have not seen the same
effect. In fact, there appears to be no advantage in adding urea to the reaction buffer,
and herein I have eliminated it from the standard protocol to keep the reaction
conditions as close to physiological conditions as possible.
3.1.2.6 DNA methylation andglobin gene regulation
Having established the effectiveness of Benzonase for the analysis of CpG
methylated DNA, the possible function and relevance ofmethylation induced A-form
DNA structures was investigated further by selecting a CpG rich gene known to be
affected in vitro by DNA methylation. For this, the human a.2-globin gene was
chosen and later the chicken pA-globin gene was analysed.
There is a strong correlation between CpG methylation of both a- and P-
globin gene control regions and transcriptional activities in different tissues (Ginder
et al., 1998). Generally, CpG methylation of globin gene promoter regions correlates
with transcriptional inactivity at developmental stages or in tissues where the genes
are not expressed (Singal et al., 1997). Abnormalities in the normal methylation
status of globin genes has been linked directly to a variety of disorders: the
thalassemias, diabetes and other blood conditions (review: Weatherall, 2001).
The correlation between transcriptional regulation and methylation of the
human a-globin locus is a little less clear than for the P-globin cluster. The p-globin
genes lack CpG islands and behave as typical tissue-specific genes. In contrast,
although the alpha-globin genes are also erythroid-specific, they are 60 % CpG rich
and do contain CpG islands. The alpha-globin genes also lack scaffold-attachment
regions, a feature that the p-globin genes possess (review: Higgs et al., 1989).
CpG islands are highly G+C rich regions of non-methylated DNA
associated with about 50% of mammalian gene promoters They remain non-
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methylated throughout development regardless of the expression of the gene, with
the exception of CpG islands in the inactive X-chromosome and those at imprinted
genes. All house keeping genes and many tissue-specific genes fall within this
group. The other 50% of mammalian genes have promoters with a G+C content and
methylation levels indistinguishable from bulk DNA. These are invariably associated
with tissue-specific genes (Antequera & Bird, 1993).
It has been long known that in many non-erythroid cell lines, the human
ot2-globin gene is not expressed, whether the CpG island is methylated or not.
However, recent RT-PCR analysis of the human a,2-globin gene has revealed that in
some non-expressing cell lines, where the CpG island is unmethylated, expression is
not completely eliminated, but reduced forty-fold. In cell lines where the CpG island,
extending into the promoter is methylated, ot2-globin gene expression is repressed
further (Cuadrado et al., 2001). There may be a specific type of chromatin
environment in different cell lines that actively represses genes not required for
proliferation. Indeed many cell cycle genes are also repressed by methylation in cell
lines. Therefore, protein factors alone may reduce expression substantially, but CpG
island methylation can completely abolish it. It is probable in this case, that the
coordinated activation and repression of the globin gene families is via methyl-CpG
mediated transcriptional mechanisms. Indeed, when the CpG islands of these genes
are found methylated, in HeLa cell extracts - they can bind to MeCPl (Boyes &
Bird, 1991). The exact organisation and control of these and other mechanisms
surrounding globin gene expression is presently not understood.
3.1.2.6.1 Preparation ofhuman a,2-globin gene fragmentsfor Benzonase analysis.
A pUC9 plasmid containing the full-length cloned version of the 1.5 kb human 012-
globin gene inserted into the Pst\ site (figure 3.11), was kindly provided by Prof.
Adrian Bird. Fragments of the gene were prepared by various methods. Initially,
plasmids were transformed into E. coli JM110 cells and grown to an O.D. of 0.8.
The plasmids were recovered by midipreparation and purified. Samples were taken
and differentially methylated. Three methylating enzymes were used: (a) Hhal
methylase (MBI) which methylates the central CG in the sequence GCGC, (b) Hpall
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methylase (MBI) which methylates the second cytosine in CCGG and (c) SlssI
methylase (NEB) with methylates every CpG. To confirm complete methylation of
the fragments they were then taken and individually challenged with methylation
sensitive and insensitive enzymes, ie: Hhal methylated fragments were challenged
with Hhal restriction enzyme. Hpall methylated fragments are challenged with
Hpall and Ss.s'1 methylated fragments are challenged with a mixture of both Hhal and
Hpall enzymes. Figure 3.12 shows the results of this analysis and is an example of
the methylation protection assay used for all methylated DNA analyses in this thesis.
They were then digested with Pvull to extract the full-length 1.5 kb gene. It was then
digested with Ncol producing two fragments, one of 1004 bp and the other of 811
bp. These enzymes are insensitive to CpG methylation or do not contain methylated
CpGs in their recognition sites. These fragments were isolated on a 1.0 % agarose
gel. They were gel purified and a sample of each recovered fragment run on a 1.0 %
agarose gel to check for purity and concentration (data not shown). The 811 bp
■yj
methylated fragments were then 5'-end labeled with P-y-ATP using T4 kinase.
These were chosen as they contain the transcriptional start and promoter region of
the a,2-globin gene. They were then cut at a single Pstl site at the start of the gene
sequence to produce a fragment of 605 bp that is labeled at the Ncol end on one
strand only. The sequence of this fragment is shown in figure 3.11. These fragments
were separated from the end that was removed and then subjected to Benzonase
digestion to reveal any regions of methylation-induced structural changes.
3.1.2.6.2 Benzonase analysis of the human a2-globin gene.
Benzonase digestion of an unmethylated 605 bp a,2-globin gene is compared to an
Sssl methylated version of the same fragment. Figure 3.11 shows the sequence of the
012-globin gene used with the methylatable CpGs highlighted. Figure 3.13 shows the
results of this assay. The marker lane provides a guide of Hhal sites in the DNA
sequence. As seen from figure 3.13, there are a number of structural changes
throughout the sequence. These are mainly located towards the end of the gel at
positions that coincide with the promoter region of the gene sequence. This
experiment was repeated several times (data not shown). Each time the results
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CG = CpG dinucleotide
= CCGG sequences, /-/pall restriction sites
= GCGC sequences, Hha\ restriction sites
= overlaps
Figure 3.11 The human a2-globin gene sequence. In A above the complete
human alpha globin gene sequence inserted into the pUC9 plasmid vector is
outlined. B The DNA sequence of the 615 bp Pst\ to A/col gene fragment
(inclusive of the enzyme recognition sites), used for Benzonase analysis. The
restriction enzyme sites for Psfl and A/col are underlined in the text at the 5' and
3' ends of the sequence respectively. The TATA box is also underlined in the text.
Other details are explained in the figure. Fragments were labelled at the A/col
end and cleaved at the Psfl end in the Benzonase digests shown. GCGC
sequences are Hha\ sites which have a strong potential to form A-DNA when
CpG methylated in previous Benzonase digests. CCGG sites are Hpall sites as













Figure 3.12 Methylation protection assay of pUC9 plasmid containing the human a2-
giobin gene. To assess that fragments are fully methylated prior to Benzonase , DNasel and
footprinting analysis- they are subjected to a methylation protection assay. M, 1 kb DNA ladder
mix (MBI-fermentas); m, pBR322 digested with BsuRI (MBI-fermentas). no meth. no digest,
Unmethylated plasmid and undigested control. Unmethylated plasmid is digested by Hha\,
HpaW and a combination of Hha\ and /-/pall. These are control lanes to demonstrate both the
activity of the enzymes and the digestion pattern of unmethylated plasmid DNA. Methylated
plasmid is also subjected to restiction digests with Hha\, HpaW and a mixture of Hha\ and HpaW.
1, the plasmid has been Hha I methylated; 2, the plasmid has been HpaW methylated; 3, the




































Figure 3.13 A Benzonase analysis of the human cc2-globin gene. Unmethylated (-)and Sssl
methylated (+) a2-globin DNA fragments were benzonase digested. Small arrowheads in the
lane M indicate marker sizes; small arrowheads on the gel indicate regions of methylation
induced DNA structural change. M, pBR322 digested with Bst/RI; m, a2-globin gene fragment
digested with Hha\. The bracketed region shows a region of a large amount of methylation
induced structural change. Long arrows indicate some of the Hha\ sites where Benzonase
shows enhanced cleavage at CpG methylated sites. The region marked between 83 and 96 bp
contains many CpGs, some in Hpall sites and some in partial Hha\ sites. It is unclear whether
methylation induced structural changes at this position are due to the HpaW sites or because
there are several methylatable CpGs in this region. Coloured bars indicate regions scanned.
The values in base pairs (bp) is given in the right hand margin of the individual fragment sizes. In
square brackets, [], underneath each value is the corresponding position in base pairs of the












Figure 3.13 B, C and D. Peak determination scans of selected regions of the Benzonase
assay shown in figure 3.14 A. Selected regions were scaned using Aida software. Each
scanned region is colour coded with reference to 3.14 A. The intensity values are arbitrary
values determined by the range in intensity range available in the data set. In B, lane 3 (-M) is
compared to lane 2 (+M). In C&D, lanes 3 are compared. (-M), unmethylated. (+M) methylated.
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Figure 3.14 Benzonase analysis of the human a2-globin gene. Unmethylated (-) and HpaW
methylated (+) a2-globin DNA fragments were benzonase digested. Small arrowheads indicate
marker sizes; large arrowhead indicates regions where no methylation induced DNA structural
changes occur compared to Figure 3.13. M, pBR322 digested with Bsi/RI; m, a2-globin gene
fragment digested with Hha\. This figure illustrates that the methylation induced changes seen in
figure 3.13 are likely due to methylation at HhaI sites and not at HpaW sites.
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selected regions is shown in figure 3.13 B, C & D. Over small regions it is clearly
seen that methylation is having a major impact on DNA structure.
To confirm that these alterations were due to Hhal methylase target site
changes, Hpall methylated fragments of the same sequence were subjected to
Benzonase analysis. The results of this experiment are shown in figure 3.14.
Although the banding patterns are not as defined as some other gels, it is clear that
there are no obvious structural transitions due to methylation of Hpall sites as
detected by this method. Therefore most Benzonase reactive structural transitions
due to CpG methylation may be due to reactivity at Hhal sites. The Hhal methylase
methylates the sequence d(GCGC), an alternating GC stretch of nucleotides, the
structure of which has been shown to potentiate the formation of A-DNA when
methylated (table 1.2). The Hpall methylase recognizes the sequence CCGG, which
is non-alternating and not shown to potentiate the formation of A-DNA. The Hpall
methylated fragment is an indicator that these methylation induced structural
changes are mainly due to methylation at Hhal sites.
Clearly there are many structural alterations and clearly there are many
methylatable sites in the DNA as seen from the DNA sequence. This experiment has
been repeated and the same structural alterations are observed (data not shown).
Clearly there are no observable changes in the Hpall sequence, indicating that the
methylation induced structural changes, as detected by Benzonase, are low or non-
reactive, unless within other alternated DNA tracts.
3.1.3 Summary
This chapter introduces the Benzonase assay for analysis of CpG methylated DNA
structure. This method demonstrates the existence of potential A-form DNA regions
in CpG methylated DNA in vitro, a feature that may have functional consequences in
terms of gene regulation in the cell.
An initial hypothesis was based on the fact the CpG methylation can induce
A-form DNA (Vargason et al., 2000, 2001; Tippin et al., 1997a & 1997b).
Experiments using plasmid DNA and digesting with Benzonase, an enzyme with a
preference for A-form DNA cleavage, revealed that the digestion rates of
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unmethylated and Sssl methylated DNA fragments were similar. Therefore, CpG
methylation alone is not enough to alter the digestion dynamics of the whole
sequence (figure 3.2) but may be having some effect at the level of the base pair.
The Benzonase assay as developed by Meiss et al., (1995) was applied to
CpG methylated DNA. Here, radiolabeled fragments ofDNA are digested and run on
a denaturing PAGE/urea gel. In figure 3.5 an unmethylated fragment of the pBR322
plasmid was compared to a methylated fragment of the same sequence of the same
fragment. In an accompanying experiment (figure 3.6), DNasel analysis was
performed on the same fragments. Peak determination scans of both of these gels
was performed and the results shown in figures 3.5 C and 3.6 C, respectively.
Several conclusions can be drawn from these analyses. (1) The fragments used here
were also used in a study to detect A-DNA with a chiral probe specifically designed
to detect A-DNA. The same sequences show enhanced activity with Benzonase
confirming that Benzonase is as reported, a useful probe for A-DNA detection. (2) A
CpG methylated sequence at 111 bp shows high reactivity with Benzonase when
compared to the unmethylated sequence. This corresponds to an alternating sequence
containing two methylated CpGs, d(CCGCGC) that has been crystallised as A-DNA
(Mooers et al., 1995; Tippin et al., 1997). (3) Other methylated CpGs do not show
heightened Benzonase reactivity even though some of these are surrounded by other
cytosine and guanine nucleotides. However, none of these other sequences show
alternation of more than three base pairs and none of them contain more than one
meCpG. Some of them may correspond to E-DNA, an intermediate in the transition
to A-DNA that can be formed from a single methylation site in the sequence
d(GGCGm5CC), (Vargason et al., 2000). This may indicate that Benzonase requires
a more pronounced change to A-DNA than the intermediate structure allows to
demonstrate hyper-reactivity. (4) DNasel analysis confirms that every CpG is
methylated and that methylation is capable of altering DNA structure at each of these
sites. It also establishes that Benzonase is capable of ignoring these structural
changes in favour ofmore pronounced changes that suit its active site.
As another test, the gene fragment originally used by Meiss et al., (1999) in
studies to determine the nuclease activity of Benzonase was used to confirm their
observations that Benzonase had a preference for A-DNA. This proved to be the case
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(figure 3.8 A, B). However, when the sequence was methylated, the pattern changed
and showed altered cleavage patterns, now preferring to cut at a methylated CpG
string of nucleotides, a feature consistent with the above observations.
Attempts to refine the Benzonase assay were made in accordance with Meiss
et al., (1995). urea was used in the reaction buffer in an effort to enhance cleavage at
potential A-form regions, while reducing cleavage at non A-form sites. Figures 3.9
and 3.10 A &B, illustrate that there is no difference in the cleavage patterns observed
in both unmethylated and methylated fragments in standard and urea containing
buffers. The structural changes due to methylation are still clearly seen in both cases,
but the addition of urea has not enhanced reactivity at specific sites, urea was not
used in any future Benzonase digests, as it was not deemed useful and detracted from
the near physiological conditions of the assay. However, it did also demonstrate that
the structural observations made were still observable in such altered conditions,
indicating a stable change in the DNA, one that is intrinsic to the sequence and not an
alteration due to environmental influences.
However, bacterial sequences do not predominantly use CpG methylation for
gene regulation in the same way as eukaryotic cells, nor do they contain a higher
order chromatin environment of regulatory proteins. To assess a gene that may use
these structural alterations a region of the human a2-globin gene was analysed. This
gene is highly CG rich and is repressed by DNA methylation in vitro and in vivo
(Boyes & Bird, 1992; Cuadrado et al., 2001). Benzonase analysis of this gene shows
an altered pattern of digestion at many Hha\ sites corresponding to the sequence
d(GCGC), predominantly at the promoter region of the genes where many regulatory
proteins involved in transcription, translation and the regulation of gene expression
may bind (figure 3.13). However, Benzonase could not detect any methylation
induced changes of the same sequence when methylated with Hpall methylase,
which methylates the sequence d(CCGG). This is shown in figure 3.14.
To conclude it appears from these initial analyses, that the degree ofA-DNA
formation as judged by the reactivity of Benzonase, is determined by the degree of
alternation of base sequence, ie: alternating strings of purines and pyrimidines are
preferred substrates. CpG methylation promotes the formation of these alternative
structures, but may require at least two adjacent methylated CpGs to do so. Thus we
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may have A-DNA type structures embedded within stretches of standard B-DNA, Z-
DNA or indeed other stable intermediate structures. The existence and interchanging
of these structures has currently no determined role in the eukaryotic cell.
The 012-globin gene provides a good starting point for finding a distinct
biological role for methylation induced A-type DNA structures. The next layer of
information above the level of DNA sequence is the compaction of DNA by
nucleosomes. However, the 012-globin sequence has not been characterized in a
chromatin context. In the lab of Dr. Jim Allan, a technique for mapping the exact
location of nucleosomes on a DNA sequence to the level of the base pair, was
developed (Davey et al., 1995). Mapping studies using the technique of monomer
extension have determined the position of nucleosomes on the chicken pA-globin
gene promoter region (Davey et al., 1997). In some cases, nucleosome positioning
could be altered by CpG methylation and was hypothesized to be due to an altered
DNA structure. Because of the wealth of knowledge about the sequence and
nucleosomal organisation of this gene, I have taken it as a model for the
determination of a potential role for A-DNA in the regulation of gene expression.
The pA-globin gene is the subject of analysis in Chapter 4: Results (II).
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Chapter 4: Results (II)
4.1 Analysis ofthe chicken ff"-globin gene
4.1.1. Introduction
In eukaryotic nuclei, the bulk of DNA is packaged into nucleosomes. Nucleosomes
consist of histone octamers containing histones H2A, H2B, H3 and H4. DNA is
folded and compacted by nucleosomes into a higher order chromatin structure, the
30nm fibre (figure 1.2), which is organised into regulatory domains (review: van
Holde, 1994). The 30nm fibre is the substrate that all eukaryotic DNA binding
proteins are faced with. The manner in which nucleosomes temporally and spatially
organise themselves to construct these domains is not fully understood. It is known
that the DNA sequence has some influence (reviews: Simpson, 1991; Thoma, 1992;
Wolffe, 1994).
As discussed in chapter 1, the mechanisms by which CpG methylation could
influence gene expression at a particular site in DNA are conceptually threefold. (1)
CpG methylation could occlude protein binding sites directly either by altering a
recognition sequence and/or by changing the structure of a protein binding site. (2)
CpG methylation can affect nucleosome positioning, with knock-on effects for gene
regulation, and (3) it could affect gene expression by interacting with MeCPs and
subsequent chromatin remodeling complexes. All of these effects are plausible and
examples exist of each. We are currently learning a great deal about the third
possibility, but little about the first and second.
In relation to nucleosome positioning, it has been shown that core histone
octamers reconstituted onto the promoter of the chicken pA-globin gene, adopt
characteristic translational positions with respect to the underlying DNA (Yenidunya
et al., 1994; Davey et al., 1995). Spatial organisation of nucleosomes may be of
prime importance in the developmental organization of this gene. In terms of DNA
structure, Davey et al., have investigated the influence of CpG methylation on
nucleosome positioning on the chicken pA-globin gene promoter. Methylation of a
CpG triplet was found to directly influence the position of an otherwise high affinity
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nucleosome binding site. This CpG triplet is located 1.5 helical turns away from the
dyad axis, orientated towards the histone core (Davey et al., 1997). This work
established that CpG methylation can influence nucleosome positioning and
potentially gene expression at the level of DNA structure (figure 4.1). Here, a very
limited number of nucleotides can influence directly the translational positioning of
nucleosomes. DNasel analysis of the pA-globin gene in unmethylated and CpG
methylated states, showed enhanced cleavage at many methylated CpGs, including
the methylated triplet, indicating methylation dependant structural changes (Davey et
al., 1997). Reasons for this were speculated on. Methylation may have influenced the
bending potential and subsequently secondary or tertiary structure of the DNA, thus
turning an otherwise high affinity nucleosome binding site, into a low affinity
binding site. It has also been demonstrated that a CpG triplet can adopt a Z-DNA
conformation under negative superhelical stress (Runkel & Nordheim, 1986). This
transition is further enhanced by CpG methylation. Based on this knowledge, Dr. C.
Davey analysed the CpG triplet in the pA-globin gene for the formation of Z-DNA
(pers. comm.). However, Z-DNA was found only to form on supercoiled DNA and
not when the DNA fragment was linearised (unpublished results). It was reasoned
that Z-DNA could not be responsible for the movement of nucleosomes away from
the methylated CpG triplet in vitro, as nucleosome movement can occur on the linear
methylated pA-globin CpG triplet, when Z-DNA cannot form there (pers. comm.).
Hence, from discussions with Dr. C. Davey it was reasoned that the pA-globin gene
promoter region may be a good candidate for A-DNA analysis, as the specific region
in the promoter region that alters nucleosome positioning consists of an alternating
sequence containing a CpG triplet. The alternating sequence begins with a Guanine,
and is of the type 5'-GGCGCGCGC-3', a sequence shown by crystallization studies
to form A-DNA. Mooers et al., (1995) demonstrated that both Gm5CGCGC and
Gm5CGm5CGC sequences form A-DNA. Tippin et al., (1997) also demonstrated that
the sequence Gm5CGm5CGCGCGC crystallizes as A-DNA. In collaboration with
Dr. C. Davey, I decided to analyse it using the Benzonase assay that I had optimized
for A-DNA analysis on CpG methylated DNA.
Concurrently, Dr. C. Davey decided to further analyse the structure of the pA-
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A hypersensitive site appears at the active pA-gIobin promoter
Figure 4.1 CpG methylation alters nucleosome positioning. A The far left illustration
represents the location of nucleosomes centrally and at the end of a piece of DNA. The central
image is a polyacrylamide gel of nucleosomes reconstituted onto DNA showing that CpG
methylation (lane 5) alters the positioning of nucleosomes 5A and 5B (compare lane 3) The far
right image is lane peak analysis of lanes 3 & 5 from the PAGE image. Subtraction of these
peaks (d) shows that the positioning of nucleosome 5A has been moved by CpG methylation. B
This figure illustrates nucleosome positioning over the pA-globin gene promoter region, the
positioning of nucleosomes 5A and 5B on this fragment and below, different factor binding sites
across the promoter region (Adapted from Davey etal., 1995, 1997). It is the region covering




Mutant No. 1 (ml)
Mutant No. 2 (m2)
Mutant No. 3 (m3)
Mutant No. 23 (m23)
Mutant No. 25 (m25)








Table 4.1: Site-directed mutagenesis in the pA-globin CpG triplet. The
wild-type sequence and mutated versions of the pA-globin triplet sequence.
The mutants were prepared by site-directed mutagenesis by Dr. C. Davey. In
red, CG nucleotides. In black, wild-type nucleotides. Underlined are the point
mutation bases as compared to the wild-type sequence.
121
Chapter 4: Results (II)
m2, m3, m23, m25 and m8a) that he prepared (table 4.1). On these, both DNasel and
nucleosome positioning studies were performed, to investigate both DNA secondary
structure and nucleosome positioning respectively. I have taken the same range of
mutants to analyse their behavior when subjected to A-DNA analysis. The results of
Dr. C. Davey's experiments are discussed in relation to my own data in support of an
argument that A-form DNA has a role to play in the positioning of nucleosomes on
DNA and potentially in the regulation of gene expression.
4.1.2 Results
4.1.2.1 jT-globin gene Fragments
To investigate the potential formation of A-DNA in the chicken pA-globin gene,
plasmids containing cloned inserts of the gene were kindly provided by Dr. C.
Davey. These included wild-type pA-globin (referred to as LE) and a selection of
mutant variants (referred to as ml, m2, m3, m23, m25 and m8a) containing point
mutations in the CpG triplet (table 4.1). These were each transformed into competent
E.coli JM110 cells and grown to an O.D. of 0.8. The cells were harvested and
plasmid midipreps prepared. In all cases, plasmids were digested with Clal and Hinf
I (NEB) restriction enzymes. The resultant fragments were resolved on a 5%
polyacrylamide gel (data not shown). A band of 219 bp was isolated comprising the
promoter region of the pA-globin gene, and containing the CpG triplet analysed
previously (Davey et al., 1995, 1997). Figure 4.2 illustrates the pA-globin DNA
fragment isolated and the DNA sequence thereof. The most significant restriction
enzyme cutting sites within the 219 bp sequence are marked. This band was purified
by dialysis in an electrophoresis tank according to the method of Dr. C. Davey. The
concentration of the isolated fragments were estimated by analysis on a 2% agarose
gel in reference to marker DNA of known concentration (data not shown). The
remainder of the DNA samples were then dephosophorylated at their 5' ends with
Bacterial Alkaline Phosphatase (BAP) or Calf Intestinal alkaline Phosphatase
(CIAP), (MBI-fermentas).
Many preparations of these fragments were prepared for the initial studies
and repeat experiments to verify the results. In some cases, the method of preparation
of fragments was altered. For instance, some of the mutant 219 bp
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Figure 4.2 The chicken (3 globin locus. A The organisation of the pA-globin gene
cluster with the organisation of the pA-globin gene highlighted (Image drawn to scale,
supplied by Dr. C. Davey). B The region of the pA-globin gene used in this study.
Numbering refers to the base pair positions relative to the transcriptional start
site.(Image not drawn to scale). C The nucleotide sequence of the 219 bp fragment
used in this study. All CG dinucleotides are highlighted in red. The CpG triplet is roughly
located at the centre of the sequence and is underlined.
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fragments were prepared by a quicker method as follows. These plasmids were
digested similarly, but isolated on a 1.8 % agarose gel. The bands corresponding to
the 219 bp fragments were cut out, placed in eppendorf tubes containing 1 ml of gel
extraction buffer and placed on a rotating wheel at 4°C overnight, to allow the DNA
to diffuse out of the gel pieces. The DNA was purified by standard phenol-
chloroform extraction and ethanol precipitation. The precipitated DNA was washed
with 80 % ethanol to remove excessive salts.
In all cases the concentration of the DNA was again estimated by running 5
% of the final volume on a 1.8 % agarose gel. For quantification of the isolated DNA
fragments a phosphorlmager (Fugifilm) was used to scan the gel and Aida™
software used to estimate the concentration as accurately as possible.
Spectrophotometry at A26o was also used to corroborate these results (data not
shown). These fragments were dephosphorylated with Shrimp alkaline Phosphatase
(SAP) instead of BAP or CIAP as it is active at 37°C and can be completely
destroyed by incubation at 65°C for 15 minutes.
The dephosphorylated 219 bp fragments (LE, ml, m2, m3, m23, m25 and
m8a) were then subjected to CpG methylation. Samples of each wild type and point
mutant were taken and split in half. One half of each sample was methylated using
Svsl methylase (NEB), which has the ability to methylate DNA at every CpG site on
both DNA strands. All DNA samples subjected to <£ssl methylation were then tested
for their complete methylation at CpG sites, by a methylation protection assay. On
every occasion that DNA was methylated, a methylation protection assay was carried
out to confirm the methylation status. In the assay, CpG methylated DNA is
challenged by use of Hhal and Hpall restriction enzymes (MBI). Both have
recognition sites containing CpG dinucleotides, but both will not cut if their
recognition sites are CpG methylated. Unmethylated DNA was used as a control to
test the integrity of the Hhal and Hpall restriction enzymes. As an additional control,
the restriction enzyme Mspl was also used. It recognizes the same sequence as Hpall,
but unlike Hpall it can cut methylated DNA (Data not shown). Once the DNA
fragments were satisfactorily methylated they were again quantified.
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4.1.2.2 Benzonase Analysis of /T4-globin Wild-Type (LE) fragments (+ Strand).
Samples of unmethylated td4-globin wild-type (LE) fragments were compared to
samples of methylated J34-globin wild-type (LE) fragments in Benzonase assays.
These Clal-Hinjl fragments contain the wild-type version of the CpG triplet analysed
by Davey etal., (1997). This is of the sequence 5'...GGCGCGCGCTGTGCT...3\
Highlighted in yellow is the CpG triplet. In blue, the alternating nucleotides, (GQ4.
The fragments were 32P-y-ATP labeled at their 5'-ends with T4 kinase. The double-
stranded fragments were restriction digested with Pstl to remove one of the labeled
ends. The fragments were then digested with Benzonase over an increasing
concentration gradient according to the standard devised protocol. The resultant
fragments were purified by phenol-chloroform extraction, ethanol precipitated and
and run on an 8% denaturing polyacrylamide gel. This is illustrated in Figure 4.3 A
and 4.3 B).
Figure 4.3 C shows a peak-determination scan of the highlighted regions in
figure 4.3 B. These peak determinations were performed using Aida'M software. It is
clearly visible from this graph that the banding pattern is incredibly similar over the
length of the selected regions, but differs significantly over the CpG triplet region.
Significantly, three peaks are visible over the CpG triplet, representing the three
methylated CpG sites.
A pattern emerges showing a striking overall similarity in digestion patterns
between unmethylated and methylated pA-globin fragments (figure 4.3 A). Apart
from the overall similarity, increased cutting is seen at hotspots in the DNA sequence
that possess an ability to form A-DNA (figure 4.3 B). At the CpG triplet
d(GCGCGCGC) located at 124 bp in the DNA sequence, a marked change is
observed across lanes 0 to 6 in the 5'-CpG methylated fragment only, clearly visible
as marked in the peak determination scan (fig. 4.3 Q. Here, it is evident that
Benzonase now recognizes a new hotspot in the sequence, indicating the formation
of A-form DNA. At this site the sequence is methylated at two overlapping Hhal
methylase d(GCGC) sites. As seen from Chapter 1, table 1.2, a sequence that begins
with a purine start and contains alternating GC sequences is more likely to form A-
DNA. In addition to this, three sequences containing 5'-methylated CpG's have been
crystallised as A-form DNA. These are d(Gm5CGCGC), d(Gm5CGm5CGC) and
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d(Gm5CGm5CGCGCGC). The table also shows that the unmethylated sequence of
d(GCGCGCGCGC) forms Z-DNA. It is the only type of alternating DNA with a
purine start that crystallizes in Z-form. For sequences of the type d(CGCGCGCG),
structural studies show the Z-conformation in both solution and crystalline states, but
only in the unmethylated form. All that is required to promote this transition is the
addition of four methyl-groups. This startling transition from the left-handed Z-form
to the right-handed B-form and A-form structures is one of the most structurally
dynamic changes in biology. Provided here may be some evidence for a functional
biological role for these transitions.
The CpG triplet in the unmethylated pA-globin gene is d(GC)4. The closest
crystallised match is (GC)5. It is likely that the unmethylated d(GC)4 also forms Z-
DNA, however as mentioned previously, this may depend on the degree of
supercoiling the sequence is subjected to. When methylated, the sequence may
conform to any one of the three methylated purine start oligomers that have been
crystallised in A-form (Chapter 1, Table 1.1). There must therefore be an equilibrium
established between the formation of A, B, and Z-DNA to enable these transitions to
be possible. There is evidence to suggest that this is so from thermodynamic studies
(Foloppe et al., 1999), and also evidence to suggest that such transitions in DNA
structure may be important in setting up higher order chromatin structure (Ohyama,
2001).
Also evident from figure. 4.3 B, is the fact that the methylation not only
causes structural changes over the methylated CpG triplet, it also has a small
spreading effect. The pattern of cutting is altered at adjacent nucleotides to the
methylated CpG triplet. This is not so surprising as the formation ofA-DNA is likely
to bring torsional strain and twisting to the adjacent nucleotides that do not form A-
DNA. This experiment was repeated at least three times more. Each time, the same
results and observations were made as above.
DNasel digestion analysis for the wild-type and mutant fragments is shown in
figure 4.5 (data from Dr. C. Davey). Nucleosome positioning data for the wild-type
and mutant fragments is shown in figure 4.6 B. Both the DNasel and nucleosome
positioning data were performed on the same fragments used in my analyses. The
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Figure 4.3 B Magnified image of highlighted section from Figure 4.3 A. This image
corresponds to the red-boxed area in figure 4.3 A. It clearly shows that at the region of the CpG
triplet as marked by the Hha\ digested fragment, there are hypersensitive sites in the Benzonase
digest in the +M lanes. These hypersensitive sites do not occur in the -M lanes. The
hypersensitivity is therefore due to a methylation dependant change in structure at the CpG
triplet, an effect that is not seen at other methyl CpGs in the fragment.
C
Figure 4.3 C Peak determination scan using Aida™software. Aida™ software was
specifically designed by Fugifilm for the purposes of Phospholmager analysis. Having scanned
PAGE/Urea gels using a Fugifilm Phospholmager, the data was analysed using lanes of equal
radiolabel intensity to establish any differences between unmethylated and methylated samples
of the globin fragment in A and B above. The intensity is in arbitrary units from the Aida software
and based on the intensity level range for the entire data set. The position refers to the position in
the gel from the starting reference point of the analysis. The region used is bordered by red box.
The upper and lower vertical limits were used. (+M), methylated fragment. (-M), unmethylated
fragment.
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only difference is that labeling was performed on the reverse strand. However, Dr.
Davey observes the same effect on nucleosome positioning on the forward strand and
the same effects with methylation induced reactivity in the DNasel experiments. I
also show here that the methylation induced structural change as detected by
Benzonase is also present on the reverse strand. The technique used for nucleosome
positioning is called monomer extension. A brief summary of these analyses is that
DNasel analysis detects alterations in methylated DNA structure at the CpG triplet.
Monomer extension analysis determines nucleosome-positioning sites on DNA. This
change in structure at the CpG triplet disrupts the positioning of nucleosome 5A from
an otherwise strong positioning site. The nature of the CpG induced structural change
is likely to be due to formation of an A-type DNA structure at this region, as detected
by Benzonase analysis.
4.1.2.3 Benzonase Analysis of /T4-globin Wild-Type (LE) fragments (- Strand).
As seen from Figure 1.5, A-DNA is a symmetrical structural transition. That is, when
A-DNA forms on one strand of a duplex, it must also exist on the other strand. This
sets it apart from other structural transitions, such as secondary structure changes that
may affect one strand and not the other. Examples include bends, kinks and
cruciform structures. To prove that the structural alterations observed are a
symmetrical event, the same fragments of the pA-globin gene were prepared,
dephosphorylated and 5'-labeled with j2P-y-ATP at both ends. This time however,
the opposite end of the DNA was cut. Instead of using Pstl, the restriction enzyme
Sau3A\ was used to remove one of the ends. Both Sau3A\ and Pstl enzymes were
specially chosen because: (a) their recognition sites lie close to either end of the 219
bp fragment, therefore eliminating only a minor part of the pA-globin fragment, and
(b) they are not enzymatically blocked by CpG methylated DNA in or near their
recognition sites. The labeled reverse strand contains the sequence 5'-
AGCACAGCGCGCGCC-3'. Again, in blue are highlighted the alternating
nucleotides, with the yellow box containing the CpG triplet. Unmethylated and
methylated fragments were benzonase digested as before and samples run on an 8%
denaturing polyacrylamide gel. This is illustrated in figure 4.4 A. As the sample was
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digested with Sau3Al at the opposite end, the resultant fragment is a different length
to the forward labeled fragment. Therefore in the Benzonase digestion assay the
appearance of the altered structure appears at a different location on the gel. The
marker lane shows the position of the CpG triplet on the forward strand, and a lower
band corresponding to the CpG triplet on the reverse strand, where the altered pattern
in the methylated lane is highlighted.
It is evident from comparing the patterns of methylated and unmethylated
DNA in figure 4.4 A and B, that here again a distinct structural change is picked up
by Benzonase. This is clearly seen when comparing lane 3 in the unmethylated
strand to lane 3 in the methylated strand. The change is again localized over the
methylated CpG triplet. It again shows that there is a spreading effect into the
adjacent nucleotides, which also exhibit altered cutting patterns. This experiment was
repeated twice more, each time a similar shift in banding patterns was observed, each
time over the methylated CpG triplet only.
Corroborating what is visible from the gel, the lane peak determinations were
again analysed using Aida™ software. As can be seen from figure 4.4 C, there are
distinct differences between unmethylated and methylated LE fragments. These
occur at a different location on the gel, as in this case the reverse strand is being
analysed. However, these alterations are again coincident with the CpG triplet
sequence when measured from theHinfI labeled end.
As the effects seen are due to analysis of methyl-groups on one strand of the
double-helix at a time, the fact that the events are symmetrical make it even more
likely that methylation is promoting a large structural change, evident on both strands
and most likely, involving tertiary structure. As Benzonase has a preference for A-
form DNA it is reasonable to suggest that this is indeed what it is recognizing in CpG
methylated DNA.
Also of interest, is the fact that not every methyl-CpG in the 219 bp fragment
becomes a 'hot-spot' for Benzonase digestion. Singly methylated CpG sites do not
seem to form a Benzonase hotspot, but at least two adjacent methylatable CpG sites
are required for Benzonase to preferably cut at that site in vitro. The following
conclusions can be drawn; (a) CpG methylation alters DNA structure in a sequence
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Figure 4.4 B. Enlarged region from Figure 4.6 A (red dashed box). Magnified view of the
Benzonase digest on the pA-globin promoter region of the labelled reverse strand. This
illustrates that methylation induced cleavage as detected by Benzonase, occurs of both strands
of the DNA helix. The arrows indicate the regions of methylation induced hypersensitivity. LE-
Hha\ is the labelled reverse strand fragment digested with Hha\. The reverse strand has Hha\
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Figure 4.4 C Peak determination scan of the Benzonase digestion analysis shown in
figure 4.4 A. Regions scanned for the p-globin reverse strand analysis are indicated in 4.4 A by
a bracket. Lane 5 for the unmethylated fragment is compared to lane 4 for the methylated
fragment. Regions where CpG methylation has induced a distinct structural change, as
detected by Benzonase, are indicated by an arrow. The intensity values along the Y axis are
arbitrary and assigned by the Aida software over the full scale of intensity values available in the
data set. The X-axis refers to position within the gel over the region scanned. (+M), methylated
fragment. (-M), unmethylated fragment.
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Figure 4.5 A DNasel analysis of pA-globin promoter fragments. DNasel analysis was
performed to identify DNA secondary structural alterations on unmethylated (-) and methylated
(+) wild-type pA-globin (LE) and mutants (m) 1,2, 3,23, 25 and 8a. The region of nucleosome 5A
positioning is bracketed. This is also the region of DNasel detected structural alterations. The
Hha\ sites representing the CpG triplet are marked with an arrow. (This data was provided by
Dr.C. Davey and annotated and interpreted here).
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Figure 4.6 B Monomer extension analysis of (3A-globin promoter fragments. Monomer extension
analysis was performed to identify nucleosme positioning sites on unmethylated (-) and methylated (+)
wild-type pA-globin (LE) and mutants (m) 1,2,3,23,25 and 8a. The position ofnucleosome 5A is clearly
seen as indicated by the arrowhead. This datawas supplied by Dr. C. Davey.
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Figure 4.5 B Magnified image of the DNasel analysis shown in figure 4.5 A. This image
shows a magnified view of the region of the CpG triplet that shows enhanced cleavage. (-) and
(+) are unmethylated and methylated lanes respectively. See imge 4.5 A forfurther information.
(Unpublished data from 4.5 A supplied by Dr. C. Davey).
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Figure 4.6 C Magnified viewof the Nucleosome Positioning analysis shown in figure 4.6
B. This image shows a magnified view of the monomer extension analysis performed as
described in figure 4.6 A, the results of which are shown in figure 4.6 B. The bands represent the
positioning of nucleosome 5A at the CpG triplet region in the LE fragments and mutant series.
See the text for more details. These images are supplied together for ease of analysis.
(Unpublished data from figure 4.6 B supplied by Dr. C. Davey).
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negative DNA strands, consistent with a tertiary structural change (c) in both DNasel
and Benzonase digestion, increased cutting was observed over the me-CpG triplet
and (d) in the Benzonase digest experiments, a spreading effect is observed from the
me-CpG triplet into the adjacent nucleotides, apparent from the altered cleavage
pattern.
4.1.2.4 Benzonase Analysis ofpA-globin LE andmutant 1 (ml) fragments
Fragments of the pA-globin LE and mutant 1 (ml) promoter regions were prepared as
described above. Clal - Hinjl fragments were labeled with 32P-y-ATP and one of the
labeled ends removed with Pst\. Thus, the forward strand of both the LE and ml
DNA fragments were labeled. The mutant ml contains the radiolabeled sequence
5\..GGGCCGCGCTGTGCT...3\ Highlighted in light green are the mutated
nucleotides. The mutation results in a sequence reduced from a CpG triplet to a CpG
doublet. Benzonase digests were carried out on these fragments according to the
standard protocol, with increasing amounts of the Benzonase enzyme.
The digests were purified as described above and run on an 8 % denaturing
PAGE/urea gel. Figure 4.7 shows the results of this experiment with a highlighted
region containing the CpG triplet. The Benzonase digests on ml provide a similar
pattern to the wild-type pattern. Comparisons of lane 2 for the methylated LE
fragment to lane 2 for the methylated ml fragment in figure 4.7 shows that
Benzonase still shows hypersensitivity at the mutated triplet. The cleavage is not as
pronounced as the wild-type LE fragment, but exists over the same region
nonetheless. The methylated sites in ml are still embedded within alternating base
pairs, but instead of a row of the wild-type eight alternating bases, there are now five.
Instead of three methylatable sites there are now two. The effect of Benzonase
cutting is reduced by the loss of one methylatable CpG but not enough to eliminate a
preferred cutting site. The banding pattern is less defined over the region especially
at the central CpG in the triplet, which is the first CpG in the mutant. The first CpG
in ml is preceeded by a cytosine residue, which could detract from the A-form
potential. I am basing this assumption on the crystallographic and structural data
available to me (table 1.2). Interestingly, DNasel data for this mutant (figure 4.5 A)
shows that CpG methylation causes DNasel hypersensitive sites in the fragment.
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Figure 4.7 Benzonase digestion of wild-type LE fragments compared to mutant 1 (ml).
Benzonase digestion was performed on Sssl methylated (+M) and unmethylated (-M) (3A-globin
promoterfragments. LE-F/hal, p-globin promoter fragment digested with Hha\, which represents
the site of the CpG triplet at 124 bp; M, pBR322-BsuRI digest marker; m, pUC19-Mspl digest
marker. Arrows indicate sites ofmethylation induced structural change.
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Comparing lanes 2 and 3 shows that there is still methylation enhanced cleavage, but
predominantly at one site and not at all three as displayed in lane 1. The
corresponding nucleosome mapping data for this mutant shows that it is still capable
of altering nucleosome positioning, when this CpG doublet is methylated (figure 4.6
B). Lanes 2 and 3 show that nucleosome 5A occupancy has been reduced at this
position, but not eliminated as successfully as the wild-type LE fragment (lane 1) nor
indeed as successfully as some of the other mutants.
It follows, that if CpG methylation in certain sequences and at certain
positions can form A-form DNA, and a subset of these sites correlate with regions
that have the ability to displace nucleosomes - then perhaps altering DNA tertiary
structure is a feature that is used at other specific sites in the regulation of
nucleosome positioning and potentially, in the regulation of gene expression. If this
hypothesis is true, we would expect to see a correlation between A-DNA formation
and loss of nucleosome positioning and vice versa, a correlation between the lack of
A-DNA formation and loss of the ability to move nucleosomes. This may indeed be
the case for ml. It is less likely to form A-DNA as it has less methylatable sites and
less alternation ofGC base pairs. It may partially form A-DNA, but this may not be
enough to exclude nucleosome 5A completely from this region when methylated.
4.1.2.5 Benzonase Analysis offf-globin LE andmutant 2 (m2) fragments.
To further investigate the nature of the structure of the CpG triplet, and to
correlate the nucleosome positioning data of Dr. C. Davey with my observations on
DNA structure, fragments of the pA-globin mutant no 2 (m2) were taken for
comparison to the wild-type. The m2 fragments contain the sequence
5'...GGCGGCCGCTGTGCT...3'. Highlighted in yellow are the CG dinucleotides,
in blue the alternating nucleotides and in light green, the mutated nucleotides. Again,
these fragments were prepared as described above for LE and ml forward strands
and Benzonase analysis carried out as before. Figure 4.8 A shows the results of this
analysis.
As can be seen from figure 4.8, the methylated LE fragment shows increased
cutting in and around the CpG triplet when compared to the unmethylated LE
fragment. This was used as a control reaction. In direct comparison, the
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unmethylated m2 fragment behaves similarly to the unmethylated LE fragment over
the region of the CpG triplet (figure 4.8 A). The pattern of digestion (lanes 1 & 2) in
the methylated m2 fragment, does show increased cutting around the CpG triplet, but
is not quite as defined as the LE fragment. This experiment was repeated producing
the same result. A comparison was made of the m2(-M) fragment and the m2(+M)
fragment using Aida™ software. The results of these scans are shown in figure 4.8 B.
This scan is not as smooth as some of the others, but despite differences in intensity
it is clear that there are structural changes present that are not present in the
unmethylated fragment.
All of the available crystallographic data (Tippin, et al., 1997), suggests that
this sequence may also form A-DNA or at least partly do so. As can be seen from the
m2 sequence, the mutant version is not too removed from the wild-type: (1) It still
retains a purine start before the alternation of the first GC dinucleotides begins, this
may contribute significantly to the promotion of A-form DNA, but (2) it has lost a
CG dinucleotide pair. As this disrupts the alternation of GC dinucleotides, it may
detract from the formation of A-DNA. (3) There are two methylatable sites in the
sequence as opposed to three in the wild type. Although the methylatable CpGs are
not adjacent to each other, they contain more alternation of base sequence around
these CpGs than ml, which may explain why this mutant is slightly better at altering
nucleosome positioning than ml (see below). However on the whole, this mutant
contains two methylatable sequences, like ml so cannot be expected to behave too
differently.
DNasel analysis on m2 (figure 4.5 A) reveals that this sequence does show
some enhanced cleavage at this position (lane 4 & 5), but it is less pronounced than
LE and most similar to the behavior of ml. The corresponding nucleosome
positioning data (figure 4.6 B) shows that nucleosomes can position at the
unmethylated m2 sequence (lane 4). There is some loss of positioning at the
methylated m2 sequence but it does not appear to be as effective as LE.
Overall, m2 may be expected to behave in a similar manner to the ml
sequence, with two me-CpGs. However, unlike the ml sequence, the methylated
CpGs are separated from each other. This results in a break in the alternation of CG










Figure 4.8 A Benzonase digestion ofwild-type LE fragments compared to mutant 2 (m2).
Benzonase digestion was performed on Sssl methylated (+M) and unmethylated (-M) pA-globin
promoter fragments. LE-Hhal, p-globin promoterfragmentdigested with Hha\, which represents
the site of the CpG triplet. Arrows indicate regions where methylation inuced structural
transitions are recognised by Benzonase.
Figure 4.8 B Peak determination scan of CpG triplet region in the mutant m2. Peak
determination scans were performed using Aida software (Fugifilm). Scans cover the Hha\ site
marked in the image above. Lane 2 of the unmethylated (-M) fragment is compared to lane 2 of
the methylated fragment. The difference in starting intensity is due to the lower incorporation
rate of the unmethylated m2 mutant. In this case the overall patterns should be compared.
Increased cutting is seen in the methylated m2 fragment as compared to the methylated
fragment. Arrows indicate regions of methylation enhanced cleavage as detected by
Benzonase.
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sequence, it is not so precise as the three discernible bands present in the methylated
wild-type fragment or ml. In line with the hypothesis of A-DNA directed
nucleosome movement at this position, the nucleosome 5A does move, but not as
well or as completely as LE.
4.1.2.6 Benzonase Analysis of/T1-globin LE andmutant 3 (m3) fragments
This mutant contains the sequence 5'...GGCGCGGCCTGTGCT. .3' and was
prepared for analysis by the same methods as ml and m2. The altered bases are
highlighted in green and consist of an inversion of the third CpG dinucleotide in the
CpG triplet. This results in a sequence that has two methylatable CpG dinucleotides
in adjacent positions embedded in a row of five alternating nucleotides. Overall, the
m3 mutant is most similar to wild-type in terms of alternation of base sequence
around the methylation sites.
Figure 4.9 A, shows a Benzonase digest on the LE fragment and the m3
mutant in both unmethylated and methylated states. The area of interest is
highlighted. As can be seen from this analysis the m3 fragment behaves very
similarly to the LE mutant as expected from the sequence structure. That is, the m3
mutant still maintains a strong reactivity with the Benzonase assay in the CpG
methylated state indicating that it still retains the propensity to form A-DNA.
Comparisons of lane 2 in each digested fragment reveals that both LE and mutant 3
respond very similarly. An Aida trace scan (figure 4.9 B) of the region shows clear
differences in the methylated and unmethylated m3 mutant fragments. The
methylated m3 mutant has also been compared to the methylated LE fragment using
an Aida™ trace scan (figure 4.9 Q. Peaks in the methylated LE fragment are
centrally located. Peaks in the methylated m3 fragment are located at the beginning
of the scan at positions coinciding with the first methylatable CpG. From known
crystal structures, the m3 mutant has the best chance of forming A-DNA in a similar
capacity to the wild-type sequence. Although it has 2 methylatable CpGs and not 3,
they are both adjacent to each other and preceeded by a purine residue. In both ml
and m2 mutants, only one of the two methylatable sites are preceeded by a purine
residue, and although both methylated ml and m2 show some Benzonase reactivity,
neither show banding patterns as similar to the wild-type situation as m3, in terms of
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Figure 4.9 A Benzonase digestion ofwild-type LE fragments compared to mutant 3 (m3).
Benzonase digestion was performed on Sssl methylated (+M) and unmethylated (-M) pA-globin
promoterfragments. LE-Hha\, p-globin promoter fragment digested with Hha\, which represents
the site of the CpG triplet. Arrowheads indicate methylation induced structural changes.
Position [mm]
Figuew 4.9 B Peak determination scans of the CpG triplet region of mutant m3. The m3
mutant is here compared in unmethylated (-M) lane 3 of 4.9 A, and methylated (+M) lane 1 of4.9
B. Methylation enhanced cleavage is shown by an arrow.
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Figure 4.9 C Peak determination analysis of a region of the mutant m3. This image
demonstrates the subtle differences shown in methylation (+M, WT) of the wild-type fragment
and methylation of the mutant m3 fragment (+M, m3). In this case arrows indicate sites of
methylation enhanced cutting. 1, refers to enhanced cleavage over the mutant m3 fragment. 2,
refers to methylation enhanced cleavage over the methylated wild-type LE fragment. Peak 3
shows enhanced cleavage at the methylated LE fragment, that is not present on the methylated
m3 fragment. Typically, the methylated LE fragment has more centrally located hypersensitive
sites, probably reflecting the methylated triplet. The m3 fragment has hypersensitive sites at the
beginning of the region, probably reflecting the methylated CpG doublet.
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regular spacing between bands and methylation induced intensity. This is reflected in
the nucleosome positioning data.
The DNasel data (figure 4.5 A) shows heightened reactivity with methylated
m3 (lane 6 & 7), but only over the methylated end of the fragment. Instead of three
distinct bands (lane 1) there is one strong band corresponding to the methylated end,
in an almost mirror image of what happens on ml (lane 3) which of course has
methylation at the opposite end of the mutated triplet than m3.
The mutant m3 is still capable of moving the position of nucleosome 5A away from
this positioning site (figure 4.6 B, lane 6 & 7). This it does with better capabilities
than both the mutant ml and m2 fragments. This is consistent with the fact that it is
most like the LE fragment is sequence organisation and Benzonase reactivity. It
appears that the extent of movement of nucleosomes at this position may correlate
well with the ability of this sequence to form A-DNA as detected by Benzonase.
4.1.2.7 Benzonase Analysis ofp4-globin mutant 23 (m23) fragments
The m23 mutant contains the altered sequence 5\..GGCGCCCGCTGTGCT...3\
The green nucleotide indicates the mutated base, the yellow blocks the methylatable
sites and the blue nucleotides are alternating bases. Benzonase analysis was
performed on radiolabeled fragments as described for the mutants above. The results
of this experiment are shown in figure 4.10. Of note with this sequence is the fact
that although there are two methylatable CpG sites present, they are (a) not adjacent
to each other, and (b) separated by non-alternating cytosine dinucleotides. This type
of arrangement is comparably less likely than either LE, ml, m2, m3 and m25 to
form A-DNA at the second CpG. DNA beginning with the sequence d(CCCG) does
not form A-DNA when methylated according to structural studies and instead forms
Z-DNA as discussed earlier. It is possible that methylation over the first part of this
sequence could serve to potentiate A-DNA whereas methylation over the second part
of this sequence could influence the formation of Z-DNA. The Benzonase digest in
figure 4.10 is unfortunately not very clear for the unmethylated region, but separate
re-running of the unmethylated sample showed a digestion pattern for the
unmethylated region similar to the methylated m23 fragment. It appears that
although Benzonase cleaves the mutated region well, it has the same pattern of
145
0123 0123 0123 0123
Figure 4.10 A i Benzonase digestion ofmutant 23 (m23) and mutant 25 (m25) fragments.
Benzonase digestion was performed on Sssl methylated (+M) and unmethylated (-M) pA-globin
promoter fragments. LE-/-//?al, p-globin promoter fragment digested with Hha\, which represents
the site of the CpG triplet. Arrowheads indicate regions of methylation induced structural
change.
■ Figure 4.10 A /'/' Enhanced view of the m23 mutant.
This image is supplied to show the unmethylated m23
mutant from figure 4.10 i above. The unmethylated
m23 mutant lane was separated from the data and the
contrast enhanced such that the banding pattern is





Figure 4.10 B & C. Peak determination scans of the CpG triplet region of mutants m23
and m25. In B above, lane 3 of the unmethylated (-M) m25 strand is compared to lane 1 of the
methylated m25(+M) strand. The intensities of each lane are different as is observed above, but
the peak pattern is similar over the region. Methylation increases Benzonase reactivity at some
regions that are marked with arrows. At these points a degree of band tightening is observed. In
image C, the methylated m25 mutant is compared to lane 1 of the methylated m23 mutant. The
m23 mutant seems to be quite regular in its banding pattern. However it does not appear to show
any major enhancements at methylated sites as we observe in other mutants. Note that m23
does not shift nucleosome 5A in the p-globin gene fragment. It does not exhibit the same
hotspots of reactivity as the m25 mutant. This may provide part of the explanation forwhy m23 is
inefficient at nucleosome displacement. Notable differences are marked with thick arrows.
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digestion as the unmethylated fragment (4.10 A, ii). So, although there are regular
bands in the cleavage pattern, they appear to be the same regular bands as appear in
the unmethylated fragment also. This could mean that methylation ofm23 does not
change the sequence structure significantly enough to induce an A-form structure. It
is difficult to draw too many conclusions from m23 in terms of Benzonase analysis
of the m23 mutant alone, but the notion that this sequence may have a different
structure at the different methylation sites, based on the 'rules' for A-DNA formation
established here, seems plausible when the nucleosome data is considered.
DNasel data for mutant m23 (figure 4.5 A, lanes 8 & 9) shows two enhanced
cleavage sites corresponding to the two methylated CpGs, confirming that there is
some type of structural change at both of these positions. The nucleosome
positioning data (figure 4.6 B) shows that this sequence can position nucleosomes
well in the unmethylated state (lane 8). Unlike any of the other mutants, the
positioning of nucleosome 5A is not moved by CpG methylation (lane 9). This is an
interesting result, as from this analysis, it appears that despite two methylation sites
on mutant 23, at the same positions as in the m2 mutant, methylation does not cause
the nucleosome to move. The intervening sequence may be having an affect and as
stated may be more likely to form Z-DNA. Negative supercoiling is known to
promote Z-DNA formation and this is a feature of nucleosomal DNA. Therefore any
part of the DNA sequence containing Z-DNA in this case may be incorporated well
into nucleosomes. This may be one explanation for loss ofmovement of nucleosomal
5A when the m23 sequence is methylated.
As stated, Benzonase is reacting with both unmethylated and methylated sites
in the m23 mutant. Despite the fact that the cleavage data for the unmethylated m23
is of low intensity, in my estimation there is no significant change in the pattern
between the different methylated states for m23. The lack of a significant
methylation induced structural change at m23 could therefore account for the lack of
nucleosome displacement observed at the methylated m23 sequence. I conclude that
for reasons discussed, the possibility exists that (a) the extent of A-DNA formation
on methylated m23 may be little or none, (b) the change in structure is thus too short
to displace nucleosome positioning effectively and possibly (c) the second
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methylation site may be promoting Z-DNA formation and as a result is incorporated
well into nucleosomes, or at least does not repel them at this position.
4.1.2.8 Benzonase Analysis offSA-globin mutant 25 (m25) fragments
The m25 mutant contains the altered sequence 5'...GGCGGGCGCTGTGCT...3'.
This mutant is similar to the m23 mutant in the sense that there are still only two
non-adjacent methylatable CpG sites. However, they are separated by two central G
residues as opposed to two central C residues. Also, there is alternation of base
sequence over both of these CpG sites, unlike the m23 sequence which has
alternation over the first CpG only. Each methylatable site is preceeded by a Guanine
residue in an alternation known to promote A-form DNA. This would imply that
perhaps the m25 mutant sequence can form A-DNA over both regions unlike m23
above.
Benzonase analysis of the m25 sequence is shown in figure 4.10, alongside
the m23 data. As predicted from the DNA sequence, known crystallographic data
and the data shown here, the methylated m25 sequence reacts well with the
Benzonase enzyme over the mutated region and shows preferred cut sites in the
methylated fragment (compare lane 3 -M and lane 2 +M).
The DNasel data (figure 4.5 A), for m25 confirms methyl-CpG induced
structural alternations. It shows enhanced cleavage at the methylated triplet region.
The enhancement is not as strong as the methylated LE fragment at any of these
positions and looks most similar to the m2 mutant. It does not have the same
regularity of spacing as the LE bands, nor the same intensity of cleavage. In fact m25
is almost identical to m2 except for one nucleotide. The nucleosome positioning data
(figure 4.6 B) shows that the unmethylated m25 sequence can position nucleosomes
(lane 10) but not as effectively as LE. From what positioning is available on this
sequence, it appears that m25 can displace its positioning with comparable effects to
ml and m2.
An Aida™ scan of the CpG triplet region for Benzonase digestion of the
unmethylated and methylated m25 fragment is shown in figure 4.10 B with changes
in banding pattern highlighted. In 4.10 C, the methylated m23 mutant, which cannot
displace nucleosome 5A, is compared to the methylated m25 mutant for band
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Figure 4.11 A Benzonase digest ofwild-type LE fragments compared to mutant 8a (m8a).
Benzonase digestion was performed on Sssl methylated (+M) and unmethylated (-M) pA-globin
promoterfragments. LE-Hha\, p-globin promoterfragmentdigested with Hha\, which represents
the site of the CpG triplet; M, pBR322-BsuRI digest marker; m, pUC19-A4spl digest marker.
Arrowheads indicated regions ofmethylation induced structural change.
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Figure 4.11 B Peak determination scans of the m8a mutant. Peak determination scans were
performed for unmethylated (-M) from lane 2 of 4.11 A and methylated (+M) from lane 1 of fig.
4.11 A, DNA fragments are shown for the m8a mutant. The m8a mutant shows a lot of similarity
over its general banding pattern, but there are some marked differences. These are marked with
arrows above the methylation induced peaks.
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distribution. The methylated m23 mutant appears to display an even enough range in
band distribution and intensity values. Differences in peak positions are indicated.
4.1.2.9 Benzonase Analysis of /T1-globin LE andmutant 8a (m8a) fragments
The m8a fragment contains the sequence 5'...GGCGGCCGCTGTGCG...3'.
This mutant is interesting as it contains only two of the wild-type methylatable CpG
sites. These are in the same organization as the m2 mutant. The difference is that
there is an additional mutation 7 bp downstream of the CpG triplet region in m8a,
producing a third methylatable CpG site. As seen from figure 4.11, the methylated
m8a mutant sequence reacts more strongly with Benzonase than the unmethylated
version as expected. Like m2 (figure 4.9), the Benzonase digestion pattern is
enhanced at the methylated sites. Also like m2, the pattern is not as defined as in LE.
An Aida™ scan of the region (figure 4.11 B) shows that the unmethylated and
methylated m2 banding patterns are very similar but the methylated m2 pattern is
shifted to the left in a manner that coincides with enhanced additional DNA bands in
the sequence.
The DNasel data (figure 4.5 A, lanes 12 & 13) shows enhanced cleavage over
the methylated cytosines. Unsurprisingly, the nucleosome positioning data for m8a
(figure 4.6 B, lanes 14 & 15) shows a pattern almost identical to m2 (lanes 4 & 5),
which is also very similar to the m25 mutant. Nucleosome positioning is very good
in the unmethylated fragment and it is removed on methylation with comparable
efficiency as the m2 or m25 mutant. Together these mutants are the most similar in
sequence construction of all of the mutants and behave similarly as shown here.
4.2 Summary
In summary, a number ofobservations and conclusions can be made.
(1) That CpG methylation of the CpG triplet in the pA-globin LE fragment causes
a significant structural alteration. This alteration has changed the structure so much
that it now becomes a preferred cleavage site for the DNA digesting enzyme,
Benzonase. As (a) Benzonase is known to have a recognition and cleavage
preference for A-form DNA, and (b) methylated DNA in this sequence context is
known to form A-DNA from crystallographic data, it is reasonable to conclude that
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by this in vitro assay, the methylated CpG triplet is forming a structure consistent
with A-DNA.
(2) The enhanced cleavage seen at the CpG triplet on the forward strand is also seen
on the reverse strand. This corroborates the hypothesis that this structure is forming
A-DNA and not some altered secondary structure in this sequence that makes DNA
more accessible to the Benzonase enzyme.
(3) There are other CpG methylatable sites in the pA-globin fragment being
analysed. None of these sites promote the formation of A-DNA. From analyzing
these sites and the surrounding sequence context, and comparing these to known
crystal structures, it appears that some degree of alternation of methylatable CG sites
is required for Benzonase hypersensitivity. The formation of A-DNA is also known
to be affected by the extent of the alternation of dinucleotides. This is clearly seen
from the analysis of the various mutants. Typically the best Benzonase reactive
sequence is the wild-type LE fragment with three methylatable CpGs. Benzonase
banding patterns are regularly spaced over this region. The methylated mutants
mostly show some reactivity with Benzonase, but the pattern is never the same or as
regularly spaced as the LE fragment. All show some DNasel reactivity as expected.
Nucleosome displacement efficiency also changes considerably over the mutant
series with the best A-forming sequences (LE, m3, then m2 and m25) showing the
best nucleosome displacement and m23 showing no significant nucleosome
displacement.
(4) Finally, the structural observations observed may have some direct relevance to
gene regulation. As described in section 4.1.1, this region of the pA-globin gene has
been analysed previously. Davey et al., (1997) have shown that this CpG triplet
when methylated disrupts the positioning of a specific nucleosome. Z-DNA analysis
of the structure showed that the triplet could form A-DNA, but only under negative
superhelical stress. The CpG triplet is part of the promoter region of the pA-globin
gene and may be a site of some importance in transcriptional regulation.
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5.1 Bandshift experiments with purified methyl bindingproteins.
I have established that CpG methylated DNA can induce dramatic changes in DNA
structure in certain sequence contexts. This structure may be an A-DNA structure as
detected by Benzonase. The sequences that react the best with Benzonase are those
of the type d(GCGCGC), when methylated. This coincides with structural data from
a variety of sources. Different structures may form in DNA due to different methyl
cytosine densities in a specific sequence context. This may be part of the key to
understanding how different methyl-binding proteins recognise and bind to different
methylated CpGs. For example the formation of A-DNA at methylated d(GC)n
sequences may be a feature recognised by some methyl-binding proteins, but
perhaps may be feature refractory to other methyl-binding proteins. To begin an
investigation into this hypothesis a series of Bandshift assays were performed. For
these a series of proteins were purified and a range of DNA oligomers specifically
designed for this purpose.
5.1.1 Design ofoligosfor Bandshift analysis.
A series of oligos were designed on the basis of NMR and crystallography studies.
Oligomers were chosen for their documented ability to form A-DNA or B-DNA.
Additionally a sequence containing a region corresponding to the pA-globin gene
CpG triplet sequence (see chapter 4) is used. It is known to change structure when
methylated, showing structural features consistent with the formation of A-DNA, as
detected by Benzonase (this thesis). Table 5.1 below summarises this information.
All oligos were made double-stranded by annealing each one with their
complementary oligo as described in Chapter 2.
5.1.2 Purification ofthe MBD domain ofMeCP2.
The -10 kDa MBD domain of MeCP2 was purified by two methods. Firstly from
Glutathione (GST)-fusion plasmid expression in E. coli, and secondly from a
histidine (HlS)-tagged fusion plasmid. The HIS tagged protein was found to be the
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most active, devoid of proteolytic digestion and the most stable in solution. The
purification results of this protein are shown below.
The full protocol for MBD purification is described in Chapter 2. In brief, a
pET6his plasmid containing the MBD domain of MeCP2 was transformed into
BL21(DE3)pLysS cells. The cells were grown and protein expression induced with
IPTG. The cells were harvested and the cell protein extracts purified. Samples were
dialysed to remove urea and SDS-PAGE gels run at each stage of the initial
purification process (data not shown). Combined samples were applied to a
Fractogel EMD-SO3-65O cation exchange column to remove E. coli proteins and to
concentrate the extracts. The bound protein was washed with increasing NaCl
concentrations. The results of this experiment are shown in figure 5.1 A and B. Lanes
o I
8 to 12 were combined, diluted and applied to a Ni charged affinity column. The
column was washed with increasing concentrations of L-histidine. Samples were
taken and applied to an SDS-PAGE gel, the results of which are shown in figure 5.2
A, B and C.








Table 5.1 DNA oligos used for Bandshift analysis. The oligos were designed for use
according to their structural characteristics. mC, methylation at 5' position of cytosine.
Bdnall, self-annealing B-DNA structural oligo. A-dnaU, self-annealing A-DNA structural
oligo, Unmethylated. A-dnaM, is the same as A-dnaU but it is methylated. It is not clear what
structure this may form when methylated. B-gloUF and B-gloUR anneal with each other to
form an unmethylated dsDNA oligomer. B-gloMF and B-gloMR are methylated versions of
the same fragment. All four B-glo oligomers correspond to the CpG triplet region of the |3A-
globin gene (see chapter 4).
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Figure 5.1 Purification of the MBD domain of MeCP2 using a cation
exchange column. The E. coli expressed MBD protein was loaded onto an
EMD S03-(S), (M) column (Merck) in Buffer A, to separate it from bacterial
proteins. The MBD protein was eluted with increasing concentrations of NaCI in
Buffer A. Fractions were collected as 1 to 2 ml samples. 1,2 refers to washes of
the bound protein with Buffer A. M, Protein Marker, broad range (Bio-Rad). The
MBD protein is eluted maximally between 0.4 M and 1 M NaCI. The samples
from 0.4 M, 0.5 M and 1 M eluents were combined and dialysed to reduce the
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Figure 5.2 Purification of the MBD domain from MeCP2 using a Nickel
affinity column. MBD purifications from an EMD-S03- cation exchange affinity
column were applied to a Nickel charged EMD chelate 650 affinity gel in Buffer A
solution. The column was washed three times with Buffer A, indicated by 1, 2, 3
in fig. A above. Low concentrations of L-histidine were used to elute unbound
proteins by competing for Ni2+ binding. Concentrations of L-histidine are
indicated by 10, 20 up to 100 mM. B, above shows the eluted MBD protein at
high concentrations of L-histidine. This is indicated by a filled arrowhead. M,
Broad range protein marker (Bio-Rad). Note that there is still some MBD protein
in the load and flowthrough indicating that the concentration of MBD in the load
was too high to completely bind to the Nickel charged column.
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5.1.3 Bandshift experiments with the purifiedMBD domain ofMeCP2.
The purified MBD domain of the MeCP2 protein is used in this analysis. The role of
MeCP2 and its characteristics are discussed in detail in Chapter 1. The aim of these
experiments was to investigate what types of sequence the MBD domain can
recognise. It is known that MeCP2 can recognise a single methyl CpG site and that
the MBD is responsible for this interaction (Meehan et al., 1992, Nan et al., 1993).
Is this dependent on the sequence surrounding the CpG step? Is it the A-form
structure of CpG methylated DNA that the MBD recognises and binds to? Can the
MBD therefore recognise unmethylated sequences that potentiate A-form DNA?
These questions were addressed by these initial bandshift experiments. From the
DNA structural data obtained here it is clear that CpG methylation can induce A-
type structures. However, the A-form structure is not seen at singly methylated CpG
sites in my analyses if they do not occur within alternating d(GC)n sequences. In
most alternating d(GC)n sequences in my analyses, the CpG steps are all usually
methylated by &xl methylase. Therefore the situation of a singly methylated CpG in
a d(GC)n stretch does not arise in many of the Benzonase digests (Chapters 3 & 4).
However the crystal structure of d(Gm5CGCGC) resolves into an A-form structure
(Mooers et al., 1995) and it is therefore possible that the MBD can recognise A-form
DNA. The solution structure ofMeCP2 does not indicate that the protein recognises
the A-DNA conformation but does indicate that the change in position of cytosine
induced by CpG methylation provides a structure that fits into the binding site of
MeCP2 (Wakefield et al., 1999). The oligos listed in table 5.1 were used for
Bandshift analysis with the purified MBD protein.
5.1.3.1 The MeCP2 MBD and the A-dnaM oligo.
A bandshift experiment with the A-dnaM oligo and the purified MBD was
performed with increasing concentrations of protein. The A-dnaM oligo was labelled
•j -y
on one strand with y- P-ATP and annealed to unlabelled copies of itself. The
oligomer was incubated with increasing concentrations of MBD in 1 X bandshift
buffer on ice, and the samples run on a 5% PAGE gel. More details can be found in
Chapter 2. The results of this experiment are shown in figure 5.3. As can be seen,
lane 0 contains no MBD and does not show any shift in position of the A-dnaM
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oligo. Increasing concentrations of MBD are used in lanes 1 to 9. As can be seen,
there is a specific bandshift with this oligo as indicated in figure 5.3. This sequence
has two methylated CpGs that are not adjacent to each other, confirming that the
MBD alone is capable of recognising a single methylated CpG.
5.1.3.2 The MeCP2 MBD and the A-dnaU oligo.
A bandshift experiment was carried out with the MBD protein and the A-dnaU oligo
in the same manner as described above. The results are shown in figure 5.4.
Increasing amounts of the MBD protein shows that it does seem to recognise the
unmethylated oligo at higher concentrations of the MBD. This interaction is much
weaker than that observed with CpG methylated DNA. The bandshift that occurs is
not a smear however, but a discrete complex. This may indicate that the MBD is
positioned at a particular region on the DNA.
5.1.3.3 The MeCP2 MBD and the A-dnaU andA-dnaM oligos with competitor.
A bandshift experiment with the MeCP2 MBD and the A-dnaU and A-dnaM oligos
was repeated in the presence of competitor DNA. The competitor used was E. coli
DNA as the traditional salmon sperm is CpG methylated and would interfere with
the results. The oligos were incubated with equal concentrations of the MBD and
increasing concentrations of competitor DNA. The results are shown in figure 5.5.
The results show that even in the presence of competitor DNA, the MBD still binds
to the A-dnaM oligo specifically with no observable interaction with the A-dnaU
oligo. Therefore the weak interaction seen with the A-dnaU oligo in figure 5.4 is
now reduced by the presence of non-specific competitor DNA.
5.1.3.4 The MeCP2 MBD and the B-dnaU oligo.
Although the MBD binds only minimally to the unmethylated A-form oligo, a
comparison was made to a typical B-form oligo, B-dnaU. This is shown in figure
5.6. It appears that the MBD can react with a typical B-form molecule, but the
complex formed appears to be a smear of weak interactions and not a discrete
complex. To do a side-by-side comparison, the double-stranded A-dnaU and B-dnaU
oligos were again independently incubated with increasing amounts ofMBD protein
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Figure 5.3 Bandshift experiment with purified MBD protein and A-dnaM
oligomer. Double stranded and radiolabelled A-dnaM oligomers were
incubated with increasing concentrations ofMBD protein. Free DNA is indicated
above by a closed arrowhead as are bound oligomers. Lane 0 is a control lane
lacking the MBD protein. Samples were run on a 5 % polyacrylamide gel.
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Figure 5.4 Bandshift analysis of the purified MBD domain of MeCP2 with
the A-dnaU oligomer. The double-stranded A-dnaU oligomer was incubated
with increasing concentrations of the purified MBD protein as indicated above.
Arrowheads indicate the positions of free DNA and MBD bound oligomer. Lane
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Figure 5.5 Bandshift analysis of purified MBD protein with the A-dnall and
A-dnaM oligomers in the presence of competitor DNA. Double-stranded
labelled oligomers were incubated with a constant amount of MBD protein
approximating 1 ug of protein per lane. Increasing amounts of non-specific, non-
methylated E. coli DNA was added to each lane except for the 0 lane control in
both cases, which contained no MBD and no competitor DNA. A-dnaM specific
bandshifts are indicated with a filled arrowhead. Samples were run on a 5 %
polyacrylamide gel. The presence of two bands may indicate the binding of one









Figure 5.6 Bandshift analysis of purified MBD protein with the B-dnaU
oligomer. Double-stranded DNA consisting of the radiolabeled B-dnaU
oligomers were incubated with increasing concentrations of the purified MBD
protein. The boxed region indicates an area of non-specific interaction with the
B-dnaU oligomer. Free DNA is indicated by an open arrowhead. Samples were
run on a 5 % polyacrylamide gel.
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and run on the same gel. The results are shown in figure 5.7. It appears that the A-
dnaU oligo reacts better than the B-dnaU oligo with MBD. This result warrants
further analysis as it is a preliminary result. There is also no competitor DNA used in
this analysis.
5.1.3.5 The MeCP2 MBD and the B-gloU and B-gloM oligomers.
To assess whether the MBD can bind to a methylated CpG string of dinucleotides as
well as it does to a single methylated CpG, I have taken a region covering the CpG
triplet region of the |3A-globin gene responsible for nucleosome displacement. It is
probable that methyl-binding proteins are involved in the regulation of pA-globin
gene expression as described in chapter 4. To assess if the MBD can recognise and
bind to this sequence, both B-gloU and B-gloM oligomers were incubated with
increasing concentrations of MBD. The results are shown in figure 5.8. and figure
5.9. Clearly, the MBD can recognise the methylated CpG triplet specifically. There
may be some non-specific contacts to the unmethylated CpG triplet, represented as a
smear on the gel, but there is no specific complex formed.
5.1.3.6 Bandshift experiments with thepurifiedxMBDl protein.
To assess the sequence specificity of other MBD containing proteins on interaction
with methylated DNA, the Xenopus MBD1 protein was used. This was provided by
Dr. I. Stancheva who obtained the sequence by DNA cloning from a Xenopus Z-Zap
library. The sequence was cloned into a pGEX-3X-GST fusion vector, expressed in
E. coli and purified. The human MBD 1 solution structure in complex with DNA has
been solved (Ohki et al., 2001). It has a very similar structure to MeCP2 across the
whole structure, including the MBD. The details of hMBDl are discussed in Chapter
1. The hMBDl binds a singly methylated CpG dinucleotide in a similar manner to
MeCP2. The xMBDl protein can also bind a single methyl CpG. A comparison of
the protein sequence of both is shown in figure 5.10 A. Bandshift experiments using
the purified xMBDl with the A-dnaU and A-dnaM double-stranded oligos is shown
in figure 5.10 B. It is clear that xMBDl can interact with the methylated oligo, but it
also appears to interact well with the unmethylated oligo. This may be for several
reasons. Perhaps there is not enough xMBD 1 to provide a distinct interaction in the
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Figure 5.7 Bandshift analysis of the purified MBD domain of MeCP2 with
the A-dnaU and B-dnaU oligomers. The double-stranded A-dnaU and B-
dnaU oligomers were incubated with increasing concentrations of purified MBD
protein as indicated. The boxed region indicates a region of non-specific
interactions with the B-dnaU oligomer. The arrows indicate discrete bands
representing MBD interactions with the A-dnaU oligomer at high concentrations
of the MBD protein. Samples were run on a 5 % polyacrylamide gel.
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Figure 5.8 Bandshift analysis of the purified MBD domain of MeCP2 with
the B-gloU oligomer. Double-stranded B-gloU oligomer was incubated with
increasing concentrations of the MBD protein as indicated. Lane 0 is a control
lane containing no MBD protein. Free DNA is indicated by a filled arrowhead.
The bracketed region shows a non-specific smeared interaction with the B-gloU
oligomer. Sampleswere run on a 5 % polyacrylamide gel.
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Figure 5.9 Bandshift analysis of the purified MBD protein with the B-gloM
oligomer. Double-stranded B-gloM labelled DNA oligomer was incubated with
increasing concentrations of the purified MBD protein. The free DNA and bound
DNA fractions are indicated in the text by filled arrowheads. Lane 0 is a control













0 0.1 0.2 0.4 1 2
Figure 5.10 Bandshift analysis of the purified xMBDl protein with the A-dnaU and A-
dnaM oligomers. A amino acid alignment showing the degree of similarity between the human
MBD1 and the xMBDl proteins. B The purified xMBDl protein provided by Dr. I. Stancheva,
was incubated at increasing concentrations with a constant amount of either double stranded
labelled A-dnaU and A-dnaM oligomers. Filled arrowheads indicate free DNA. Open
arrowheads indicate a specific xMBDl bandshift with both the A-dnaU oligomer and the A-
dnaM oligomer. Sampleswere run on a 5 % polyacrylamide gel.
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methylated lane, or perhaps the xMBDl activity is low in this purification. It is also
very possible that this result reflects the fact that xMBDl can interact with A-form
DNA. The number of methylated CpGs may be too few, or not in the correct
sequence context to show enhanced binding with the CpG methylated A-dnaM.
There is also no competitor DNA used in this study, but nevertheless some
interaction is observed.
5.1.4 Footprinting analysis of the p4-globin gene promoter region with purified
MBD protein.
Having analysed the CpG triplet of the chicken pA-globin gene promoter region in
detail and performed bandshift analysis as described above, I decided to attempt
DNasel footprinting analysis on the pA-globin gene promoter region using the MBD
domain of MeCP2 that I had purified. The aim is to bind the protein to the DNA
sequence and digest away the sequence surrounding the protein binding site. Initial
tests estimated a concentration of DNasel that would cleave approximately 50 % of
the DNA sequence (data not shown). DNA fragments were prepared as described for
Benzonase analysis of the pA-globin gene promoter region. Fragments were labelled
at the HinfI end of Sssl methylated DNA. The DNA was purified and aliquoted into
Bandshift buffer with increasing concentrations of MBD protein on ice. An equal
amount ofDNasel was added to each sample and the digestion reaction carried out at
room temperature. Digested fragments were purified and run on an 8 % denaturing
PAGE/urea gel. The gel was dried and exposed to a Fugifilm phosphorImaging
screen. After two days the screen was phosphorlmaged. The resultant image is
shown in figure 5.11. As can be seen from this image, there appears to be some
binding of the MBD to DNA at the region of the CpG triplet. There is also another
footprint downstream of the CpG triplet region. This may correspond to a single
methylated CpG site located 45 bp downstream of the CpG triplet sequence. It
therefore appears that the MBD ofMeCP2 is capable of binding specifically to both
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Figure 5.11 DNasel footprint
analysis of methylated pA-
globin LE fragments with
increasing amounts of MBD
protein and a constant
amount of DNasel. M, pBR322-
BsivRI digest marker; m, pUC19-
Msp\ digest marker; LE-Hhal, LE
fragment digested with Hha\.
Elipsoids show the protection in
the sequence due to MBD
binding. DNasel concentrations
were the same in each digested
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5.1.5 Summary
These Bandshift experiments are initial attempts to unravel the specificities of
binding of the methyl-binding proteins. Here I have demonstrated a distinct
preference for methyl-CpGs by the MBD protein. It is irrelevant whether there are
one or three methylated sites present in the bound sequence. It binds equally well to
both the double-stranded A-dnaM and B-gloM oligomers. It appears that the MBD
can specifically recognise the methyl-CpGs themselves and the effect they produce
at a local structural level, ie: at the level of the dinucleotide pair. This is consistent
with the known structure of the MBD and the determination of how it interacts with
DNA.
It also appears that the MBD can bind the unmethylated A-form A-dnaU
oligo to form a discrete complex, albeit at high concentrations of MBD only. This
reactivity is reduced significantly in the presence of non-specific competitor. The
MBD also shows some reactivity with the B-dnaU sequence, but this interaction is
weak and smeared across the gel.
The xMBDl protein is most similar to human MBD1. When used in the
bandshift assay it appears to react poorly with the methylated A-gloM fragment
when compared to the unmethylated fragment. As stated, this may be for several
reasons but could provide an example of an MBD protein that can recognise
methylated DNA when it is presented as an A-form structure.
Footprinting analysis of the pA-globin gene promoter sequence (see Chapter
4 for details) clearly shows that the MBD is capable of locating to CpG methylated
DNA in vitro over the triplet region and at high concentrations, has a weak affinity
for unmethylated DNA. It is possible that in vivo the MeCP2 protein can locate to
this sequence, although it is currently not known what methyl binding proteins
operate at the promoter region in vivo.
A series of questions were posed in section 5.1.3 on how the MBD domain
recognised methylated CpGs. To reiterate: It is known that MeCP2 can recognise a
single methyl CpG site and that the MBD is responsible for this interaction (Meehan
et al., 1992, Nan et al., 1993). Is this dependent on the sequence surrounding the
CpG step? Is it the A-form structure of CpG methylated DNA that the MBD
recognises and binds to? Can the MBD therefore recognise unmethylated sequences
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that potentiate A-form DNA? To summarise and answer these questions, it is (a)
clear that the MBD ofMeCP2 alone can recognise and bind to methylated DNA, (b)
clear that the MBD of MeCP2 recognises the CpG alone and does not seem
concerned about changes in DNA structure surrounding a meCpG step, (c) apparent
that A-forming sequences alone are not sufficient to appreciably compete for the
binding of the MBD protein or the xMBD 1 protein, and (d) not clear whether other
MBD proteins that can only bind to multiple meCpGs (the MeCPl complex), do so
because they recognise methylated A-form DNA.To thoroughly prove that A-DNA
has a role in the determination of where and when methyl-binding proteins can bind
to their target DNA, a great deal more experiments are required. Presented in this
thesis is proof of the existence of A-form structures in methylated DNA. It is clear
that in some cases the formation of A-DNA can alter nucleosome positioning. From
other studies it is also clear that different MBDs have different methylated sequence
preferences. It may be the case that the effect of where and when methyl-binding
proteins bind to their cognate sequence, is dependent on the response of
nucleosomes to an altered DNA structure. Bandshift analysis can provide us with
information on the methylation density that different methyl-binding proteins can
bind to. To investigate this further, a variety of other purified MeCPs would need to
be tested thoroughly for their binding preferences. A specific set of immediate
questions need to be addressed. Firstly, do any of the other methyl-binding proteins,
(hMBDl, xMBD3, MBD4 and Kaiso) show distinct differences in their binding
capacities? Do any of these proteins show a distinct preference for methylated A-
form DNA? If not, it is possible that an undetermined component of the MeCPl
complex of proteins (see fig. 1.7), is responsible for the direction of where and when
different methyl-binding proteins bind. Another possibility is the highly flexible, yet
variable loop structure present in the MBD1 and MeCP2 protein structure. The loop
changes conformation on binding to different methylated cytosine residues. This
may determine what further interactions are possible in terms of higher order
chromatin. A combination of competitive bandshifts with a greater range of both
DNA and RNA sequences would need to be performed to reveal individual MBD
protein specificities. It may be that competition with dsDNA A-forming sequences is
only observed in the presence of the MeCPl complex (see figure 1.7). Bandshift
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experiments with the purified MeCP 1 complex from Xenopus oocyte extracts could
shed some light on this distinct possibility. A further great advantage in
understanding the mechanism of MBD protein binding, will be the inevitable
elucidation of the NMR structures of MBD interactions with methylated DNA.
Indeed, we are still not sure how many methyl-binding proteins currently exist. Until
now a selection have been identified that contain an MBD. Kaiso is one example of a
methyl-binding protein that does not contain an MBD domain. There may be others
in existence that use these extraordinary CpG methylation-induced transitions in




Note: I have included a Summary at the end of each chapter where I have
discussed the results in each chapter. Therefore I have used this chapter to both
summarise the data as a whole and speculate on the potential implications of these
findings.
The subject of this thesis has been an investigation into the structure of CpG
methylated DNA. As described in Chapter 1, there is a lot of evidence to support the
idea that DNA methylation can alter DNA secondary structure. There is also
substantial evidence to support the idea that the cytosine residue is crucial in
determining the equilibrium between B-DNA, Z-DNA and A-DNA (Foloppe et al,
1999). Only recently was a naturally occurring nuclease from Serratia marcescens,
Benzonase, discovered with the ability to cleave DNA with a distinct preference for
A-form DNA. This enzyme had never been applied to CpG methylated DNA before.
Here it is demonstrated for the first time, that CpG methylated DNA can potentiate
the formation of A-DNA in vitro, using an assay based on the specificity of the
DNA/RNA nuclease, Benzonase.
6.1 The Benzonase Enzyme: History and specificity for A-form DNA.
The Serratia marcescens extracellular endonuclease is a 266 amino acid protein that
is proteolytically processed upon excretion to give an active protein of 245 amino
acids (Ball et al., 1987). It is commercially available as Benzonase and is used in
industry for the downstream processing of pharmaceuticals. The structure has been
solved by crystallographic analysis (Miller et al., 1994) and shown to be a dimer of
identical subunits (Friedhoff et al., 1994), although mutational analysis shows that
dimerisation is not necessary for activity (Franke et al., 1998). It is an extremely
stable enzyme with a temperature optimum between 37 and 44°C and requires a
divalent cation such as Mg2+ for activity. The commercial product was obtained from
Merck as a 30 kDa protein which has been purified to purity grade I: 99 %, with no
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detectable protease activity present. It is supplied at 25 U/pl and is incredibly potent.
1 U can degrade 37 pg of DNA in 30 minutes (Merck, technical information).
Benzonase has a broad substrate range. It can cleave both single and double
stranded DNA and RNA, producing 5'-phosphorylated mono-, di-, tri and
tetranucleotides (Nestle & Roberts, 1969a, 1969b). Meiss et al., (1995) have
investigated the specificity of Benzonase on different types of DNA and RNA and
found that although it will cleave all nucleotide sequences, it has preferred cleavage
sites. Other non-specific nucleases show similar specificities. For example, DNasel
has sequence preferences that are explained by both local and global variations in
DNA structure (Drew & Travers, 1984; Fox, 1986) as well as DNA flexibility
(Hogan et al., 1989) and DNA bending (Brukner et al., 1990). For DNasel, nuclease-
olionucleotide complex structures have been crystallised and therefore it is possible
to rationalise sequence preferences (Weston et al., 1992). Only the three dimensional
structure has been solved for Benzonase alone, without oligonucleotide binding; by
Miller et al., (1994), refined by Lunin et al., (1997) and more recently to a resolution
of 1.1 A by Shlyapnikov et al., 2000). Meiss et al., (1995) have compared the
specificity of Benzonase and DNasel for a series of oligonucleotides, none of which
contained CpG methylated DNA. They observed marked differences in preferred
cleavage sites. The most notable difference observed by Meiss et al., (1995), was
that Benzonase has preferential cleavage of d(G).d(C) tracts, which are not attacked
preferentially by DNasel. Both have an inability to cleave dsDNA at d(A).de¬
tracts, a sequence that has a small minor groove width. The minor groove can vary in
width quite substantially. For example, the sequence d(CGATTAATCG) has a
narrow minor groove width measuring 2.6 A, whereas the sequence
d(CCGGCGCCGG) has a minor groove width of 8.9 A (Heinemann et al., 1994).
Benzonase, like DNasel attacks DNA at the minor groove. This is speculated on by
Meiss et al., but it is also seen in thesis, that in sequences where DNA is preferably
cleaved by DNasel, there is often no overlap with Benzonase (chapter 3). When the
two enzymes do converge with the same digestion pattern, it is at regions known to
have a much larger minor groove than average, that fall under the classification ofA-
DNA. It appears that the minor groove must be widened more for Benzonase than
for DNasel, for it to show enhanced cleavage (Meiss et al., 1995, and this thesis).
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In line with this, further investigations by Meiss et al. (1999), have confirmed
that Benzonase does indeed prefer A-form nucleic acids as substrates. Steady-state
kinetic analysis of the cleavage of a selection of olgonucleotides, in conjunction with
structural data from circular dichroism spectroscopic analysis, suggests that
oligonucleotides adopting an A-conformation are preferred over those that potentiate
a B-conformation. Both single-stranded and double-stranded substrates of both A-
DNA and B-DNA were used in this study. The substrate showing the best cleavage
kinetics was a dsRNA oligomer of the sequence called r(r)= r(GCAAAAAAGCG),
which is known to fonn an A-form structure. A feature of the A-conformation is a
C3'-endo sugar pucker conformation and a tilt of the bases relative to the helix
(Olson, 1975). These features are found in this oligomer and in others that also
reacted well with Benzonase, but were intermediate in their establishment of the A-
conformation. This aspect of the reactivity of Benzonase has been a vital
understanding in terms of this thesis. If Benzonase can recognise the C3'-endo
pucker then this provides us with a fairly specific A-DNA nuclease. This work also
revealed that Benzonase prefers double-stranded substrates over single-stranded,
rendering it a useful tool for the analysis of methylation induced A-form DNA, as it
can ignore any unusual secondary structure abnormalities or regions of single-
strandedness in the sequence (Meiss et al., 1999). Further analysis to confirm this
was performed on a range of dsDNA oligomers that had the propensity to form
either A-form or B-form DNA. In all cases, Benzonase reacts with the
phosphodiester bonds of the A-conformation oligomers much more readily (Meiss et
al., 1995, 1999). Of special note is that although the authors declare there is a
cleavage preferance for G+C rich regions, this does not reflect a base preference.
The oligo d(G).d(C) substrate is cleaved preferentially and has a greater tendancy
than oligo d(GC) to be A-form (Heinemann et al., 1987, 1994; Meiss et al., 1999).
Cleavage in alternating d(CG) sequences that adopt the B-conformation in
physiological conditions is low (Butkus et al., 1987).
Interestingly, in the analysis of single stranded substrates it was found that
the sites ofhydrolytic attack are altered when the oligonucleotide is rendered double-
stranded. The variations indicate that Benzonase is sensitive to local structural
variations of the phosphodiester backbone of nucleic acids. Further to this,
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mutational analysis of conserved amino acids at the Benzonase binding site do not
affect its activity a great deal. The results of several amino acid substitutions at these
conserved sites confirms that substrate recognition covers the whole substrate
binding site and is not the result of a particular residue at the catalytic centre (Meiss
et al., 1999). Based on these many observations by Meiss et al., (1995, 1999), I was
convinced of its ability to recognise and cleave A-form DNA sequences with a great
deal of specificity. I decided to apply this knowledge of Benzonase reactivity to CpG
methylated DNA to see if it too would show enhanced cleavage, in comparison to
unmethylated DNA. This would indicate regions of potential A-form DNA, not only
providing a new type of assay for the analysis of methylated DNA, but also
underlining a potential role for A-form DNA in gene regulation.
6.2 CpG Methylation Potentiates the formation ofA-form DNA.
The hypothesis was that CpG methylation could potentiate an A-form structure. This
could make CpG methylated DNA a preferential target for Benzonase digestion.
Heavily methylated DNA might therefore be digested faster than non-methylated. A
pilot experiment used Benzonase to digest unmethylated and SssI methylated
pBR322 plasmid (figure 3.2). There did not appear to be any significant increase in
the overall rate of digestion by Benzonase. I concluded that although the enzyme
may be expected to digest methylated DNA faster than unmethylated DNA, this
effect would not be observed unless the plasmid was incredibly CG rich. There were
enough unmethylated sites in pBR322 to keep the overall digestion rates constant.
This did not exclude the possibility that at the level of the methylated base pair some
local effect could be observed. This aspect was pursued as described below.
I decided to use Benzonase to develop an assay similar to that used by Meiss
et al., 1995, 1999. To establish that the method I was developing would be effective
in detecting regions of A-form DNA, a variety of tester fragments were used,
illustrating the ability of this assay to detect sequences known to potentiate A-DNA.
The first of these is a fragment of the pBR322 plasmid covering the ampicillin
resistance gene (AmpR). The region covered in my assay is larger that used by Mei et
al., (1988) who used a Ruthenium based chiral probe to detect A-DNA. The region
that does overlap with their analysis, shows the same digestion hotspots in the
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unmethylated fragment using Benzonase as Mei et al., (1988) observed using their
Ruthenium probe, confirming the usefulness of Benzonase for A-DNA analysis.
When this sequence is CpG methylated, the pattern of specificity of Benzonase
changes (figure 3.5 A). Although there are several methylatable CpGs in this
fragment, there is only one region that shows enhanced cleavage with Benzonase.
This corresponds to a region covering a Hhal recognition site and covers the
sequence 5'..GGTTCCGCGCAC..3'. There are two methylatable CG sites adjacent
to each other here that are responsible for the altered cleavage at this site. This is the
first example of the detection of methylation induced A-form DNA using this assay.
In a later additional experiment I decided to analyse the reverse strand of this
fragment. There is a structural change in the sequence at the expected location
although the marker lane nor the separation of bands in the gel, is as good as I had
hoped. It is therefore included in the Appendix, Chapter 7 as figure 7.1.
Sssl methylase methylates every CG dinucleotide pair in the pBR322
fragment, and was confirmed to do so by a methylation protection assay (data not
shown). DNasel shows enhanced cleavage at methyl CpGs as determined by Fox,
(1986). I performed DNasel analysis on this fragment to confirm that there were
structural alterations present in the DNA sequence due to methylation, that were not
being picked up by Benzonase. DNasel analysis of the pBR322 gene fragment
detects that CpG methylation does induce DNA structural changes at each
methylated cytosine, including the site that shows enhanced cleavage with
Benzonase (figure 3.6 A). This experiment confirms that the Benzonase enzyme
requires a larger change in structure than DNasel requires, for it to react
preferentially. Both DNasel and Benzonase are sensitive to groove width as
described above. It appears that Benzonase requires a larger widening of the minor
groove of DNA to show preferential cleavage at methylated sites, a feature that is
consistent with A-form DNA.
Another tester fragment was then subjected to Benzonase analysis. An 167
bp insert (the 'Pingoud' fragment) into pGEM9Zf(-) was designed and kindly
provided by Dr. Pingoud. This fragment had been used by Meiss et al., (1999) to
demonstrate the sequence specificity of the Serratia nuclease and was part of their
analysis that concluded that the nuclease could recognise and cleave A-form DNA
177
Chapter 6: Discussion
preferentially. In my analysis I have proven that my Benzonase reaction conditions
provide the same pattern of digestion as that shown by Meiss et al., (1999) for this
fragment in the unmethylated state. However, when I methylate this fragment the
pattern of digestion changes (figure 3.8). Now some sites show enhanced cleavage
where they were largely unreactive in the unmethylated fragment. The major
difference seen is at a d(GC)n string that it is largely unreactive in the study by Meiss
et al., but is highly reactive in my analysis when this sequence is CpG methylated.
This confirms again that Benzonase is indeed a useful tool for the analysis of methyl
CpG induced DNA structure. This time it is capable of recognising A-form
structures in a much longer sequence context. Long alternating d(GC)n are
commonly found at CpG islands at gene promoters. These are usually unmethylated
at gene promoters, apart from at the inactive X-linked gene loci and some imprinted
genes. Normally unmethylated CpG islands can become aberrantly methylated
rendering the gene inactive. CpG island methylation can sometimes lead to the
progression of cancer, especially if the silenced gene is involved in the processes of
apoptosis, DNA repair or cell-cycle control mechanisms (Jones & Baylin, 2002). It
is possible that A-DNA may form at aberrantly methylated CpG islands in vivo,
which is probably then recognised by the methylation machinery.
Having established that CpG methylation can potentiate A-form DNA, I then
tried to refine the conditions of the experiments by using Urea. Meiss et al, (1999)
had reported that Urea increases specificity of the enzyme. I attempted this with both
the pBR322 fragment and the Pingoud fragment. However I did not see any
enhanced specificity in my assays with Urea, (figure 3.9 and 3.10). Interestingly for
the commercial Benzonase documentation from Merck, they report that any
increased specificity seen by the use of Urea is a pseudo-effect and reflects the
digestion of DNA in these conditions. Perhaps the timescale used in my analyses
was not sufficient to show digestion by Urea, but sufficient to show digestion due to
Benzonase. In all methylated fragments however, Benzonase did show heightened
reactivity at the same sequences in the presence of Urea, confirming that the changes
seen were not due to the reaction conditions, and were not altered in the presence of
Urea. This may indicate that the methylation induced structural transitions
recognised by Benzonase are indeed very stable. The reactivity of Benzonase at
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various methylated sites in DNA is summarised in table 6.1 below, along with a list
ofDNA sites recognised by DNasel analysis, that are not recognised by Benzonase.
(+) Benzonase Cleavage (+) DNasel Data Source








(+) DNasel (-) Benzonase Cleavage Data Source
CG Figure 3.6 A
GGCG Figure 3.6 A
CCCCG Figure 3.6 A
GCGG Figure 3.6 A
Table 6.1: Benzonase and DNasel digestion: Preferred cleavage sites at CpG
methylated DNA sites. The above table indicates sites shown to react with Benzonase
from Results, Chapter 3 and one example from Results, chapter 4. (+) indicates enhanced
cleavage with either Benzonase or DNasel. (-) indicates sequences that do not show
enhanced cleavage with Benzonase, but do show enhanced cleavage with DNasel. The
data source refers to the various gels where reactivity has been observed. All of the
sequences were Sssl methylated, therefore although not indicated in the sequences above,
it is assumed that all of the above sequences are methylated at CpG dinucleotides.
Having established the technique and some of the sequence preferences of
Benzonase for methylated DNA, I decided to focus on a eukaryotic gene sequence,
where DNA methylation is known to have an effect on gene expression. The 012-
globin gene was chosen for several reasons. It is highly CG rich and possesses a
CpG island, which is usually unmethylated, but can become methylated in some cell




The developmental regulation of globin gene expression is intensely studied
because of their importance in many common inherited diseases, in particular the
thalassemias. A high degree of conservation of these developmental control
mechanisms has been observed from human to avian species. In vertebrates, the a-
and p~ globin genes are expressed sequentially and exclusively in erythroid cells
during defined stages of development. The human a-like gene family is comprised
of a gene cluster in a 26 kb region on chromosome 16 in the order (5'-<^(embryonic)-
oi2 (adult)-ai (adult)-0i(foetal/adult)-3') and P-like gene family on chromosome 11
(5'-£(embryonic)-Gy(foetal)-Ay(foetal)-5(adult)-P(adult)-3'). The avian p-type
globin cluster (5'-p(embryonic)-pH(adult)-p(adult)-s(embryonic)-3') is arranged
differently with the two embryonic genes flanking two adult genes. Both a- and [3-
globin gene sequences regulate the timing of gene expression via locus control
regions (LCRs), erythroid specific enhancers, located kilobases upstream of each
gene cluster (review: Weatherall, 2001). Figure 6.1 illustrates the organisation of the
human a- and P-globin gene families. The chicken p-globin locus is discussed later,
but like the human globin genes sweeping changes in gene expression patterns are
also observed. This figure is used to illustrate the dramatic changes in expression
that occur throughout early development. CpG methylation could provide part of the
explanation as to how these genes are expressed and shut down at various stages of
development. At present it is not understood how CpG methylation may be involved
in developmental changes of gene expression at the globin loci.
There are many Hhal sites in the 012-globin promoter region, which had
already been shown to be very responsive to Benzonase in the studies thus far.
Benzonase analysis of a region of the a2-globin promoter region shows the most
reactivity seen with Benzonase to this point (figure 3.13). There are many sites that
show an altered structure due to CpG methylation. These mainly consist of Hhal
recognition sites, although there are two overlapping Hpall sites that seem to show
some reactivity with Benzonase. At this region between 80 and 89 bp, marked in
figure 3.13, it is possible that Hpall recognition sites do contribute to a change in
structure when methylated. It is also possible that because there is some alternation
of sequence, and at least one partial Hhal site at this region, that it is not the Hpall
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Figure 6.1 The chromosomal organisation of the human globin genes.
This diagram illustrates the organisation of the globin gene families. Vertical arrows indicate the
location of DNasel hypersensitive sites that are thought to be involved in globin gene regulation.
The p-globin family is clustered on chromosome 11 and the a-globin family on chromosome 16.
LCR, locus control region. HS-40, Hypersensitive site 40. The products of the °y-and V genes
are g-chains with either glycine (Gy) or alanine (Ay) at position 136. The central diagram
summarises information on the levels of expression of the a-,|3 - and y-globin genes through
early development. This information is coupled to both the tissue of expression in the body and
the cell-type where expression is found. A megalocyte is a large red-cell precursor, a macrocyte
is a large red cell and a normocyte is a normal-sized red cell. Of note is the major shift in
expression of the globin genes throughout development. At about 12 weeks, post conception,
the expression of the p-globin gene gradually rises until it reaches a maximum circa 36 weeks of
post-natal development. The reverse pattern is seen for y-globin gene expression. It reaches a
minimum at 36 weeks post-natal development. The a-globin gene maintains a steady state of
expression from 12 weeks post-conceptual development. The most dramatic changes in gene
expression occur in early post-conceptional development. Embryonic e-globin rises and falls
dramatically before the 12 week stage, at which point the a-, p-andy-genes come into play. It is
these sweeping changes in gene expression that the interplay of CpG methylation and




confirm that these changes were due to heightened reactivity at alternating (GC)n
regions, the experiment was repeated, but this time using Hpall methylase to
methylate the fragment. The Hpall recognition sequence is not an alternating
sequence. In this experiment I observed that there were now no observable highly
reactive sites in the methylated sequence as compared to the unmethylated sequence
(figure 3.14). This implies that Benzonase is only highly reactive with some of the
methylated sites and not others. Sequences that show alternation of GC residues
seem to react well with the enzyme. These sequences in their methylated state are
also the most consistent A-forming structures, as previously discussed. For the
relevance of these results to gene regulation I have investigated the literature for
relevant information on the regulation of globin gene expression, as discussed below.
A map encompassing 300 kb in and around the human alpha-globin cluster
also shows that a 26 kb cluster is also embedded within a region of unusually high
CG content (Fischel-Ghodsian et al., 1987). Like other tissue-specific CpG island
genes, both ai and a.2 genes are completely unmethylated in non-erythroid and
erythroid tissues tested including sperm, but are only expressed in erythroid tissues
(Bird et al., 1987; Antequera al., 1989; Vyas et al., 1992). One major difference in
a-globin gene regulation is that both the human and rabbit alpha-globins can be
expressed in transfected erythroid and non-erythroid cells in the absence of an
enhancer. This enhancer independent expression of the alpha gene requires extensive
sequences not only from the 5' flanking sequences but also from the intragenic
region. Whether this is due to an intragenic enhancer with binding sites for gene
specific proteins or due to an extension of the promoter into the intragenic region
was addressed by Shewchuk et al., (1997). They concluded that both possibilities
above were not likely by their analysis, but that the CpG island extended into the
intergenic region and the effect seen was a general one; ie: When the size of the CpG
island is increased, the level of gene expression increases concomitantly. They also
show that the CpG island provides a chromatin environment that promotes
transcription.
Apart from the aforementioned evidence on CpG island methylation
causing gene inactivation in cell lines, accumulating evidence for natural expressing
cells also exists. This identifies the interweaving of both DNA methylation and
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chromatin structure as of major importance in the regulation of both tissue-specific
and developmental stage specific expression of the a-globin gene cluster.
Throughout the a-globin gene family there are many DNasel hypersensitive (HS)
sites, which correlate with changes in chromatin structure at different developmental
stages (Yagi et al., 1986). These changes also correspond with sequential changes in
the DNA methylation status 5' to the coding region of the a-globin genes in the
switching from embryonic > foetal > adult haemoglobin gene expression (Haigh et
al., 1982; Michalowsky et al., 1989). A major LCR is located 40 kbp upstream of the
human embryonic ^-globin gene. It too is required for the expression of the ar-
globin gene and most of the chromosomal deletions that cause alpha-thalassemia
either remove the alpha-globin genes and/or the LCR (HS-40) (Barbour et al., 2000).
In vivo footprinting of this region identified binding sites for GATA-1, AP-l/NF E2
and unknown CACC / GGTGG binding proteins all ofwhich are required for correct
LCR function (Strauss et al., 1992). In terms of protein binding, Rein et al., 1995,
have demonstrated that NF-1 also binds, and is partly responsible for alpha globin
repression, but concluded that there may also be different forms of NF 1 repressing
alpha-globin expression (Rein et al., 1995). Additionally, in the 5'-flanking and
internal regions of the rabbit a-globin gene, which constitutes the CpG island and
confers enhancer-independent transcription, contains binding sites for transcription
factors alpha-IRP (-53 to -44), CP-1 (-73 to -69) and Spl (-95 to -90) relative to the
CAP site. Spl also binds to sequences in intron 1 and unidentified proteins also bind
to CCAC and C5 motifs in the 3' UTR. Exon 1 also contains a binding site for the
nuclear protein YY1. The human alpha-globin gene also contains multiple copies of
the Spl binding sequence. Interestingly deletion of the alpha-globin 5' flanking
region in transient transfection assays, has no effect on a-globin gene expression.
However, when the deleted construct is introduced into chromatin, loss of the 5'
region decreases expression by 90 %. Footprint analysis and functional assays show
that the ability of the 5' flanking region to increase a-globin gene activity is
mediated in a chromatin context by its multiple binding sites for Spl. Spl has a
recognition site consisting of alternating d(CG) residues and does not lose its ability
to bind a recognition site when it is CpG methylated in vitro, but perhaps interaction
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with methyl-binding proteins may influence transcriptional regulation at these sites
(Pondel et al., 1995).
Finally, a recent study underlies the role that CpG methylation and
associated proteins have in globin gene regulation, methylation of a 248 bp region
proximal to the avian embryonic p-globin gene has been found to correlate inversely
with stage specific expression in avian erythroid cells. Transient transfection of the
CpG methylated 248 bp region into primary erythroid cells, in the absence of
promoter methylation and in the context of nucleosomes, forms a methyl-specific
complex containing MBD-2 and HDAC-1 proteins (Singal et al., 2002). Similar
mechanisms may be involved in the sequential expression of the a-globin genes and
others throughout development.
My attention then shifted to a gene that could provide information pertinent
to both DNA and chromatin structure. As discussed in Chapter 4, this involved
analysis of the chicken pA-globin gene. This gene had previously been analysed by
Dr. C. Davey. It contains a CpG triplet sequence in the promoter region that causes
alterations in DNA structure when CpG methylated in addition to nucleosome
displacement (Davey et al., 1997). I began a collaboration with Dr. Davey on the
nature of this structural change. Dr. Davey analysed the region for the formation of
Z-DNA but found that it could only form on a supercoiled template and not on linear
DNA. Nucleosome displacement occurs on linear DNA and is therefore not due to
Z-DNA formation (pers. comm.). I analysed the same gene region with Benzonase
digestion analysis for the presence ofA-DNA (figure 4.3). The results clearly show a
methylation dependent structural change at the position of the CpG triplet. In
addition, Benzonase analysis of the reverse strand of this sequence also showed a
methylation dependent change, (figure 4.4) indicating the change in structure was a
consistent feature of both strands and less likely to be some kind of secondary
structure alteration located on one side of the helix. From my analysis it appears that
this region of the chicken pA-globin gene can form A-DNA, which coincides with
the region responsible for methylation induced nucleosome displacement.
A series of point mutations and insertion mutations of the CpG triplet were
analysed by Benzonase digestion to assess their A-forming potential, and to ascertain
whether this coincided with nucleosome mobility or not. Dr. Davey performed
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DNasel analysis and nucleosome mapping (monomer extension) on these mutants.
The details of these are discussed in Chapter 4. A summary of the data and the
sequences of the wild-type and mutant fragments are shown in table 6.2. The pattern
that emerged from Benzonase analysis of the mutated CpG triplet sequences was one
of a graded response, dependent on how many methylated CpGs are present, whether
they lie in adjacent positions and whether there is alternation of base sequence
around the methylated sites. All of the methylated mutants retained some ability to
show enhanced reactivity with Benzonase but sometimes provided slightly different
cleavage patterns or different band intensities than the wild type. For example, the
Name Sequence Benzonase DNasel Nucleosome
Displacement
LE CGCGCGCTGTGCT ***** ***** *****
ml GCCGCG **** **** **
m2 CGGCCG *** *** ***
m3 CGCGGC **** *** ****
m23 CGCCCG *** **** *
m25 CGGGCG *** *** ***
m8a CGGCCGCTGTGCG *** *** ***
Table 6.2 Tabulated information for Benzonase, DNasel and Nucleosome
displacement analyses. Benzonase analysis was performed as described in this thesis on
the pA-globin gene promoter and a selection of mutations in the CpG triplet. The star rating is
as follows. Five stars, very strong reaction with Benzonase, DNasel and ability to displace
nucleosome 5A (see chapter 4). Four stars, very good; Three stars, good; Two stars, poor;
One star, negligible. These ratings are based on unmethylated and methylated fragments in
a side by side analysis. They are a guide only and are not quantitatively analysed.
ml mutant has two adjacent meCpGs, the first of which is not a good A-forming
sequence as it begins with a pyrimidine (see table 1.2). This is reflected in the
Benzonase pattern (figure 4.7). There are at least two main hypersensitive sites in the
methylated ml fragment that correspond with the methylated LE fragment. One of
these bands is less intense than it appears in the methylated LE fragment. In the
methylated LE fragment the strong central hypersensitive band as indicated in figure
4.7 is most probably the centrally methylated CpG and is a strong hypersensitive site
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because the methylated LE fragment contains three methylated CpGs and has a
greater potential to form A-DNA. In agreement with the formation of A-DNA at the
methylated LE CpG triplet, nucleosome 5A is displaced (figure 4.6 B). In
accordance with some A-DNA formation, as judged by Benzonase on the ml
fragment, nucleosome 5A is again displaced but not as effectively. DNasel analysis
shows three strong hypersensitive sites over the CpG triplet for the methylated LE
fragment (figure 4.5 A). For ml, there is one major DNase hypersensitive site and
two minor ones, reflecting the fact that there are less methylatable sites in this
fragment. It should be taken into account here that DNasel activity on DNA will not
detect A-form sequences, but it will detect methylated CpGs that cause structural
alterations in DNA (Fox, 1986 and figures 3.5 B and 3.6 B). Therefore in many cases
the DNasel assay will detect sequences where the minor groove has widened, but
does not account for the spreading effect that must occur as the helix changes from a
B-form molecule to an A-form molecule. Benzonase is able to detect sequences that
are partly A-form as reported by Meiss et al., (1999), therefore for all of the mutants
Benzonase may be detecting regions that are partly A-form and/or a result of nearby
sequences that have adopted the A-conformation. As seen from previous Benzonase
digests, (Chapter 3) two adjacent CpGs in an alternating sequence provides enough
sequence to show enhanced cleavage at adjacent methyl CpGs. The CpG triplet
mutations are over a very small region of 6 bp. This provides only a very small
region to look for the formation of or lack of formation ofA-DNA. The less likely a
sequence is to form A-DNA from our structural knowledge of it, the less likely it is
to react with Benzonase and demonstrate a pattern akin to the wild-type situation.
However, as all of these sequences have some A-form potential, they are all
expected to react with Benzonase to some extent, and they do. They are therefore all
expected to move nucleosome positioning of 5A, and they do with varied success,
apart from mutant 23.
Mutants 2, 25 and 8a all behave very similarly with respect to Benzonase
analysis (figures 4.8, 4.9 and 4.10, respectively). They have a high degree of
alternation of base sequence and are expected to form A-DNA from structural
studies (Table 1.2). They all show enhanced cleavage in the Benzonase assay on the
methylated strand, however the banding pattern is not as clear or as defined as we
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see in the wild-type LE methylated fragment. The m2 and m25 fragments contain
two methylatable CpGs. The m8a fragment contains the same two methylatable
CpGs as the m2 mutant and also an additional CpG 6 bp downstream of the triplet.
The additional CpG does not in my estimation change the behaviour of the m8a
mutant in terms of Benzonase analysis or nucleosome positioning analysis; m8a
behaves similarly to m2 in both respects. I believe the additional CpG downstream
of the triplet sequence in m8a, is too far removed from the critical site of nucleosome
occupation to have any major effect. The DNasel data does acknowledge the
presence of this extra methylated CpG however and but it does not change the
DNasel pattern at the mutated triplet sequence (figure 4.5 A). DNasel analysis of all
of these fragments shows hypersensitive sites at the same positions as the methylated
LE fragment (figure 4.6 B), but they are not of the same intensity. As expected,
nucleosome positioning analysis shows that all of these mutants are capable of
shifting nucleosome 5A to some extent, as they all demonstrate some reactivity in
the Benzonase assay.
The m3 mutant behaves the most similar to the wild-type situation. It
contains two methylated CpGs with a high degree of alternation of base sequence
and a purine start before the first methyl CpG, all features which help potentiate the
formation ofA-DNA (see table 1.2). In these terms it has the most similar structural
characteristics to the wild-type situation and it is therefore expected that it should
show the same kind of response in the Benzonase assay (figure 4.9). Benzonase
analysis shows hypersensitive sites over the same three sites in the methylated m3
fragment as shown in the methylated LE fragment. Crucially there seems to be
strong reactivity over the central band in this hypersensitive region, which probably
represents the second methyl CpG in the mutated triplet and the corresponding
central CpG in the methylated LE fragment. As there is a third less strong
hypersensitive site in the benzonase analysis of the m3 mutant, this probably
represents a spreading effect of A-form DNA potentiated by the first two methylated
CpGs in the sequence. These first two methyl CpGs seem important for the
positioning of nucleosomes. Only the LE and m3 mutants have methylation of the
first two CpGs out of all of the sequences analysed. These two sites must be
important for nucleosome positioning as when m3 is methylated at these two sites
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nucleosome 5A is shifted with the same efficiency as in the wild-type situation
(figure 4.6 B). DNasel analysis of the m3 fragment reveals that it too has
hypersensitive sites on the methylated fragment over the same three sites as the
methylated LE fragment, one of these is strong and represents the first methyl CpG.
The last of the mutants analysed is m23. This provided the most revealing
information from the mutants as it is not capable of shifting the position of
nucleosome 5A (figure 4.6 B). All of the mutants show reactivity to Benzonase. The
mutants LE and m3 are the most similar in their benzonase patterns. Both shift
nucleosome 5A very efficiently. The mutants m2, m25 and m8a show the most
similarity in reactivity to Benzonase and show similar efficiencies in moving
nucleosome 5A. There are some differences in their ability to do this, but this can be
explained by their A-form potential as defined by the degree of alternation of base
sequence, whether the methylated CpG is preceeded by a purine (typically Guanine),
and how many methylatable CpGs are present in this sequence. The mutant m23
however, does not effectively remove nucleosome 5A. There are two non-adjacent
methylatable sites in this mutant. Benzonase analysis may show some reaction with
but it is difficult to pick out the same three definable bands as observed in the
methylated LE fragment. The pattern of unmethylated and methylated m23
fragments are very similar, and therefore methylation may be inducing little or no A-
form structures.
The first methylated CpG in the m23 mutant has good A-form potential, but
the second CpG has the lowest A-form potential of any of the sequences analysed.
The second CpG is preceeded by two Cytosines, which detracts from the A-form
potential of this sequence. Therefore the only real contribution to the formation ofA-
DNA may be in theory from the first CpG. In support of a central role for cytosine, it
has been found that of all the deoxyribonucleosides, Cytosine has intrinsic
conformational properties that may play a decisive role in the equilibrium between
A, B and Z-forms of DNA (Foloppe et al., 1999). Another important point to
remember is that structures are now emerging that contain the properties of both A-
and B-form DNA. The dodecamer d(CGCCCGCGGGCG) has been solved as a
kinked A-DNA molecule with B-DNA features (Malinina et al., 1999). This
indicates that the possibility exists for a given sequence to manifest features of
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different types of DNA conformation. In light of the results from the other mutant
sequences, the Benzonase analysis for m23 is perhaps not as clear as the other
mutant Benzonase experiments, but it is known from earlier experiments that a
single CpG site is not detected by Benzonase if it lies outwith an alternating d(CG)n
sequence. It should also be pointed out, that even if m23 is forming A-DNA, as it
appears to be, it may be the case that it is not forming over enough DNA sequence,
or at the correct region of DNA, to disrupt nucleosome positioning when
incorporated into them.
In summary the mutants supply a graded response to their different sequence
contexts. Overall, as the sequences are similar among the triplet mutants and as a
result I do not wish to overinterprete the data. However, the combined information
from structural studies, Benzonase analysis and DNasel analysis do provide a
reasonable explanation for a link between methylation induced A-form or A-like
DNA and the translational positioning of nucleosomes. That is, the fully methylated
CpG triplet is absolutely required to show the best reactivity with the Benzonase,
DNasel and nucleosome positioning data inclusively. The methylated mutant m3
shows the best Benzonase alignment with the wild-type digestion pattern and also
shows the best displacement of nucleosome 5A. Mutant ml shows good reactivity
with Benzonase over the methylated sites but with less hypersensitivity than wild-
type. It still shifts nucleosome 5A, but with poor efficiency. The methylated mutants
m2, m25 and m8a also react well with Benzonase but not with the same pattern as
the wild-type mutant. They also have the ability to shift nucleosome 5A but not as
efficiently as the methylated LE or m3 mutants. Differences between their abilities
can be partly explained by sequence context. The methylated mutant m23, although
showing reactivity with Benzonase, is not capable of shifting nucleosome 5A. This
may for reasons discussed above. Table 6.2 summarises the information gleaned
from my experiments on the pA-globin gene in addition to nucleosome and DNasel
data obtained by Dr. C. Davey.
The relevance of this structural information to the pA-globin gene regulation
is not presently understood. Methylation of the CpG triplet was induced artificially
in these sequences in vitro. However, before embarking on this project Davey et al.,
(1997) had already established that hypermethylation of the CpG triplet occurs in
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embryonic erythrocytes and adult brain cells, whereas hypomethylation of the CpG
triplet is observed in adult erythrocytes. Methylation at the CpG triplet is therefore
developmentally regulated in a similar manner to other sites within the immediate
promoter region of this gene (Davey et al., 1997). It is also of importance to state
that although the above information has been rationalised in terms of CpG density
and sequence context, it is also relevant where the CpG triplet is positioned over the
nucleosome. DNA sequence at the boundary of a nucleosome does not contribute
substantially to the positioning signal (reviews: Simpson, 1991; Thoma, 1992).
However, the CpG triplet in the wild-type situation that shifts nucleosome 5A, is
located within the nucleosome, orientated towards the histone core and centred at 1.5
turns from the dyad axis. This is an exacting demand for the positioning of the CpG
triplet and nucleosomes as other studies on the effect of methylation on translational
nucleosome positioning have not shown any major effect due to methylation, but did
affect histone-octamer DNA contacts (Nightingale & Wolffe, 1995).
At 1.5 turns from the dyad axis, the outward facing major groove ofDNA is
about 20 times wider than typical linear DNA and confers a kink in the DNA at this
location (Hogan et al., 1987). It is therefore expected that the corresponding minor
groove would be significantly narrowed at this position. This position is also
important for histone H4 binding and for H4 inducement of a kinked structure at this
position (Ebralidse et al., 1988; Arents & Moudrianikis, 1993). The reasons for
methylation induced repositioning of nucleosome 5A were speculated on in terms of
a structural transition induced by Davey et al., (1997).
As stated Dr. C. Davey has since investigated the Z-form potential of the
CpG triplet region but this proved not to be a viable explanation on linear DNA, only
on supercoiled DNA (pers. comm.). I have here investigated the potential of CpG
methylation to induce A-form DNA by using the A-DNA detecting enzyme,
Benzonase. I have clearly shown that CpG methylation at the CpG triplet region
induces an A-DNA conformation in the sequence, as detected by Benzonase. Further
to this I have shown that over a range of mutant sequences that remove one of the
three methylatable sites, the overall behaviour of the mutants is that there is a loss in
their ability to move nucleosome 5A. This effect may be partly to do with the extent
of A-DNA formation and partly to do with whether each mutant can position at the
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nucleosome dyad axis efficiently. This may explain why mutant 23 displays some A-
form potential but does not move nucleosome 5A. The methylation induced
structural change in this mutant may be either not pronounced enough to deflect
nucleosome 5A or avoids positioning at 1.5 turns from the dyad axis. In addition the
existence of A-form DNA at this sequence also fits into what we know about DNA
structure as it is wrapped around the nucleosome. As stated, the major groove is
widened and the minor groove reduced at 1.5 turns from the dyad axis. This is
completely the opposite structural conformation than that seen in A-form DNA. A-
DNA has a typically narrowed major groove and an expanded minor groove. A
nucleosome presented with an A-form structure at 1.5 turns from the dyad axis may
not be able to manipulate any suitable change in this structure and may be very
refractory to positioning at this site. In effect the nucleosome may be bounced along
to find a more suitable positioning site as a result.
The existence of CpG triplets, the methylation thereof and the promotion of
A-DNA may be a discrete and precise mechanism of altering nucleosome
positioning at specific sites. Davey et al., (1997) report that (CpG)3 occurs at a
frequency one order of magnitude greater than expected in a collected database of
CpG island gene sequences. Also of note is that within this database there are only
two instances ofmotifs longer than (CpG)5, one of (CpG)6 and one of (CpG) 12. Only
a minor fraction of the CpG triplets are located within coding sequences (Davey et
al., 1997). This implies that if CpG triplets are involved in the modulation of
chromatin structure they probably do so mainly in the promoters of CpG island
containing genes where they may influence the binding of protein factors to DNA
and/or to nucleosomes. CpG islands are usually methylated along the inactive X-
chromosome, and at some imprinted genes, therefore regulation mediated by the
formation of A-DNA type structures may be part of the transcriptional control
mechanism at these genes. Along this stretch of the (3 -globin gene promoter,
various regulatory factors bind to the promoter region. These include the
transcription machinery and regulatory factors such as CTCF. The displacement of
nucleosomes by this structural change may influence the binding of CTCF and Spl,
both ofwhich bind to alternating CGs. It may also influence transcription factors, in
addition to potentially binding one of the methyl-binding proteins, and recruiting
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histone deacetylases and associated chromatin regulatory complexes, as described in
section 1.2.
Are there any other examples of methylation induced repositioning of
nucleosomes? Dr. C. Davey has since moved onto analysis of a variety of the
imprinted gene regions including the HI9, Igf2 and Igf2r human gene sequences. He
has recently observed changes in nucleosome positioning at the human HI 9 gene.
The paternally inherited H19 gene is silenced and the maternally inherited gene is
active. A 2 kb CpG rich differentially methylated domain (DMD) located upstream
of the H19 gene is essential for gene repression. Within this, a 1.2 kb region
functions specifically as a silencer element, or imprinting control region (ICR) on the
methylated paternal chromosome (Brenton et al., 1999; Drewell et al., 2000). The
activity of the DMD is modified depending on its methylation status. On the
maternal chromosome it is unmethylated and probably acts as a methylation sensitive
insulator, disrupting the interaction of downstream enhancers with the Igf2 promoter
(Thorvaldsen et al., 1998; Hark et al., 2000; Kanduri et al., 2000a). The disruption of
the maternal unmethylated ICR is partly due to binding the factor CTCF which has a
CG rich consensus sequence. When the ICR is methylated, CTCF binding is
abolished, allowing the downstream enhancers to interact with the paternal Igf2
(Kanduri et al., 2000b; Bell & Felsenfeld, 2000). Assays using HeLa cells
transfected with the H19 DMD region linked to a reporter gene shows that this
region recruits MeCP2 and is therefore likely to do so on the endogenous methylated
paternal allele (Drewell et al., 2002).
Following on from discussions on the work presented here, I requested
whether any nucleosome repositioning was observed that coincided with methylation
of a CpG triplet. The H19 gene provides us with another example of this situation. A
CpG triplet in this sequence has the ability to shift nucleosome positioning when it is
CpG methylated (pers. comm.). In light ofmy observations on the CpG triplet at the
pA-globin gene promoter, Dr. C. Davey provided me with the human H19 gene,
which I performed Benzonase analysis on. Unfortunately because of delays with
enzyme deliveries some of the sequence had digested from overexposure to
radiolabel. Time constraints prevented me from repeating this experiment. The result
is included in the Appendix, Chapter 7 (figure 7.2).
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Another attempt in the pursuit of methylation induced A-form structures led
me to analyse a Chromatin Immunoprecipitation (ChIP) gene sequence pulled down
in vivo by Dr. I. Stancheva using xMeCP2 from NIH T5T cells, in the laboratory of
Dr. R. Meehan. Dr. Stancheva provided me with the pull-down sequence from the
ChIP assay which was found to contain an alternating d(GC)n string of nucleotides. I
designed PCR primers for the sequence and prepared and purified fragments for
Benzonase analysis. I then performed Benzonase analysis on these fragments a
number of times but each time the results were not decisive. Although no
methylation induced changes in DNA structure were observed I believe this was a
failure of some part of the protocol and not a real result, as the ChIP fragment has the
hallmarks of a good A-fonning region within the DNA sequence. I have included
this experiment as figure 7.3. in the Appendix, Chapter 7.
Having established that CpG methylation can induce the formation of A-
DNA in certain sequence contexts and also correlates with one case of nucleosome
repositioning, I turned my attention to some observations made by Dr. R. Meehan. In
competition experiments I made some initial investigations into whether CpG
methylation induced A-DNA formation can have a direct effect on the methyl
binding proteins. This was based on an observation made by Dr. R. Meehan (figure
1.7). In this experiment it was found that the A-DNA forming double-stranded
oligomers, poly (dl.dC) and poly d(I.C).d(I.C), which form A-DNA structures, were
capable of competing successfully with CpG methylated DNA for MeCPl complex
binding. However, A-form dsRNA consisting of poly(I).poly(C) cannot compete for
MeCP 1 complex binding. I decided to see if similar observations could be made with
the MBD domain of MeCP2. I expressed and purified the protein effectively and
used it in bandshift analysis with a series of ds DNA oligomers which I specifically
designed to either promote the formation of A-DNA or B-DNA. Table 5.1 provides
the sequence of each oligomer used.
The results of these experiments show that the MeCP2 MBD domain is
capable of binding both the A-dnaM oligomer (figure 5.3) containing two non-
adjacent meCpGs and the B-gloM oligomer (figure 5.9) containing three adjacent
alternating meCpGs. The MBD protein binds equally well to both of these oligomers.
It was already known that the MBD could recognise a single methyl CpG (Nan et al.,
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1993). From bandshift analysis here it is demonstrated that the MBD can bind to
meCpGs in isolation, irregardless of the sequence context and also to a stretch of
alternating (CG)3 nucleotides containing three methylatable CpGs. It is therefore
likely that the MBD domain operates independently of whether the target
methylation site is in an A-form structure or not. This is also verified by the
publication of the solution structure for the MBD domain (Wakefield et al., 1999).
However there are also contacts within the MeCP2 protein surrounding the MBD
that may influence further what sites the protein can bind to, and of course, other
chromatin associated proteins may additionally influence what subset of meCpG
sites the MeCP2 protein can bind to.
Bandshift experiments using an unmethylated sequence that forms A-DNA
also shows interaction with the MBD protein (figure 5.4, 5.7). The bands formed are
specific, but only at high concentrations of the MBD. When competitor DNA was
added to the situation the A-dnaU oligomer interaction is diminished (figure 5.5).
When the MBD protein is given a B-form DNA substrate as a potential binding
sequence, the result is a smear across the gel. There are no specific contacts in this
situation (figure 5.6). Another unmethylated oligomer, B-gloU also shows a smear
across the gel with the MBD protein (figure 5.8). This sequence corresponds to the
CpG triplet region of the pA-globin gene analysed in Chapter 4 and may potentially
form Z-DNA in the unmethylated state (see table 1.2). Following on from these
initial experiments on the MBD protein, I then used purified xMBDl protein to
determine which oligomers the protein could recognise. The xMBDl was provided
with the A-dnaU and A-dnaM oligomers as potential substrates. The protein seems to
bind equally well to both oligomers. There does not seem to be any enhanced
reactivity with the methylated oligomer, A-dnaM, unlike the way the MBD protein
reacts with this sequence. This may be for several reasons. Perhaps the xMBDl
protein can recognise A-form DNA and as a result does not interact to any greater
extent with the methylated oligomer. Of course it is also possible that the xMBDl
protein interacts with A-form DNA minimally but cannot interact with the two
methylation sites presented in the A-dnaM oligo well. Although the MBD from
human MBD 1 can bind to a single methylated site, this may differ with the Xenopus
form, despite the overall sequence similarity.
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These initial bandshift experiments perhaps provide some information with respect to
the role of MeCP binding to the overall mechanism of methyl-mediated repression.
The MBD of MeCP2 and the xMBDl proteins recognise at least one methyl CpG.
The MBD seems capable of recognising the meCpG in sequences that potentiate A-
form DNA and also in sequences that do not. I would conclude that although both
proteins show interactions with A-form DNA, this is not as specific as the effect seen
with the MeCPl complex, where the presence of A-forming sequences efficiently
competes with methylated DNA for MeCPl complex binding (figure 1.7). The
MeCP 1 complex has been shown to require a densely methylated substrate of 11 or
more methyl CpGs (Meehan et ah, 1989). A long alternating d(CG)n substrate could
provide a very good sequence for A-DNA formation and this may be important in the
decision of what sites the MeCPl complex can bind to, leaving other methyl binding
proteins such as MBD1 and MeCP2 to recognise and bind to other methylated sites.
However, the meCpG binding activity in the MeCP 1 complex has been shown to be
due to MBD2, which binds to a single meCpG (Ng et al., 1999). Why then does this
discrepancy exist? It is very possible that other proteins within the MeCP 1 complex
direct MBD2 to meCpG regions that are densely methylated. It is therefore also
possible that such proteins associated with the MBD1, MeCP2 and other MeCPs,
perhaps do so on the basis of methylation density and resultant secondary structure
alterations.
6.3 How can methylation induced changes in DNA structure influence where and
when methyl-bindingproteins bind?
In this thesis there is evidence that CpG methylation can induce potential A-form
regions in DNA as detected by Benzonase analysis. It is also known that different
MeCPs can detect and bind to different meCpG densities and are influenced by
sequence context. How CpG methylation density may relate to changes in DNA
structure and subsequent protein binding is illustrated in figure 6.2 below.
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Figure 6.2 MeCPs target corepressor
complexes to methylated DNA. On the
left are different situations the MeCPs may
recognise. Empty circles represent
unmethylated CpGs, whereas full circles
are methylated CpGs. (A), hypomethylated
DNA with occasional meCpGs. (B), fully
methylated sequence with a low density of
CpGs. (C) and (D) are two sequences with
a high number of CpGs but with different
organisations that may be recognised by
different MeCPs. (E) includes the
nucleosome structure to illustrate that it
may be the ability or positioning of methylated CpGs around the nucleosome that can
influence the binding of MeCPs and potentially other components of the chromatin network.
(Image from Ballestar & Wolffe,2001).
Ballestar and Wolffe (2001), state that different sequences containing different CpG
densities have different affinities for MeCP proteins. Their work pertaining this
remains unpublished. They also speculate on the role of DNA structure in this
process. I believe in this thesis a potential mechanism is revealed. If methylation
induced A-DNA formation is not for the recognition of MeCP proteins, or some
component of an MeCP-associated complex, it must have some other potential role.
The first of these could be in the direct exclusion of nucleosomes. It is recognised
that some DNA binding factors require removal or remodelling of nucleosomes, to
gain access to their cognate binding sites (diMauro et al., 2002). MeCP2 for
example, does not require this. Overexpression of MeCP2 in transient transfection
studies shows that the MeCP2 molecules can still gain access to and bind mouse
heterochromatin (Nan et al., 1996). It must be able to gain direct access to binding
sites. One explanation is that MeCP2 can bind nucleosomal DNA to form discrete
complexes (Chandler, 1999). Another explanation offered here is that nucleosomes
encountering A-DNA stretches, particularly of the type d(CG)3 are moved away from
this region leaving it free to interact with MeCP2. These two explanations are not
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mutually exclusive. Both could exist for different situations of MeCP binding.
Further to this explanation, it has been shown that bending and kinking disruptions to
DNA, and particularly the formation of A-DNA, can disrupt or prevent nucleosome
formation (Hovatter & Martinson, 1987). Further to this, it has also recently been
speculated on that the formation of both positive and negative superhelical writhes
are organisers of local chromatin structure for transcription in eukaryotes (review:
Ohyama, 2001). Therefore in regions with a high density of methylated CpGs,
nucleosomes may be refracted and MeCPs allowed access to their binding sites. We
have also observed that in the case of the (3A-globin promoter, CpG methylation of a
CpG triplet sequence can alter nucleosome positioning. This too could affect the
binding of methyl-binding proteins and/or alter the positioning of chromatin-
associated proteins on DNA.
The solution structures of the unliganded MBD domain from human MBD1
(Ohki et al., 2001) and rat MeCP2 (Wakefield et al., 1999) provide additional pieces
of information to the puzzle of methylation mediated repression mechanisms. Both
MBD domains have similar structures suggesting that all MBDs adopt a similar
structural fold (figure 1.9). The MBD domain is wedge shaped, the faces of which
are comprised of a (3-sheet on one side and an a-helix and hairpin loop on the other.
A highly flexible loop connects two of the P-strands at the vertex of the wedge.
When the MBD domain of MBD1 binds to DNA, the flexible loop undergoes a
major structural change, adopting a hairpin structure consistent with an induced fit
mechanism. Unusually, the recognition surface of MBD 1 is asymmetric. Therefore,
each methyl group can be recognised independently. One methyl group fits into one
pocket of the hydrophobic contact surface, the other methyl group fitting into another
region of the hydrophobic surface. Residues from Loop 1 of the structure contact one
side of the DNA backbone, while residues from the a-helix contact the opposite
strand backbone. Because of the asymmetry of binding to a symmetrically
methylated CpG, the orientation of the MBD and any associated protein complex,
will change by 180° depending on which functional groups bind to a meCpG on a
particular strand (Ohki et al., 2001, Wade & Wolffe, 2001). The functional
consequences of asymmetric binding remain unexplored at present. Flowever, this
may also mean that as the distortion of a particular meCpG increases, due to DNA
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bending, the formation of alternative DNA conformations such as A-DNA and Z-
DNA, the greater the influence on the asymmetric binding of MeCP associated
protein complexes. Again, it is unknown what influence an altered DNA structure
has on the 3-dimensional position of methyl associated complexes, and what this
might mean in a functional context.
An intriguing possibility for the role of A-form DNA in the regulation of
methylation-mediated repression, is the potential involvement ofRNA in the process.
RNA mediated gene silencing involves small RNAs that can trigger gene silencing in
both the cytoplasm and nucleus. RNA mediated silencing can occur at the
transcriptional and post-transcriptional level. In brief, the recently discovered process
of RNA interferance (RNAi) in animals, (Fire et al., 1998), and the related
phenomenon of post-transcriptional gene silencing (PTGS) in plants involve a
dsRNA that is cleaved into shorter units that act as guides for recognition and
cleavage of homologous mRNA. The dsRNA guides can be created by transcription
through inverted DNA repeats, simultaneous synthesis of sense and antisense RNAs,
viral replication and the activity of cellular or viral RNA dependent RNA
polymerases (RdRP) on single-stranded templates (review: Matzke et al., 2001).
Similarly, RNA-directed DNA methylation in plants requires dsRNAs that are
cleaved into small RNAs similar to the guide RNAs formed in the PTGS/RNAi
processes. Only DNA sequences complementary to the guide RNA become
modified, suggesting RNA-DNA interactions, a highly specific interaction, but with
the possibility of any sequence being a potential target of this mechanism.
How might this mechanism be used to target methylation in mammals? The
protein machinery involved is currently not known. There are suggestions that small
RNAs form DNA-RNA hybrids in unusual structures that might attract
Methyltransferases (Mtases), (Mette et al., 2000; Waterhouse et al., 2001; Smith et
al., 1991). Alternatively, Mette et al., suggest that small RNAs may bind Mtases and
thus guide them to target DNA sites. For example an MTase from plants possesses a
chromodomain and is called a chromomethylase (Lindroth et al., 2001).
Chromodomains are typically involved in interacting with chromatin proteins to
modulate gene expression. A chromomethylase has not been discovered in mammals
thus far. In addition a selection of dsRNA deaminase cDNAs from Xenopus, thought
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to be involved in RNA editing, possess a C-tenninal region with homology to C5-
Methyltransferases (Hough & Bass, 1997). Despite the fact that this provides an
astonishing ancient link between methylation-mediated repression mechanisms and
our ancient origins in an RNA world, it also raises the possibility that MTases may
still be able to recognise the A-conformation in DNA. However, adding weight to an
RNA-chromatin driven hypothesis, is the Drosophila histone acetylase MOF, which
contains a chromodomain shown to interact with RNA (Akhtar et al., 2000). It is
therefore possible that not only DNA methylation, but chromatin modifications such
as acetylation and methylation of histones might also be targeted by RNA. In
mammals, X-chromosome inactivation and some cases of genomic imprinting in
mammals involve non-coding RNAs or overlapping sense and antisense RNAs,
which may play a role in a homology driven mechanism for DNA methylation and/or
chromatin modifications.
A role for A-form DNA in RNA mediated repression? Thus far I have proven
the existence of CpG methylation induced alternative structures in DNA. The
structures formed are akin to the A-conformation ofDNA, as detected by Benzonase.
The extent of transition to this form is dependent on the number ofmethylatable sites
and the sequence context of the DNA being methylated. It is possible that these
sequences are differentially recognised by methyl binding proteins that have
recognition regions apart from their MBD that are sensitive to the helical
conformation of DNA. However, preliminary bandshift analyses with purified
proteins only show slight preferences for A-form DNA, and I therefore do not wish
to conclude that they specifically recognise A-DNA, although many remain untested.
If the MeCP protein alone does not recognise the change in structure, it may require
another component.
There is preliminary evidence for this from unpublished competitive
bandshift analysis kindly provided by Dr. R. Meehan, that this might be the case for
the MeCPl complex. The complex is successfully competed away from methylated
DNA with an excess of A-forming non-methylated dsDNA sequence. The complex
may therefore contain an uncharacterised component that is competed away from its
methylated target sequence by an excess of A-forming sequences. It is also possible
that an MBD within the complex or another associated protein, may independently
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recognise A-form structures and as a result, recognise and bind to the excess of A-
forming structures in the competitive bandshift. This explanation would also account
for the fact that the MeCP 1 complex requires a long alternating methylated binding
sequence, even though the MBD2 protein which forms an integral part of the
complex, can bind singly methylated CpGs.
We also know that the formation of A-DNA in methylated sequences is
refractory to nucleosome positioning from unpublished collaborative data supplied
by Dr. C. Davey. This is especially true if the methylated sequence coincides with
regions of nucleosome induced bending in the DNA. This may have consequences in
terms of higher order chromatin structure directly by the displacement of
nucleosomes, or may simply allow methyl binding proteins access to their binding
sites.
Finally the aforementioned possibility of an RNA component is intriguing, as
dsRNA is known to possess an A-conformation. Unlike DNA, a dsRNA always
adopts an A-form helix (Dock-Bregeon et al., 1989). Despite the fact that A-form
dsRNA does not compete for MeCPl complex binding (figure 1.7) I am confident
that some role for dsRNA remains to be discovered in humans. Perhaps A-form
DNA/RNA hybrids could compete for complex binding? This conformational change
may promote homology driven binding by complementary A-forming RNAs that
recognise the helical change as well as the sequence. There is some evidence for this
from Xenopus laevis. An unusual dsRNA binding protein has been discovered called
dsRBP-Zfa. It is unusual in that it contains zinc fingers as the recognition domain, a
highly common motif for transcription factors and other DNA binding motifs, and
also possesses a nuclear localisation signal (NLS), (Finerty & Bass, 1999). This
protein binds to dsRNA and also to RNA-DNA hybrids with almost equal affinity,
via separate zinc finger motifs. Other dsRNA binding proteins have reduced ability
to bind RNA-DNA hybrids. There are separate zinc fingers for DNA and RNA
interactions. Crucially this protein greatly prefers to recognise the A-conformation,
independent of sequence context and is the first Zinc Finger protein that shows
specific binding to dsRNA and RNA/DNA hybrids (Finerty & Bass, 1997).
The possibility exists that similar dsRNA binding proteins with or without
sequence preference can interact with dsRNA/DNA sequences based on an affinity
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for A-form structures. In speculation, dsRNA binding proteins may associate with
small RNAs produced from non-coding sequences associated with regions of DNA
targeted for methylation. They may associate with complexes that contain MTases
that have RNA binding abilities, or indeed with histone acetylases that have RNA
binding abilities. These RNA associated protein complexes may contain helicases to
unwind DNA and components of the methylation machinery, such that dsRNA
binding proteins, Methyl-binding proteins, and other components are then tethered to
the correct region of DNA destined for targeted DNA methylation and/or associated
chromatin modifications.
No evidence exists thus far in mammals for a mechanism based on the
experimental evidence presented in this thesis. A role for the formation of A-form
DNA in methylated gene sequences has also not been elucidated thus far. I believe
that I have presented evidence to support a potential role for A-form DNA in the
mechanism of methyl-mediated repression. The elucidation of this mechanism
undoubtedly awaits more surprises. It is a process that is becoming intriguingly




This chapter describes work that was carried out in the process of investigating the
CpG methylated DNA structure. Some of this work concerns the Benzonase assay
and consists of data not shown in the main text. The rest refers to the use of a
retroviral integrase based assay to determine regions of non B-form DNA structure.
This assay has been described in Chapter 3 and illustrated in figure 3.1.
7.1 Benzonase analysis ofa DNA fragmentfrom pBR322
A DNA fragment corresponding to the reverse strand of the pBR322 fragment
analysed in Chapter 3 (see figures 3.4 & 3.5) was analysed by Benzonase analysis.
The resultant gel from this experiment is detailed here as the results were perhaps not
clear enough to incorporate in the main thesis. The aim of this experiment was to
show that the same fragment could display methylation induced structural changes
on the reverse strand at the same position observed on the forward strand. This effect
was later proved by analysis of the p-globin gene fragment shown in figure 4.4,
which confirmed that methylation induced structural changes were observable on the
reverse strand and thus more likely to be a change in structure on both strands and
not restricted to one of the DNA strands. The results of Benzonase analysis of the
reverse strand pBR322 fragment are shown in figure 7.1
7.2 Benzonase analysis ofa DNA fragmentfrom the human HI9 gene.
An attempt was made to show that a methylation induced structural change at a CpG
triplet region in the human imprinted H19 gene, could react with Benzonase to show
enhanced cleavage at this region. The methylated CpG triplet region has been shown
to displace a nucleosome by Dr. C. Davey in the H19 gene. If Benzonase analysis
can also highlight this region as a potential A-forming sequence, then it would
provide the second example of a methylated CpG triplet that can directly alter
nucleosome positioning at a region of potential importance in terms of gene
regulation. Unfortunately, degradation of this sequence ensued due to time delays in
receiving restriction enzymes. The results of this experiment are shown in figure 7.2.
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The H19 gene, as well as other imprinting genes, are worth investigating in the future
in terms of potential regions ofmethylation induced A-form DNA structures coupled
to nucleosome rearrangement and this information is provided here as a good
candidate for investigation by others. Time constraints prevented me from
investigating further.
7.3 Benzonase analysis ofa DNA fragmentfrom a xMeCP2 ChIP assay.
Another attempt to show methylation induced A-form structures was performed on a
fragment pulled down in a Chromatin Immuno-Precipitation assay with xMeCP2 as
bait in NIHT5T cells. The DNA sequence pulled down by xMeCP2 is called Chip30
and was cloned into pBS-SK(-). The plasmid insert was amplified by PCR and
subjected to Benzonase analysis. The resultant gel is shown here in figure 7.3, but the
sequence is so long that banding patterns are not clear on this gel and the results
inconclusive. However, the sequence is probably worth reinvestigating by other
interested parties in the future and is included here for reference purposes.
7.4 The integrase assay: Expression ofHIV-1 integrase
Initial attempts to investigate the structure ofmethylated DNA were based on the use
of an assay based on the ability of HIV-1 integrase to direct integration of dsDNA
sequences containing viral recognition sequences at each end, into a target DNA
sequence. The assay is described in section 3.1.1 and figure 3.1. I attempted to use
this assay in the investigation of CpG methylated DNA structure. The process began
with the purification of HIV-1 integrase by essentially the same methods as that
described for the histidine-tagged MBD protein. The HIV-1 integrase protein was
expressed from a pET6h plasmid vector in E. coli BL21(DE3)pLysS cells. The
protein extracts containing HIV-1 integrase were purified on a cation exchange
column and further purified on a Nickel charged affinity column. Purified protein
was subsequently treated with Thrombin protease to remove the histidine tag.
Thrombin was removed by purification over a Benzamidine 6B column that has a
strong affinity for thrombin, and subsequently re-purified over a Nickel charged
column to remove excess cleaved histidine tags from the protein solution. The
purified protein was stored in a glycerol-based suspension and stored at -80°C.
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Figure 7.1 Benzonase Analysis of the reverse strand of a pBR322 fragment. PAGE/Urea
analysis of the The forward strand of this fragment has already been analysed in figure 3.5. The
reverse strand was also Benzonase digested to demonstrate that the methylation enhanced
cleavage observed on the Benzonase digested forward strand was also present on the reverse
strand. There is a site in the sequence which may or may not be due to methylation enhanced
cleavage. This is marked with a long arrow. There may also be some DNasel or radiolabel
caused digestion in this fragment prior to Benzonase analysis, as the banding pattern shifts on
addition of Benzonase. This gel is incorporated for reference purposes. The existence of
Benzonase enhanced cleavage on the reverse strand of methylated fragmentswas later proved
by experiments in Chapter 4 (see figure 4.4). -M, unmethylated DNA. +M, methylated DNA. M,
marker lane containing forward strand of pBR322 fragment digested with Hha\.
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Figure 7.2 Benzonase analysis of a
region of the human H19 gene. The
human H19 gene was analysed by
Benzonase analysis and the results
run on a 8 PAGE/Urea gel. It contains
a CpG triplet region within the
Differentially methylated Region
(DMR), a region of importance in
terms of gene expression. There has
been some digestion of this fragment
due to long waits for restriction
enzyme delivery. -M, unmethylated.
+M, methylated. M, marker lane. H19
gene fragment digested with Hha\.
This gel is provided for referenve
purposes and also for information
pertaining to the H19 gene. I believe
re-analysis of this sequence by others
may reveal a similar phenomenon to
that observed at the (3-globin
promoter region in terms of
nucleosome displacement.
Arrows indicate regions
— of potential methylation
induced structural
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Figure 7.3 Benzonase analysis of a
Chromatin Immunoprecipitation
assay DNA sequence. The DNA
sequence used here was pulled down by
xMeCP2 in a ChIP assay to determine the
preferred binding site of xMeCP2 protein
in vivo. The sequence was pulled out on
several occasions. It is referred to as
Chlp30 as this is the simply the clone
number. The sequence contains a CpG
triplet sequence like that analysed in the
b-globin gene promoter region (Chapter
4). 1, pBR322/BsuR1 marker. 2,
pUC19/Mspl marker. 3, Hha\ digested
DNA fragment. 4, HpaU digested DNA
fragment. Samples were either
unmethylated, -M or methylated with
either Hha\ methylase (+Hhal.M) or with
Hpall methylase (+Hpall.M). Samples
were Benzonase digested and run on a 6
% PAGE/Urea gel and autoradiographed.
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Other aspects of the assay involved the preparation of target DNA for
integration of DNA mediated by the purified enzyme. The pUC9-a2-globin sequence
was used for this purpose. The plasmid was transformed into XL 1-blue cells and
midipreped. The plasmid was cleaned twice by phenol-chloroform extraction and
ethanol precipitation. DNA primers were designed for the purposes of the assay. The
forward primer was designed to anneal to the DNA substrate destined for plasmid
integration. The reverse primer was designed to anneal to a region just outside the
gene insert of the pUC9 plasmid. The DNA substrate was a short dsDNA fragment
containing recognition sites for HIV-1 integrase at each end. Initial attempts to
assemble all the components of the assay did not appear to work. Target plasmid
DNA along with purified HIV-1 integrase and substrate DNA were incubated
together, according to the method of Chow, 1997. After the integration reaction, PCR
was performed to identify regions of DNA within the 012-globin sequence containing
integrants. The forward PCR primer was radiolabeled with 32P-y-ATP. The reverse
primer remained unlabelled. Primers were added to the plasmid mix, which should
contain HIV-1 directed DNA integrants. PCR was performed on the target plasmid.
Fractions were taken and run on a 5% PAGE gel to identify if there was a ladder of
radiolabelled DNA fragments produced, prior to separation by denaturing
PAGE/Urea. There did not appear to be a ladder or DNA smear produced as
determined by PAGE. A denaturing PAGE/Urea gel was then run to determine more
clearly if there were any PCR fragments produced. The experiment did not seem to
work. Many attempts were made but to no avail. To ascertain that the plasmid did
indeed contain the correct sequence it was subcloned into a pBS-SK(-) plasmid and
sent away for sequencing within the University. The resultant gene sequence
confirmed that the plasmid did contain the full sequence of the HIV-integrase
protein. Primer sequences were re-evaluated and the procedure re-tried. Experiments
to discover the stage of the procedure were also carried out. For example, an
experiment was carried out to discover whether the substrate DNA was being
efficiently integrated into the target sequence or not. Variations in the PCR
conditions used were attempted. Although the experiments to decipher the reasons
for failure of the assay were not exhaustive, they were very time consuming and
cumbersome. It was concluded that perhaps there was a problem with the extensive
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rounds of purification the HIV-1 integrase protein had suffered, that perhaps it was
not folded correctly, or for some unknown reason it was not active in my attempts at
the assay. The results of the assay, had it worked correctly, were to discover regions
of methylation induced structural change as detected by HIV-1 integration hotspots.
The nature of the structural changes could not be decided on from this analysis. It
was hoped also to use a chiral probe to detect the formation of A-form DNA in these
sequences, but requests for the Ruthenium based complex were refused. Because of
the cumbersome nature of this approach, the problems associated with optimisation,
the fact that it would not be easily determinable if any methylation-induced
structures were of the A-conformation, this approach was abandoned and the more
decisive nature of Benzonase explored for structural analysis ofmethylated DNA.
7.5 Expression and Purification of the HIV-1 integraseprotein.
A plasmid obtained from Dr. Craigie containing a soluble active mutant of the HIV-1
integrase protein (Jenkins et al., 1996) was expressed and purified as described in
Chapter 2. In brief, cells were transformed with pIN1 ~288/F 185K/C280S, were grown
and protein expression induced with IPTG. Cells were harvested and homogenised to
release cellular proteins. Cell extracts were centrifuged to remove cell debris and
filtered to ensure as much cellular material as possible is removed. Purified extracts
were applied to a Nickel charged Chelating Sepharose Fast Flow (Pharmacia)
column as there is a strong binding reaction with Histidine tags and Ni2+ ions. The
protein was initially eluted with Imidazole, a strandard elutant for Ni2+ charged
elution (data not shown). Although this elution worked very well, there was some
degradation of the protein. It was also feared that the high concentrations of
Imidazole used were interfering in some way with further purifications, the purity of
the protein and the ability of it to perform in the Integrase assay. L-histidine was then
used instead of Imidazole. It is a successful competitor at low concentrations and
results in a highly purified product with high reactivity. Data for the expression and
L-histidine purification ofHIV-1 integrase is shown in figures 7.4 & 7.5. The protein
concentration was estimated by spectrophotometry to be approximately 1.2 mg/5.5
ml or 0.21 mg/ml and migrates at approximately 33 kDa.
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Figure 7.4 Expression of HIV-1 integrase protein. Image is an 8 % SOS-
PAGE gel. A plasmid containing a soluble active mutant of the HIV-integrase
protein was transformed into E. coli BL21(DE3)pLysS cells. Batches of cell
cultures were induced with IPTG apart from lane 1, which contains a cell culture
not induced with IPTG and therefore contains only E. coli proteins. The arrow
indicates the position of HIV-1 integrase expression in the cell culture.
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Figure 7.5 Purification of a histidine tagged HIV-integrase protein. The
soluble HIV-1 integrase mutant expressed and shown in figure 7.4 was applied
to a Nickel affinity column and eluted with increasing concentrations of L-
histidine. A closed arrowhead indicates the position of the eluted protein. There
is a small amount of degradation in the Integrase purification, but this is minimal




7.6 Cleavage ofHIV-1 integrase histidine tag with Thrombin
Some proteins require cleavage of their artificial tag to enable correct folding of the
protein for proper enzymatic activity. It was decided that the presence of the histidine
tag might inhibit the activity of HIV-1 integrase in the Integrase based assay.
Thrombin protease was used to cleave at two thrombin recognition sites to remove
the histidine tag as follows. Combined samples from elution with 40 mM and 45 mM
L-histidine (figure 7.5) were dialysed to reduce the L-histidine concentration and re¬
applied to a Nickel charged Chelating Sepharose Fast Flow (Pharmacia) column.
Thrombin protease (Pharmacia) was diluted as required and 400 units applied to the
Nickel-bound HIV-1 integrase protein. The column was stirred gently and incubated
at room temperature for two hours and the cleaved protein washed through the
column with elution buffer F containing only 20 mM L-histidine. Histidine tags
should remain bound to the column and the flowthrough mostly contain cleaved
protein. The flowthrough appeared to contain cleaved protein (data not shown) and
was applied to a Benzamidine Sepharose 6B column to remove the contaminating
thrombin protease.
7.7 Removal of Thrombin with a Benzamidine Sepharose 6B column
Eluted cleaved protein was applied to a Benzamidine Sepharose 6B (Pharmacia)
column to remove thrombin protease. Benzamidine Sepharose is p-
aminobenzamidine (PAB) covalently attached to Sepharose 6B. PAB is a synthetic
inhibitor of trypsin-like serine proteases and can thus be used for their removal.
Cleaved protein was applied to a Benzamidine column in a solution containing 200
mM NaCl. The column was washed through with binding buffer (50 mM Tris-Cl, pH
8.0 containing 200 mM NaCl), to remove the cleaved protein. Thrombin was later
eluted in separate fractions with 500-1 M NaCl. The results of this experiment are
shown in figure 7.6.
7.8 Concentration ofelutedprotein on a Fractogel EMD-SO3 column.
Fractions containing cleaved and purified HIV-1 integrase were combined and
concentrated by application to a Fractogel EMD-SO3" strong cation exchange
column. Proteins are reatained efficiently on the column when the pH of the buffer is
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about 1 unit below their isoelectric point (pi). Samples were loaded in a 200 mM
NaCl containing buffer and washed to remove any contaminants. Protein was eluted
sharply in small volumes using 1 M NaCl. The results are shown in figure 7.7.
7.9 Western Blotting to detectpresence ofHIV-1 integrase
Western Blotting was performed at different stages of the purification procedure.
Two examples are included here. Figure 7.8 clearly shows the reaction to an anti-
histidine tag antibody. Only cells that contain the expressing plasmid that have also
been induced with IPTG show strong reactivity with the antibody, confirming that
the protein is indeed a histidine tagged product produced by IPTG induced
expression from the transformed plasmid vector.
7.10 The Integrase Assay: Attempts at DNA structural analysis.
Having gone to great lengths to purify the HIV-1 integrase protein, I assembled the
other components for the Integrase assay. A pUC9 plasmid containing the human ci2-
globin gene was midipreped and purified. Approximately 10 pg of plasmid DNA was
methylated with SissI methylase. Unmethylated and methylated plasmids would
provide target DNA in the assay. Donor DNA, destined for integration to the plasmid
DNA was prepared in accordance with Chow, 1997. The oligomers used were H-
U5V2 (5'-ACTGCTAGAGATTTTCCACAT-3') and H-U5V1-2 (5'-
ATGTGGAAAATCTCTAGCA-3'). 100 pmol of H-U5V1-2 was 5' labelled with
32P-y-ATP and annealed to H-U5V2. This dsDNA labelled fragment served as the
Donor DNA. Attempts at the Integrase assay ensued. 5 pmoles of HIV-1 integrase
were incubated with lpg of Target DNA plasmid and 15 nM of Donor dsDNA
oligomers. PCR was carried out on the fragments but it did not produce a smear or
ladder ofDNA products as hoped. Samples of several PCR reactions were run on 12
% PAGE gels, but not products were observed (data not shown). At this point it was
attempted to see if the HIV-1 integrase was capable of integrating the dsDNA
oligomers. 12 % PAGE gels were again run, but directly after the integration
reaction, prior to the PCR step. Again, the plasmid did not appear to show strong
radioactivity as assessed by autoradiography, and there was assumed to be little or no
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Figure 7.6 Removal of Thrombin Protease with a Benzamidine 6B column.
The cleaved HIV-1 integrase protein is applied to the column in solution with
Thrombin Protease. Thrombin binds to the column with strong affinity and HIV-1
integrase is washed through in the flow through, lane 1, and the first fewwashes,
lanes 2-4. Washing the column with a high salt solution removes Thrombin from
the column; lanes 7-9. Both HIV-1 integrase and Thrombin protease have
similar molecular weights and are therefore not readily distinguishable by gel






Figure 7.7 Concentration of HIV-1
integrase. Fractions of HIV-1
integrase that have been purified,
thrombin cleaved and separated from
contaminating thrombin were pooled
and applied to a cation exchange
column, EMD-S03- (Merck) to
concentrate the protein samples.
Samples were loaded in 200 mM salt
and eluted in concentrated form with 2
ml volumes of 1M NaCI containing
Buffer solution.
B







Figure 7.8 HIV-1 integrase
expression. A, Western blot
of an IPTG induced cell
culture (+) and three other
cultures without IPTG
induction (-). 1, cells only. 2,
3, 4, cells with pIN plasmid.
B, Gel used in Western blot,
pre-transfer. HIV-integrase
expression (HIV-IN) with (+)
or without (-) a histidine tag.
C, Western blot of gel image
shown in B, confirming that
the histidine tag has been
removed. The antibody used




Figure 7.9 Construction of a methyl CpG specific nuclease. Verification of some attempts
at analysis of fusion constructs in the pursuit of creating a methyl CpG specific nuclease. A, an 8
% SDS-PAGE gel of fusion constructs expressed in E. coli BL21(DE3)pLysS cells. pET6h,
histidine fusion vector. pGST, GST fusion vector. MBD, methyl binding domain of MeCP2. MN,
Micrococcal nuclease. Fok, Fok\ cleavage domain. Pro and Leu refer to Proline and Leucine
linker / hinge sequences for flexibility in the protein. Numbering, 7,11,12,13,14,16; refers to
plasmid clone number. Western analysis with anti-histidine tag antibody weakly detects clones
in lanes 7 & 8 in figure B, which is numbered to indicate labelling is the same as in A. Anti-GST
antibody detects strongly the fusion protein in lane 6, with perhaps some free GST also. None of
the new constructs show any expression with IPTG induction, nor reaction to antibodies.
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It was thought sensible to sequence the vector to ensure it contained the full-
length HIV-1 integrase sequence and was not producing a different protein product.
1 78R
The HIV-1 integrase protein was expressed from a pET15b vector (called pIN "
here) or pIN1"288/ F185K/C280S (Jenkins et al., 1996) and ligated at an Ndel-BamHl
digested site. The HIV-1 integrase sequence was excised from pET15b by restriction
digests with Xbal and BamHl and ligated into an Xbal and BamHl digested
pBLUESCRIPT II KS (+/-) plasmid. The ligation reaction was transformed into E.
coli XL 1-blue cells, plated on LB plates with Ampicillin to 50 pg/ml and incubated
at 37°C overnight. Single colonies were picked and grown up in 5 ml of LB/Amp.
Minipreps were prepared of the plasmid DNA and the presence of the HIV-1
integrase DNA sequence tested for by restriction digest analysis (data not shown).
The presence of the annealed sequence was verified. The pBS(HIV-l integrase)
plasmid was sent for sequencing. The results showed that the plasmid did indeed
contain the HIV-1 integrase sequence.
Several possibilities could have been pursued with respect to optimising the
Integrase assay. Some of these have been tested. It would have been advantageous to
definitively prove whether the protein activity was low in my purified fractions. It
may also have been the concentration and quality of components in the integration
reaction. There may also have been problems with the PCR detection of integrants.
All of these components would have taken some time to optimise. Unfortunately, it
then appeared that we would not be able to investigate any methylation induced
structural changes with an A-form detecting Ruthenium based probe. Requests for
this chemical were denied. The pursuit of this technique was then questioned and this
project unfortunately abandoned. Later, the existence of Benzonase proved to be a
unique and informative way around the problem, and the pursuit of methylation
induced structural studies was continued.
7.11 Creation ofa CpG methylation specific restriction enzyme.
After leaving the Integrase Assay Project and alongside the Benzonase assay project,
I attempted to create a restriction enzyme with the ability to cleave CpG methylated
DNA specifically. No such restriction enzyme currently exists. This was a project
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started by Dr. R. Meehan and continued in the laboratory by an honours student. The
basic premise was to fuse the methyl-binding domain (MBD) of MeCP2 to the
cleavage domain of Fokl restriction enzyme. Various constructs had already been
made by others, containing either the GST- or HIS-tagged MBD of MeCP2 and/or
the Fokl or Micrococcal (MNase) nuclease domain. It had been found that MBD-
Fokl fusion constructs could not cleave CpG methylated DNA and a linker or hinge
region may be required to enable both domains of the fusion protein to operate
effectively. I was provided with a series of pET6h fusion proteins containing the
MBD of MeCP2 fused to different types of linker region (proline or leucine rich),
followed by the Fokl nuclease domain. These had not all been tested conclusively.
Plasmid constructs were tested for the correct size and orientation of the DNA insert.
Several were then selected for analysis. Western blots were probed with anti-HIS or
anti-GST antibodies. Unfortunately, only the only positive control clones reacted
well with the antibodies. The results of one of these experiments is shown in figure
7.9. Due to the uncertainty of this project it was not pursued any further, but may
provide an interesting side-project for other lab members. I would suggest two other
approaches. (1) To manipulate SlssI methylase, which methylates a single CpG, and
enable it to cleave CpG sites instead. This may be done by targeted mutation of the
methyltransferase part of the enzyme or by targeted deletion coupled with the fusion
of another cleavage domain, perhaps that of Hhal restriction enzyme. (2)
Interestingly, because Benzonase has been shown to have heightened ability to
cleave at methylated DNA to begin with, it would be interesting to both investigate
whether Benzonase is some kind ofmethyl-binding protein and also to perhaps fuse
the already sequence biased cutting domain with the recognition domain of MeCP2
or indeed, one of the other MBDs. No tool yet exists for the cleavage of every CpG
in a sequence. The closest determination of methylated sites in a DNA sequence is
performed by Bisulphite mapping. To this end, the development of a CpG specific
nuclease would be highly advantageous in this field. Unfortunately it was not one I
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